Related Materials - European Society of Cardiology

esc Guidelines 

committee for Practice Guidelines 

to improve the quality of clinical practice and patient care in europe 

additional references 

Joint esc/eacts Guidelines on 

Myocardial revascularisation 

For more information 

www.escardio.org/guidelines

ESC/EACTS Page 1 of 34 

Additional references listed by 

chapter of the full text document 

1. Preamble (no references) 

2. Introduction ...................................................................................... 1 

3. Scores and Risk Stratification, Impact of Comorbidity ....... 2 

4. Process for Decision Making and Patient Information ........ 3 

4.1 Patient information .................................................................. 3 

4.2 Multidisciplinary decision making (Heart Team) ............ 3 

5. Strategies for Pre-Intervention Diagnosis and Imaging ....... 3 

5.1 Detection of coronary artery disease ............................... 4 

5.2 Detection of ischaemia .......................................................... 4 

5.3 Hybrid / combined imaging ................................................... 5 

5.4 Invasive tests.............................................................................. 5 

5.5 Prognostic value ....................................................................... 5 

5.6 Detection of myocardial viability ........................................ 5 

6. Revascularisation for Stable Coronary Artery Disease ...... 5 

6.1 Evidence basis for revascularisation ................................... 5 

6.2 Impact of ischaemic burden on prognosis........................ 6 

6.3 Optimal medical therapy versus PCI ................................ 6 

6.4 PCI with DES versus BMS ..................................................... 6 

6.5 CABG versus medical therapy ............................................ 6 

6.6 PCI versus CABG ................................................................. 6 

6.7 Recommendations ................................................................... 7 

7. Revascularisation in Non ST-segment Elevation ................... 8 

Acute Coronary Syndromes 

7.1 Intended early invasive or conservative strategies ........ 8 

7.2 Risk stratification ..................................................................... 8 

7.3 Timing of angiography and intervention ........................... 9 

7.4 Coronary angiography, PCI and CABG............................. 9 

7.5 Patient subgroups ..................................................................... 9 

8. Myocardial Revascularisation in ST-segment ......................... 10 

Elevation Myocardial Infarction 

8.1 Reperfusion Strategies ........................................................... 10 

8.2 Mechanical complications ...................................................... 12 

9. Special Conditions .......................................................................... 13 

9.1 Diabetes ...................................................................................... 13 

9.1.1 Indications for myocardial ........................................ 13 

revascularisation 

9.1.2 Type of intervention: CABG .................................... 13 

versus PCI 

9.1.3 Specific aspects of PCI ............................................... 13 

9.1.4 Type of CABG intervention ..................................... 13 

9.1.5 Antithrombotic pharmacotherapy ......................... 13 

9.1.6 Antidiabetic medications........................................... 14 

9.2 Myocardial Revascularisation in Patients with ................ 15 

Chronic Kidney Disease 

9.3 Myocardial Revascularisation in Patients .......................... 15 

Requiring Valve Surgery 

9.4 Associated Carotid / Peripheral Arterial Disease ......... 15 

9.4.1 Associated coronary and carotid artery .............. 15 

disease 

9.4.2 Associated coronary and peripheral arterial ...... 16 

disease 

9.5 Myocardial Revascularisation in Chronic Heart ............. 16 

Failure 

9.6 Crossed Revascularisation Procedures ............................. 17 

9.6.1 Revascularisation for acute graft failure ............... 17 

9.6.2 Revascularisation for late graft failure .................. 18 

9.6.3 Revascularisation for acute failure after PCI ...... 18 

9.6.4 Elective revascularisation for late failure ............. 19 

after PCI 

9.6.5 Hybrid procedures ...................................................... 19 

9.7 Arrhythmias in Patients with Ischaemic Heart ............... 20 

Disease 

9.7.1 Atrial fibrillation ........................................................... 20 

9.7.2 Supraventricular arrhythmias other ...................... 21 

than atrial fibrillation or flutter 

9.7.3 Ventricular arrhythmias............................................. 22 

9.7.4 Concomitant revascularisation in heart .............. 23 

failure patients candidates for 

resynchronization therapy 

10. Procedural aspects of CABG ...................................................... 23 

10.1 Preoperative management .................................................. 23 

10.2 Surgical procedures .............................................................. 24 

10.3 Early postoperative risk....................................................... 24 

11. Procedural aspects of PCI ............................................................ 25 

11.1 Impact of clinical presentation ........................................... 25 

11.2 Specific lesion subsets .......................................................... 26 

11.3 Drug-eluting stents ................................................................ 28 

11.4 Adjunctive invasive diagnostic tools ................................. 30 

12. Antithrombotic Pharmacotherapy ............................................ 31 

12.1 Elective PCI ............................................................................. 31 

12.2 Non ST-segment Elevation Acute Coronary ............... 31 

Syndrome 

12.3 ST-segment Elevation Myocardial Infarction ................ 31 

12.4 Points of interest and special conditions ....................... 32 

13. Secondary prevention.................................................................... 32 

13.1 Background and rationale .................................................. 32 

13.2 Modalities ................................................................................ 33 

13.3 Settings...................................................................................... 33 

14. Strategies for follow-up................................................................. 33 

2. Introduction 

Effler db, groves lk, favaloro rg. [surgical treatment of coronary 

arteriosclerosis.]. Prensa Med Argent 1964;Suppl.:SUPPL-5. 

Gruentzig AR, King SB, III, Schlumpf M, Siegenthaler W. Long-term 

follow-up after percutaneous transluminal coronary angioplasty. 

The early Zurich experience. N Engl J Med 1987;316(18):1127- 

1132. 

Sergeant P, Blackstone E, Meyns B, Stockman B, Jashari R. First 

cardiological or cardiosurgical reintervention for ischemic heart 

disease after primary coronary artery bypass grafting. Eur J 

Cardiothorac Surg 1998;14(5):480-487. 

Taggart DP. Thomas B. Ferguson Lecture. Coronary artery 

bypass grafting is still the best treatment for multivessel and 

left main disease, but patients need to know. Ann Thorac Surg 

2006;82(6):1966-1975. 

Wijns W, Kolh P. Appropriate myocardial revascularization: a 

joint viewpoint from an interventional cardiologist and a cardiac 

surgeon. Eur Heart J 2009;30(18):2182-2185.


3. Scores and Risk Stratification, 

Impact of Comorbidity 

Bhatti F, Grayson AD, Grotte G, Fabri BM, Au J, Jones M, 

Bridgewater B. The logistic EuroSCORE in cardiac surgery: how 

well does it predict operative risk? Heart 2006;92(12):1817-1820. 

Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello 

D, Cincotta G, Miano M, Patane M, Tamburino C, Tolaro S, Patane 

L, Calafiore AM, Tamburino C. Usefulness of SYNTAX score 

to select patients with left main coronary artery disease to be 

treated with coronary artery bypass graft. JACC Cardiovasc 

Interv 2009;2(8):731-738. 

Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, 

Tamburino C. Usefulness of the SYNTAX Score for Predicting 

Clinical Outcome After Percutaneous Coronary Intervention of 

Unprotected Left Main Coronary Artery Disease. Circ Cardiovasc 

Interv 2009;2(4):302-308. 

Choong CK, Sergeant P, Nashef SA, Smith JA, Bridgewater B. The 

EuroSCORE risk stratification system in the current era: how 

accurate is it and what should be done if it is inaccurate? Eur J 


De Maria R, Mazzoni M, Parolini M, Gregori D, Bortone F, Arena V, 

Parodi O. Predictive value of EuroSCORE on long term outcome 

in cardiac surgery patients: a single institution study. Heart 

2005;91(6):779-784. 

Gyongyosi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, 

Neunteufl T, Badr-Eslam R, Winkler S, Nyolczas N, Posa A, 

Leisch F, Karnik R, Siostrzonek P, Harb S, Heigert M, Zenker G, 

Benzer W, Bonner G, Kaider A, Glogar D. 2-year results of the 

AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the 

SYNTAX (synergy between percutaneous coronary intervention 

with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 

2009;2(8):718-727. 

Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, 

Higgins RS, Isom OW, Smith CR, Jones RH. Risk stratification of 

in-hospital mortality for coronary artery bypass graft surgery. J 

Am Coll Cardiol 2006;47(3):661-668. 

Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, Kim JJ, Park 

SW, Park SJ. EuroSCORE as a predictor of death and myocardial 

infarction after unprotected left main coronary stenting. Am J 

Cardiol 2006;98(12):1567-1570. 

Kolh PH. Importance of risk stratification models in cardiac surgery. 

27 ed. 2006. p. 768-769. 

Lemesle G, Bonello L, de LA, Steinberg DH, Roy P, Pinto Slottow 

TL, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, 

Kent KM, Lindsay J, Pichard AD, Waksman R. Prognostic value of 

the Syntax score in patients undergoing coronary artery bypass 

grafting for three-vessel coronary artery disease. Catheter 

Cardiovasc Interv 2009;73(5):612-617. 

Nashef SA. Editorial comment: What to do with EuroSCORE in 

2009? Eur J Cardiothorac Surg 2009;36(5):805-806. 

Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Comparison of 

19 pre-operative risk stratification models in open-heart surgery. 

Eur Heart J 2006;27(7):867-874. 

O’Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, 

Maloney CT, Nowicki ER, Levy DG, Tryzelaar JF, Hernandez F, 

. Multivariate prediction of in-hospital mortality associated with 

coronary artery bypass graft surgery. Northern New England 

Cardiovascular Disease Study Group. Circulation 1992;85(6):2110- 

2118. 

Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, 

Holmes DR, Jr., Mack MJ, van den Brand M, Morel MA, van 

Es GA, Kleijne J, Koglin J, Russell ME. The SYNergy between 

percutaneous coronary intervention with TAXus and cardiac 

surgery (SYNTAX) study: design, rationale, and run-in phase. Am 

Heart J 2006;151(6):1194-1204. 

Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/ 

SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for 

Coronary Revascularization: a report by the American College 

of Cardiology Foundation Appropriateness Criteria Task Force, 

Society for Cardiovascular Angiography and Interventions, 

Society of Thoracic Surgeons, American Association for Thoracic 

Surgery, American Heart Association, and the American Society 

of Nuclear Cardiology Endorsed by the American Society of 

Echocardiography, the Heart Failure Society of America, and the 

Society of Cardiovascular Computed Tomography. J Am Coll 

Cardiol 2009;53(6):530-553. 

Romagnoli E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, 

Niccoli G, Leone AM, Porto I, Mazzari MA, Mongiardo R, Rebuzzi 

AG, Schiavoni G, Crea F. EuroSCORE as predictor of in-hospital 

mortality after percutaneous coronary intervention. Heart 

2009;95(1):43-48. 

Roques F, Michel P, Goldstone AR, Nashef SA. The logistic 

EuroSCORE. Eur Heart J 2003;24(9):881-882. 

Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, 

Kappetein AP, Van DN, Mack M, Holmes D, Feldman T, Morice 

MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, 

Morel MA, Mohr FW. Assessment of the SYNTAX score in the 

Syntax study. EuroIntervention 2009;5(1):50-56. 

Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, 

Chen A, Ferguson TB, Jr., Grover FL, Edwards FH. The Society of 

Thoracic Surgeons: 30-day operative mortality and morbidity risk 

models. Ann Thorac Surg 2003;75(6):1856-1864. 

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, 

Dawkins K, van den Brand M, Van DN, Russell ME, Mohr FW, 

Serruys PW. The SYNTAX Score: an angiographic tool grading 

the complexity of coronary artery disease. EuroIntervention 

2005;1(2):219-227. 

Toumpoulis IK, Anagnostopoulos CE, DeRose JJ, Swistel DG. 

European system for cardiac operative risk evaluation predicts 

long-term survival in patients with coronary artery bypass grafting. 

Eur J Cardiothorac Surg 2004;25(1):51-58. 

Toumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose JJ, Jr. 

Does EuroSCORE predict length of stay and specific postoperative 

complications after cardiac surgery? Eur J Cardiothorac Surg 

2005;27(1):128-133. 

Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den 

Brand MJ, Colombo A, Morice MC, Dawkins K, de BB, Kornowski 

R, de SS, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, 

Wittebols K, Stoll HP, Boersma E, Parrinello G. Cyphering the 

complexity of coronary artery disease using the syntax score 

to predict clinical outcome in patients with three-vessel lumen 

obstruction undergoing percutaneous coronary intervention. Am 

J Cardiol 2007;99(8):1072-1081.


4. Process for Decision Making and 

Patient Information 

4.1 Patient information 

Directive 2001/20/EC of the European Parliament and of the 

Council of 4 April 2001 on the approximation of the laws, 

regulations and administrative provisions of the Member States 

relating to the implementation of good clinical practice in the 

conduct of clinical trials on medicinal products for human use. OJ 

L 121:34-44, Directive 2001/20/EC of the European Parliament 

and of the Council of 4 April 2001 on the approximation of the 

laws, regulations and administrative provisions of the Member 

States relating to the implementation of good clinical practice 

in the conduct of clinical trials on medicinal products for human 

use. OJ L 121:34-44, (2009). 

Curzen N, Smith S. Consent in cardiology: there may be trouble 

ahead? Heart 2005;91(7):977-980. 

Larobina ME, Merry CJ, Negri JC, Pick AW. Is informed consent 

in cardiac surgery and percutaneous coronary intervention 

achievable? ANZ J Surg 2007;77(7):530-534. 

McNutt RA. Shared medical decision making: problems, process, 

progress. JAMA 2004;292(20):2516-2518. 

Spring B. Health decision making: lynchpin of evidence-based 

practice. Med Decis Making 2008;28(6):866-874. 

Whittle J, Conigliaro J, Good CB, Kelley ME, Skanderson M. 

Understanding of the benefits of coronary revascularization 

procedures among patients who are offered such procedures. Am 

Heart J 2007;154(4):662-668. 

Woolf SH, Chan EC, Harris R, Sheridan SL, Braddock CH, III, 

Kaplan RM, Krist A, O’Connor AM, Tunis S. Promoting informed 

choice: transforming health care to dispense knowledge for 

decision making. Ann Intern Med 2005;143(4):293-300. 

4.2 Multidisciplinary decision making 

(Heart Team) 

Blankenship JC, Klein LW, Laskey WK, Krone RJ, Dehmer GJ, 

Chambers C, Cowley M. SCAI statement on ad hoc versus the 

separate performance of diagnostic cardiac catheterization 

and coronary intervention. Catheter Cardiovasc Interv 

2004;63(4):444-451. 

Breeman A, Hordijk-Trion M, Lenzen M, Hoeks S, Ottervanger 

JP, Bertrand ME, Sechtem U, Zaliunas R, Legrand V, de Boer MJ, 

Stahle E, Mercado N, Wijns W, Boersma E. Treatment decisions 

in stable coronary artery disease: insights from the Euro Heart 

Survey on Coronary Revascularization. J Thorac Cardiovasc Surg 

2006;132(5):1001-1009. 

Dawson A, Garrard E. In defence of moral imperialism: four equal 

and universal prima facie principles. J Med Ethics 2006;32(4):200- 

204. 

Feldman DN, Minutello RM, Gade CL, Wong SC. Outcomes 

following immediate (ad hoc) versus staged percutaneous 

coronary interventions (report from the 2000 to 2001 New York 

State Angioplasty Registry). Am J Cardiol 2007;99(4):446-449. 

Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs A, 

Sharma S, Katz S, King SB, III. Predictors and outcomes of ad hoc 

versus non-ad hoc percutaneous coronary interventions. JACC 


Krone RJ, Shaw RE, Klein LW, Blankenship JC, Weintraub WS. 

Ad hoc percutaneous coronary interventions in patients with 

stable coronary artery disease--a study of prevalence, safety, 

and variation in use from the American College of Cardiology 

National Cardiovascular Data Registry (ACC-NCDR). Catheter 


Okelo S, Taylor AL, Wright JT, Jr., Gordon N, Mohan G, Lesnefsky 

E. Race and the decision to refer for coronary revascularization: 

the effect of physician awareness of patient ethnicity. J Am Coll 

Cardiol 2001;38(3):698-704. 











Cardiol 2009;53(6):530-553. 

Reyna VF. Theories of medical decision making and health: an 

evidence-based approach. Med Decis Making 2008;28(6):829- 

833. 

5. Strategies for Pre-Intervention 

Diagnosis and Imaging 

Abdulla J, Abildstrom SZ, Gotzsche O, Christensen E, Kober L, 

Torp-Pedersen C. 64-multislice detector computed tomography 

coronary angiography as potential alternative to conventional 

coronary angiography: a systematic review and meta-analysis. Eur 

Heart J 2007;28(24):3042-3050. 

Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates 

G, Freeman M, Nahmias C, Hendry P, Burns RJ, Lamy A, 

Mickleborough L, Kostuk W, Fallen E, Nichol G. Positron emission 

tomography and recovery following revascularization (PARR-1): 

the importance of scar and the development of a prediction rule 

for the degree of recovery of left ventricular function. J Am Coll 

Cardiol 2002;40(10):1735-1743. 

Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, 

Heyndrickx GR, Pijls NH, de BB. Long-term clinical outcome 

after fractional flow reserve-guided percutaneous coronary 

intervention in patients with multivessel disease. J Am Coll Cardiol 

2005;46(3):438-442. 

Di Tanna GL, Berti E, Stivanello E, Cademartiri F, Achenbach S, 

Camerlingo MD, Grilli R. Informative value of clinical research 

on multislice computed tomography in the diagnosis of coronary 

artery disease: A systematic review. Int J Cardiol 2008;130(3):386- 

404. 

Diamond GA, Forrester JS. Analysis of probability as an aid in 

the clinical diagnosis of coronary-artery disease. N Engl J Med 

1979;300(24):1350-1358. 

Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, 

Underwood DA, Simpfendorfer CC. A prospective comparison 

of rubidium-82 PET and thallium-201 SPECT myocardial perfusion 

imaging utilizing a single dipyridamole stress in the diagnosis of 

coronary artery disease. J Nucl Med 1990;31(12):1899-1905. 

Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak 

SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning 

WJ. Coronary magnetic resonance angiography for the detection 

of coronary stenoses. N Engl J Med 2001;345(26):1863-1869. 

Morise AP, Jalisi F. Evaluation of pretest and exercise test scores 

to assess all-cause mortality in unselected patients presenting for 

exercise testing with symptoms of suspected coronary artery 

disease. J Am Coll Cardiol 2003;42(5):842-850. 

Mowatt G, Cook JA, Hillis GS, Walker S, Fraser C, Jia X, Waugh 

N. 64-Slice computed tomography angiography in the diagnosis


and assessment of coronary artery disease: systematic review and 

meta-analysis. Heart 2008;94(11):1386-1393. 

Pepine CJ, Geller NL, Knatterud GL, Bourassa MG, Chaitman BR, 

Davies RF, Day P, Deanfield JE, Goldberg AD, McMahon RP, . The 

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a 

randomized clinical trial, baseline data and implications for a longterm 

outcome trial. J Am Coll Cardiol 1994;24(1):1-10. 

5.1 Detection of coronary artery disease 

Abdulla J, Abildstrom SZ, Gotzsche O, Christensen E, Kober L, 

Torp-Pedersen C. 64-multislice detector computed tomography 

coronary angiography as potential alternative to conventional 

coronary angiography: a systematic review and meta-analysis. Eur 

Heart J 2007;28(24):3042-3050. 

Di Carli MF, Dorbala S, Curillova Z, Kwong RJ, Goldhaber SZ, 

Rybicki FJ, Hachamovitch R. Relationship between CT coronary 

angiography and stress perfusion imaging in patients with suspected 

ischemic heart disease assessed by integrated PET-CT imaging. J 

Nucl Cardiol 2007;14(6):799-809. 

Di Tanna GL, Berti E, Stivanello E, Cademartiri F, Achenbach S, 

Camerlingo MD, Grilli R. Informative value of clinical research 

on multislice computed tomography in the diagnosis of coronary 

artery disease: A systematic review. Int J Cardiol 2008;130(3):386- 

404. 

Jahnke C, Paetsch I, Nehrke K, Schnackenburg B, Gebker R, Fleck 

E, Nagel E. Rapid and complete coronary arterial tree visualization 

with magnetic resonance imaging: feasibility and diagnostic 

performance. Eur Heart J 2005;26(21):2313-2319. 

Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak 

SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning 

WJ. Coronary magnetic resonance angiography for the detection 

of coronary stenoses. N Engl J Med 2001;345(26):1863-1869. 

Mowatt G, Cook JA, Hillis GS, Walker S, Fraser C, Jia X, Waugh 

N. 64-Slice computed tomography angiography in the diagnosis 

and assessment of coronary artery disease: systematic review and 

meta-analysis. Heart 2008;94(11):1386-1393. 

Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, 

Kwong RY, Di Carli MF. Interrelation of coronary calcification, 

myocardial ischemia, and outcomes in patients with intermediate 

likelihood of coronary artery disease: a combined positron 

emission tomography/computed tomography study. Circulation 

2008;117(13):1693-1700. 

Vanhoenacker PK, Heijenbrok-Kal MH, Van HR, Decramer I, 

Van Hoe LR, Wijns W, Hunink MG. Diagnostic performance of 

multidetector CT angiography for assessment of coronary artery 

disease: meta-analysis. Radiology 2007;244:419-428. 

5.2 Detection of ischaemia 

De Lorenzo A, Hachamovitch R, Kang X, Gransar H, Sciammarella 

MG, Hayes SW, Friedman JD, Cohen I, Germano G, Berman DS. 

Prognostic value of myocardial perfusion SPECT versus exercise 

electrocardiography in patients with ST-segment depression on 

resting electrocardiography. J Nucl Cardiol 2005;12(6):655-661. 

De Winter O, Velghe A, Van d, V, De BP, De BM, Van De Wiele C, 

De BG, Gillebert TC, Dierckx RA, De SJ. Incremental prognostic 

value of combined perfusion and function assessment during 

myocardial gated SPECT in patients aged 75 years or older. J Nucl 

Cardiol 2005;12(6):662-670. 

Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise 

echocardiography or exercise SPECT imaging? A meta-analysis of 

diagnostic test performance. JAMA 1998;280(10):913-920. 

Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, 

Underwood DA, Simpfendorfer CC. A prospective comparison 

of rubidium-82 PET and thallium-201 SPECT myocardial perfusion 

imaging utilizing a single dipyridamole stress in the diagnosis of 

coronary artery disease. J Nucl Med 1990;31(12):1899-1905. 

Hanekom L, Cho GY, Leano R, Jeffriess L, Marwick TH. 

Comparison of two-dimensional speckle and tissue Doppler 

strain measurement during dobutamine stress echocardiography: 

an angiographic correlation. Eur Heart J 2007;28(14):1765-1772. 

Jung PH, Rieber J, Stork S, Hoyer C, Erhardt I, Nowotny A, Voelker 

W, Weidemann F, Ertl G, Klauss V, Angermann CE. Effect of 

contrast application on interpretability and diagnostic value of 

dobutamine stress echocardiography in patients with intermediate 

coronary lesions: comparison with myocardial fractional flow 

reserve. Eur Heart J 2008;29(20):2536-2543. 

Madler CF, Payne N, Wilkenshoff U, Cohen A, Derumeaux GA, 

Pierard LA, Engvall J, Brodin LA, Sutherland GR, Fraser AG. Noninvasive 

diagnosis of coronary artery disease by quantitative stress 

echocardiography: optimal diagnostic models using off-line tissue 

Doppler in the MYDISE study. Eur Heart J 2003;24(17):1584- 

1594. 

Malm S, Frigstad S, Torp H, Wiseth R, Skjarpe T. Quantitative 

adenosine real-time myocardial contrast echocardiography for 

detection of angiographically significant coronary artery disease. J 

Am Soc Echocardiogr 2006;19(4):365-372. 

Marwick TH, Case C, Leano R, Short L, Baglin T, Cain P, Garrahy P. 

Use of tissue Doppler imaging to facilitate the prediction of events 

in patients with abnormal left ventricular function by dobutamine 

echocardiography. Am J Cardiol 2004;93(2):142-146. 

Morita K, Inoue T, Okamoto S, Hirata K, Tamaki N. [Clinical value 

of 13N-ammonia PET in assessment of cardiac disease: metaanalysis]. 

Kaku Igaku 2007;44(4):365-372. 

Mowatt G, Brazzelli M, Gemmell H, Hillis GS, Metcalfe M, Vale 

L. Systematic review of the prognostic effectiveness of SPECT 

myocardial perfusion scintigraphy in patients with suspected 

or known coronary artery disease and following myocardial 

infarction. Nucl Med Commun 2005;26(3):217-229. 

Muzik O, Duvernoy C, Beanlands RS, Sawada S, Dayanikli F, Wolfe 

ER, Jr., Schwaiger M. Assessment of diagnostic performance of 

quantitative flow measurements in normal subjects and patients 

with angiographically documented coronary artery disease by 

means of nitrogen-13 ammonia and positron emission tomography. 

J Am Coll Cardiol 1998;31(3):534-540. 

Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy 

P, Carlos RC. Diagnostic performance of positron emission 

tomography in the detection of coronary artery disease: a metaanalysis. 

Acad Radiol 2008;15(4):444-451. 

Pedone C, Schinkel AF, Elhendy A, van Domburg RT, Valkema 

R, Biagini E, Simoons ML, Bax JJ, Poldermans D. Incremental 

prognostic value of dobutamine-atropine stress 99mTctetrofosmin 

myocardial perfusion imaging for predicting outcome 

in diabetic patients with limited exercise capacity. Eur J Nucl Med 

Mol Imaging 2005;32(9):1057-1063. 

Sanfilippo AJ, Abdollah H, Knott TC, Link C, Hopman W. Stress 

echocardiography in the evaluation of women presenting with 

chest pain syndrome: a randomized, prospective comparison with 

electrocardiographic stress testing. Can J Cardiol 2005;21(5):405- 

412. 

Schepis T, Gaemperli O, Koepfli P, Namdar M, Valenta I, Scheffel H, 

Leschka S, Husmann L, Eberli FR, Luscher TF, Alkadhi H, Kaufmann 

PA. Added value of coronary artery calcium score as an adjunct to 

gated SPECT for the evaluation of coronary artery disease in an 

intermediate-risk population. J Nucl Med 2007;48(9):1424-1430. 

Schinkel AF, Elhendy A, Biagini E, van Domburg RT, Valkema R, 

Rizello V, Pedone C, Simoons M, Bax JJ, Poldermans D. Prognostic 

stratification using dobutamine stress 99mTc-tetrofosmin 

myocardial perfusion SPECT in elderly patients unable to perform


exercise testing. J Nucl Med 2005;46(1):12-18. 

Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi 

N, Ahlstrom H, Dill T, Larsson HB, Flamm SD, Marquardt M, 

Johansson L. MR-IMPACT: comparison of perfusion-cardiac 

magnetic resonance with single-photon emission computed 

tomography for the detection of coronary artery disease 

in a multicentre, multivendor, randomized trial. Eur Heart J 

2008;29(4):480-489. 

Senior R, Becher H, Monaghan M, Agati L, Zamorano J, 

Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: 

evidence-based recommendations by European Association of 

Echocardiography. Eur J Echocardiogr 2009;10:194-212. 

Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus 

M, Squicciarini S, al-Aouar ZR, Schork A, Kuhl DE. Comparison 

of rubidium-82 positron emission tomography and thallium-201 

SPECT imaging for detection of coronary artery disease. Am J 

Cardiol 1991;67(16):1303-1310. 

5.3 Hybrid / combined imaging 

van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma 

E, Wijns W, Stolzmann P, Alkadhi H, Valenta I, Stokkel MP, Kroft 

LJ, de RA, Pundziute G, Scholte A, van der Wall EE, Kaufmann PA, 

Bax JJ. Prognostic value of multislice computed tomography and 

gated single-photon emission computed tomography in patients 

with suspected coronary artery disease. J Am Coll Cardiol 

2009;53(7):623-632. 

5.4 Invasive tests 





2005;46(3):438-442. 

Botman CJ, Schonberger J, Koolen S, Penn O, Botman H, Dib 

N, Eeckhout E, Pijls N. Does stenosis severity of native vessels 

influence bypass graft patency? A prospective fractional flow 

reserve-guided study. Ann Thorac Surg 2007;83(6):2093-2097. 

5.5 Prognostic value 

Aldrovandi A, Maffei E, Palumbo A, Seitun S, Martini C, Brambilla 

V, Zuccarelli A, Tarantini G, Weustink AC, Mollet NR, Ruffini L, 

Crisi G, Ardissino D, de Feyter PJ, Krestin GP, Cademartiri F. 

Prognostic value of computed tomography coronary angiography 

in patients with suspected coronary artery disease: a 24-month 

follow-up study. Eur Radiol 2009;19(7):1653-1660. 

Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck 

E, Paetsch I. Prognostic value of cardiac magnetic resonance stress 

tests: adenosine stress perfusion and dobutamine stress wall 

motion imaging. Circulation 2007;115(13):1769-1776. 

Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann 

KE. The prognostic value of normal exercise myocardial perfusion 

imaging and exercise echocardiography: a meta-analysis. J Am Coll 

Cardiol 2007;49(2):227-237. 

Mowatt G, Brazzelli M, Gemmell H, Hillis GS, Metcalfe M, Vale 

L. Systematic review of the prognostic effectiveness of SPECT 

myocardial perfusion scintigraphy in patients with suspected 

or known coronary artery disease and following myocardial 

infarction. Nucl Med Commun 2005;26(3):217-229. 







2009;53(7):623-632. 

5.6 Detection of myocardial viability 

Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates 

G, Freeman M, Nahmias C, Hendry P, Burns RJ, Lamy A, 

Mickleborough L, Kostuk W, Fallen E, Nichol G. Positron emission 

tomography and recovery following revascularization (PARR-1): 

the importance of scar and the development of a prediction rule 

for the degree of recovery of left ventricular function. J Am Coll 

Cardiol 2002;40(10):1735-1743. 

Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola 

SH. Hibernating myocardium: diagnosis and patient outcomes. 

Curr Probl Cardiol 2007;32(7):375-410. 

Underwood SR, Bax JJ, vom DJ, Henein MY, Knuuti J, van Rossum 

AC, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W. 

Imaging techniques for the assessment of myocardial hibernation. 

Report of a Study Group of the European Society of Cardiology. 

Eur Heart J 2004;25(10):815-836. 







2009;53(7):623-632. 

6. Revascularisation for Stable 

Coronary Artery Disease 

6.1 Evidence basis for revascularisation 

Influence of diabetes on 5-year mortality and morbidity in a 

randomized trial comparing CABG and PTCA in patients with 

multivessel disease: the Bypass Angioplasty Revascularization 

Investigation (BARI). Circulation 1997;96(6):1761-1769. 

The final 10-year follow-up results from the BARI randomized trial. 


Bair TL, Muhlestein JB, May HT, Meredith KG, Horne BD, 

Pearson RR, Li Q, Jensen KR, Anderson JL, Lappe DL. Surgical 

revascularization is associated with improved long-term outcomes 

compared with percutaneous stenting in most subgroups of 

patients with multivessel coronary artery disease: results from 

the Intermountain Heart Registry. Circulation 2007;116(11 

Suppl):I226-I231. 

Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, 

Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA. 

Systematic review: the comparative effectiveness of percutaneous 

coronary interventions and coronary artery bypass graft surgery. 

Ann Intern Med 2007;147(10):703-716. 

Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong 

JB. A meta-analysis of randomized controlled trials comparing 

coronary artery bypass graft with percutaneous transluminal 

coronary angioplasty: one- to eight-year outcomes. J Am Coll 

Cardiol 2003;41(8):1293-1304. 

Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R, Hu S. Comparison of 

drug-eluting stents and coronary artery bypass surgery for the 

treatment of multivessel coronary disease: three-year follow-up 

results from a single institution. Circulation 2009;119(15):2040- 

2050. 

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR,


Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van 

DN, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary 

intervention versus coronary-artery bypass grafting for severe 

coronary artery disease. N Engl J Med 2009;360(10):961-972. 

Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, 

Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx 

B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after 

coronary stenting versus bypass surgery for the treatment 

of multivessel disease: the final analysis of the Arterial 

Revascularization Therapies Study (ARTS) randomized trial. J Am 

Coll Cardiol 2005;46(4):575-581. 

Taggart DP. Thomas B. Ferguson Lecture. Coronary artery 

bypass grafting is still the best treatment for multivessel and 

left main disease, but patients need to know. Ann Thorac Surg 

2006;82(6):1966-1975. 

6.2 Impact of ischaemic burden on 

prognosis 

Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 

27th Bethesda Conference: matching the intensity of risk factor 

management with the hazard for coronary disease events. Task 

Force 5. Stratification of patients into high, medium and low risk 

subgroups for purposes of risk factor management. J Am Coll 

Cardiol 1996;27(5):1007-1019. 

Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. 

Prognostic value of dipyridamole technetium-99m sestamibi 

myocardial tomography in patients with stable chest pain who are 

unable to exercise. Am J Cardiol 1994;73(9):647-652. 

6.3 Optimal medical therapy versus PCI 





Ann Intern Med 2007;147(10):703-716. 

Brophy JM, Belisle P, Joseph L. Evidence for use of coronary 

stents. A hierarchical bayesian meta-analysis. Ann Intern Med 

2003;138(10):777-786. 





Cardiol 2003;41(8):1293-1304. 

Wijeysundera HC, Ko DT. Does percutaneous coronary 

intervention reduce mortality in patients with stable chronic 

angina: are we talking about apples and oranges? Circ Cardiovasc 

Qual Outcomes 2009;2(2):123-126. 

6.4 PCI with DES versus BMS 

Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A 

hierarchical Bayesian meta-analysis of randomised clinical trials of 

drug-eluting stents. Lancet 2004;364(9434):583-591. 

Hill R, Bagust A, Bakhai A, Dickson R, Dundar Y, Haycox A, Mujica 

MR, Reaney A, Roberts D, Williamson P, Walley T. Coronary 

artery stents: a rapid systematic review and economic evaluation. 

Health Technol Assess 2004;8(35):iii-242. 

Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, 

Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth 

M, Pfisterer ME, Schomig A. Analysis of 14 trials comparing 

sirolimus-eluting stents with bare-metal stents. N Engl J Med 

2007;356(10):1030-1039. 

6.5 CABG versus medical therapy 

Sixth National Adult Cardiac Surgical Database Report 2008. 

Dendrite Clinical Systems, Henley-on-Thames, Oxfordshire, UK; 

2008. 

6.6 PCI versus CABG 







Suppl):I226-I231. 

Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni 

P, Valgimigli M, Migliorini A, Antoniucci D, Carrie D, Sangiorgi 

G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen 

EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, 

Sheiban I. A collaborative systematic review and meta-analysis 

on 1278 patients undergoing percutaneous drug-eluting stenting 

for unprotected left main coronary artery disease. Am Heart J 

2008;155(2):274-283. 





Ann Intern Med 2007;147(10):703-716. 

Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka 

I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski 

A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal 

J, Martin JL, Tendera M. Acute and late outcomes of unprotected 

left main stenting in comparison with surgical revascularization. J 


Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, 

Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev 

I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka 

R, Serruys PW, Colombo A. Favorable long-term outcome after 

drug-eluting stent implantation in nonbifurcation lesions that 

involve unprotected left main coronary artery: a multicenter 

registry. Circulation 2007;116(2):158-162. 





Cardiol 2003;41(8):1293-1304. 

Kappetein AP, on behalf of the SYNTAX investigators. Optimal 

revascularization strategy in patients with three-vessel disease and/ 

or left main disease.The 2-year Outcomes of the SYNTAX Trial. 

ESC Congress 2009 Sep 21; http://www.escardio.org/congresses/ 

esc-2009/congress-topic/Pages/Interventional-cardiology.aspx. 





2050. 

Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini 

C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros WM, 

Marinelli G, Di BR, Branzi A. Comparison between coronary 

angioplasty and coronary artery bypass surgery for the treatment 

of unprotected left main coronary artery stenosis (the Bologna 

Registry). Am J Cardiol 2006;98(1):54-59. 

Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa 

RA, Lansky AJ, Teirstein PS. Serial angiographic follow-up of 

sirolimus-eluting stents for unprotected left main coronary artery


revascularization. J Am Coll Cardiol 2006;47(4):871-877. 

Serruys P. Two-year outcomes from the SYNTAX trial. 2009 Sep 21; 



Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park 

SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong 

IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stents 

versus coronary-artery bypass grafting for left main coronary 

artery disease. N Engl J Med 2008;358(17):1781-1792. 

Taggart DP, Kaul S, Boden WE, Ferguson TB, Jr., Guyton RA, Mack 

MJ, Sergeant PT, Shemin RJ, Smith PK, Yusuf S. Revascularization 

for unprotected left main stem coronary artery stenosis stenting 

or surgery. J Am Coll Cardiol 2008;51(9):885-892. 

Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia 

HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de JP, 

De FP, Serruys PW. Distal left main coronary disease is a major 

predictor of outcome in patients undergoing percutaneous 

intervention in the drug-eluting stent era: an integrated clinical 

and angiographic analysis based on the Rapamycin-Eluting Stent 

Evaluated At Rotterdam Cardiology Hospital (RESEARCH) 

and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital 

(T-SEARCH) registries. J Am Coll Cardiol 2006;47(8):1530-1537. 

6.7 Recommendations 

Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial 

viability testing and impact of revascularization on prognosis 

in patients with coronary artery disease and left ventricular 

dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7):1151- 

1158. 







Suppl):I226-I231. 

Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni 

P, Valgimigli M, Migliorini A, Antoniucci D, Carrie D, Sangiorgi 

G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen 

EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, 

Sheiban I. A collaborative systematic review and meta-analysis 

on 1278 patients undergoing percutaneous drug-eluting stenting 

for unprotected left main coronary artery disease. Am Heart J 

2008;155(2):274-283. 

Bourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O’connor 

CM. Revascularization in patients with coronary artery disease, 

left ventricular dysfunction, and viability: a meta-analysis. Am 

Heart J 2003;146(4):621-627. 

Buszman P, Szkrobka I, Gruszka A, Parma R, Tendera Z, Lesko B, 

Wilczynski M, Bochenek T, Wojakowski W, Bochenek A, Tendera 

M. Comparison of effectiveness of coronary artery bypass grafting 

versus percutaneous coronary intervention in patients with 

ischemic cardiomyopathy. Am J Cardiol 2007;99(1):36-41. 

Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka 

I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski 

A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal 

J, Martin JL, Tendera M. Acute and late outcomes of unprotected 

left main stenting in comparison with surgical revascularization. J 


Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 

27th Bethesda Conference: matching the intensity of risk factor 

management with the hazard for coronary disease events. Task 

Force 5. Stratification of patients into high, medium and low risk 

subgroups for purposes of risk factor management. J Am Coll 

Cardiol 1996;27(5):1007-1019. 

Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, 

Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev 

I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka 

R, Serruys PW, Colombo A. Favorable long-term outcome after 

drug-eluting stent implantation in nonbifurcation lesions that 

involve unprotected left main coronary artery: a multicenter 

registry. Circulation 2007;116(2):158-162. 

Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER, 

Gimple LW, Ragosta M. Comparison between visual assessment 

and quantitative angiography versus fractional flow reserve for 

native coronary narrowings of moderate severity. Am J Cardiol 

2002;90(3):210-215. 

Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, 

Brooks MM, Carrie D, Clayton TC, Danchin N, Flather M, Hamm 

CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes 

N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, 

Owens DK, Pocock SJ. Coronary artery bypass surgery compared 

with percutaneous coronary interventions for multivessel 

disease: a collaborative analysis of individual patient data from ten 

randomised trials. Lancet 2009;373(9670):1190-1197. 

Kappetein AP, on behalf of the SYNTAX investigators. Optimal 

revascularization strategy in patients with three-vessel disease and/ 

or left main disease.The 2-year Outcomes of the SYNTAX Trial. 



Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, 

Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, 

Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety 

and efficacy of drug-eluting and bare metal stents: comprehensive 

meta-analysis of randomized trials and observational studies. 

Circulation 2009;119(25):3198-3206. 





2050. 

Naik H, White AJ, Chakravarty T, Forrester J, Fontana G, Kar S, 

Shah PK, Weiss RE, Makkar R. A meta-analysis of 3,773 patients 

treated with percutaneous coronary intervention or surgery for 

unprotected left main coronary artery stenosis. JACC Cardiovasc 

Interv 2009;2(8):739-747. 

O’connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman 

MF, Landolfo KP, Lee KL, Califf RM, Jones RH. Comparison of 

coronary artery bypass grafting versus medical therapy on longterm 

outcome in patients with ischemic cardiomyopathy (a 25-year 

experience from the Duke Cardiovascular Disease Databank). Am 

J Cardiol 2002;90(2):101-107. 

Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini 

C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros WM, 

Marinelli G, Di BR, Branzi A. Comparison between coronary 

angioplasty and coronary artery bypass surgery for the treatment 

of unprotected left main coronary artery stenosis (the Bologna 


Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa 

RA, Lansky AJ, Teirstein PS. Serial angiographic follow-up of 

sirolimus-eluting stents for unprotected left main coronary artery 

revascularization. J Am Coll Cardiol 2006;47(4):871-877. 

Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, 

Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo 

J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, 

Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy 

E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D. Percutaneous 

coronary intervention versus coronary bypass graft surgery 

for diabetic patients with unstable angina and risk factors for


adverse outcomes with bypass: outcome of diabetic patients in 

the AWESOME randomized trial and registry. J Am Coll Cardiol 

2002;40(9):1555-1566. 

Serruys P. Two-year outcomes from the SYNTAX trial. 2009 Sep 21; 


esc-2009/congress-topic/Pages/Interventional-cardiology.aspx . 

Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, 

Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx 

B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after 

coronary stenting versus bypass surgery for the treatment 

of multivessel disease: the final analysis of the Arterial 

Revascularization Therapies Study (ARTS) randomized trial. J Am 

Coll Cardiol 2005;46(4):575-581. 

Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. 

Prognostic value of dipyridamole technetium-99m sestamibi 

myocardial tomography in patients with stable chest pain who are 

unable to exercise. Am J Cardiol 1994;73(9):647-652. 

Tarakji KG, Brunken R, McCarthy PM, Al-Chekakie MO, Abdel- 

Latif A, Pothier CE, Blackstone EH, Lauer MS. Myocardial 

viability testing and the effect of early intervention in patients 

with advanced left ventricular systolic dysfunction. Circulation 

2006;113(2):230-237. 

Tsuyuki RT, Shrive FM, Galbraith PD, Knudtson ML, Graham 

MM. Revascularization in patients with heart failure. CMAJ 

2006;175(4):361-365. 

Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia 

HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de JP, 

De FP, Serruys PW. Distal left main coronary disease is a major 

predictor of outcome in patients undergoing percutaneous 

intervention in the drug-eluting stent era: an integrated clinical 

and angiographic analysis based on the Rapamycin-Eluting Stent 

Evaluated At Rotterdam Cardiology Hospital (RESEARCH) 

and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital 

(T-SEARCH) registries. J Am Coll Cardiol 2006;47(8):1530-1537. 

Wijeysundera HC, Ko DT. Does percutaneous coronary 

intervention reduce mortality in patients with stable chronic 

angina: are we talking about apples and oranges? Circ Cardiovasc 

Qual Outcomes 2009;2(2):123-126. 

7. Revascularisation in Non STsegment 

Elevation Acute Coronary 

Syndromes 

de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, 

Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt 

FW. Early invasive versus selectively invasive management for 

acute coronary syndromes. N Engl J Med 2005;353(11):1095- 

1104. 

Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, 

Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ. Interventional 

versus conservative treatment for patients with unstable angina 

or non-ST-elevation myocardial infarction: the British Heart 

Foundation RITA 3 randomised trial. Randomized Intervention 

Trial of unstable Angina. Lancet 2002;360(9335):743-751. 

Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L. 

5-year outcomes in the FRISC-II randomised trial of an invasive 

versus a non-invasive strategy in non-ST-elevation acute coronary 

syndrome: a follow-up study. Lancet 2006;368(9540):998-1004. 

7.1 Intended early invasive or conservative 

strategies 

Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit 

of early invasive therapy in acute coronary syndromes: a metaanalysis 

of contemporary randomized clinical trials. J Am Coll 

Cardiol 2006;48(7):1319-1325. 

Cannon CP. Revascularisation for everyone? Eur Heart J 

2004;25(17):1471-1472. 





1104. 

Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper 

JS, Ohman EM, James S, Topol E, Wallentin L, Simoons ML. Longterm 

results after the glycoprotein IIb/IIIa inhibitor abciximab in 

unstable angina: one-year survival in the GUSTO IV-ACS (Global 

Use of Strategies To Open Occluded Coronary Arteries IV--Acute 

Coronary Syndrome) Trial. Circulation 2003;107(3):437-442. 

7.2 Risk stratification 

Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, 

Lagerqvist B, Lindahl B, Venge P, Wallentin L. The prognostic 

and therapeutic implications of increased troponin T levels and 

ST depression in unstable coronary artery disease: the FRISC 

II invasive troponin T electrocardiogram substudy. Am Heart J 

2002;143(5):760-767. 

Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, 

Lagerqvist B, Lindahl B, Wallentin L. ST depression in ECG at entry 

indicates severe coronary lesions and large benefits of an early 

invasive treatment strategy in unstable coronary artery disease; 

the FRISC II ECG substudy. The Fast Revascularisation during 

InStability in Coronary artery disease. Eur Heart J 2002;23(1):41- 

49. 

Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS. 

Evaluation of risk scores for risk stratification of acute coronary 

syndromes in the Myocardial Infarction National Audit Project 

(MINAP) database. Heart 2009;95(3):221-227. 

Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon 

CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox 

KA. Predictors of hospital mortality in the global registry of acute 

coronary events. Arch Intern Med 2003;163(19):2345-2353. 

James SK, Lindback J, Tilly J, Siegbahn A, Venge P, Armstrong P, Califf 

R, Simoons ML, Wallentin L, Lindahl B. Troponin-T and N-terminal 

pro-B-type natriuretic peptide predict mortality benefit from 

coronary revascularization in acute coronary syndromes: a 

GUSTO-IV substudy. J Am Coll Cardiol 2006;48(6):1146-1154. 

Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, 

Lagerqvist B, Stridsberg M, Venge P, Wallentin L. N-terminal probrain 

natriuretic peptide in relation to inflammation, myocardial 

necrosis, and the effect of an invasive strategy in unstable coronary 

artery disease. J Am Coll Cardiol 2003;42(11):1909-1916. 

Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus 

femoral access for coronary angiography or intervention and the 

impact on major bleeding and ischemic events: a systematic review 

and meta-analysis of randomized trials. Am Heart J 2009;157:132- 

140. 

Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Stahle 

E, Swahn E, Venge P, Siegbahn A, Wallentin L. FRISC score for 

selection of patients for an early invasive treatment strategy in 

unstable coronary artery disease. Heart 2005;91(8):1047-1052. 

Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. 

Mechanisms behind the prognostic value of troponin T in unstable


coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 

2001;38(4):979-986. 

Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, 

Ryden L, Wallentin L. Diabetes mellitus: the major risk factor in 

unstable coronary artery disease even after consideration of the 

extent of coronary artery disease and benefits of revascularization. 


Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, 

Steg G, Eagle KA, Anderson FA, Budaj A, Fox KA. Validity of a 

risk-prediction tool for hospital mortality: the Global Registry of 

Acute Coronary Events. Am Heart J 2009;157:1097-1105. 

Windhausen F, Hirsch A, Sanders GT, Cornel JH, Fischer J, van 

Straalen JP, Tijssen JG, Verheugt FW, de Winter RJ. N-terminal 

pro-brain natriuretic peptide for additional risk stratification in 

patients with non-ST-elevation acute coronary syndrome and an 

elevated troponin T: an Invasive versus Conservative Treatment 

in Unstable coronary Syndromes (ICTUS) substudy. Am Heart J 

2007;153(4):485-492. 

Wollert KC, kempf t, Lagerqvist B, Lindahl B, olofsson s, allhoff 

t, peter t, Siegbahn A, Venge P, Drexler H, Wallentin L. growth 

differentiation factor 15 for risk stratification and selection of an 

invasive treatment strategy in non ST-elevation acute coronary 

syndrome. Circulation 2007;116:1540-1548. 

Yan AT, Jong P, Yan RT, Tan M, Fitchett D, Chow CM, Roe MT, 

Pieper KS, Langer A, Goodman SG. Clinical trial--derived risk 

model may not generalize to real-world patients with acute 

coronary syndrome. Am Heart J 2004;148(6):1020-1027. 

7.3 Timing of angiography and 

intervention 

Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le BH, 

Choussat R, Leclercq F, Silvain J, Duclos F, Aout M, Dubois-Rande 

JL, Barthelemy O, Ducrocq G, Bellemain-Appaix A, Payot L, 

Steg PG, Henry P, Spaulding C, Vicaut E. Immediate vs delayed 

intervention for acute coronary syndromes: a randomized clinical 

trial. JAMA 2009;302(9):947-954. 

Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, 

Bestehorn HP, Schmitt C, Seyfarth M, Dirschinger J, Schomig A. 

Evaluation of prolonged antithrombotic pretreatment («coolingoff» 

strategy) before intervention in patients with unstable 

coronary syndromes: a randomized controlled trial. JAMA 

2003;290(12):1593-1599. 

Riezebos RK, Ronner E, Ter BE, Slagboom T, Smits PC, ten Berg 

JM, Kiemeneij F, Amoroso G, Patterson MS, Suttorp MJ, Tijssen 

JG, Laarman GJ. Immediate versus deferred coronary angioplasty 

in non-ST-segment elevation acute coronary syndromes. Heart 

2009;95(10):807-812. 

Ryan JW, Peterson ED, Chen AY, Roe MT, Ohman EM, Cannon 

CP, Berger PB, Saucedo JF, DeLong ER, Normand SL, Pollack CV, 

Jr., Cohen DJ. Optimal timing of intervention in non-ST-segment 

elevation acute coronary syndromes: insights from the CRUSADE 

(Can Rapid risk stratification of Unstable angina patients Suppress 

ADverse outcomes with Early implementation of the ACC/AHA 

guidelines) Registry. Circulation 2005;112(20):3049-3057. 

Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, 

White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, 

Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman 

SG, Mahaffey KW. Time to coronary angiography and outcomes 

among patients with high-risk non ST-segment elevation acute 

coronary syndromes: results from the SYNERGY trial. Circulation 

2007;116(23):2669-2677. 

7.4 Coronary angiography, PCI and CABG 

Bjessmo S, Ivert T, Flink H, Hammar N. Early and late mortality 

after surgery for unstable angina in relation to Braunwald class. 

Am Heart J 2001;141(1):9-14. 

Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. 

Mechanisms behind the prognostic value of troponin T in unstable 

coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 

2001;38(4):979-986. 

Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, melikian 

n, Vanderheyden M, Heyndrickx G, Wyffels E, Wijns W, de 

BB. Severity of coronary arterial stenosis responsible for acute 

coronary syndromes. Am J Cardiol 2009;103:1183-1188. 

Monteiro P. Impact of early coronary artery bypass graft in 

an unselected acute coronary syndrome patient population. 

Circulation 2006;114(1 Suppl):I467-I472. 

Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener 

SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL. In unstable angina 

or non-ST-segment acute coronary syndrome, should patients 

with multivessel coronary artery disease undergo multivessel or 

culprit-only stenting? J Am Coll Cardiol 2007;49(8):849-854. 

7.5 Patient subgroups 

Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, 

Fernandez-Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin 

L, Wijns W. Guidelines for the diagnosis and treatment of non- 

ST-segment elevation acute coronary syndromes. Eur Heart J 

2007;28(13):1598-1660. 

Bauer T, Koeth O, Junger C, Heer T, Wienbergen H, Gitt A, Zahn 

R, Senges J, Zeymer U. Effect of an invasive strategy on in-hospital 

outcome in elderly patients with non-ST-elevation myocardial 

infarction. Eur Heart J 2007;28(23):2873-2878. 

Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw 

TR, Wheatley DJ, Knight R, Pocock SJ. 5-year outcome of an 

interventional strategy in non-ST-elevation acute coronary 

syndrome: the British Heart Foundation RITA 3 randomised trial. 

Lancet 2005;366(9489):914-920. 

From AM, Rihal CS, Lennon RJ, Holmes DR, Jr., Prasad A. Temporal 

trends and improved outcomes of percutaneous coronary 

revascularization in nonagenarians. JACC Cardiovasc Interv 

2008;1(6):692-698. 

Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Early invasive 

treatment benefits patients with renal dysfunction in unstable 

coronary artery disease. Am Heart J 2006;152(6):1052-1058. 

Lee CH, Tan M, Yan AT, Yan RT, Fitchett D, Grima EA, Langer A, 

Goodman SG. Use of cardiac catheterization for non-ST-segment 

elevation acute coronary syndromes according to initial risk: 

reasons why physicians choose not to refer their patients. Arch 

Intern Med 2008;168(3):291-296. 

Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, 

Stenestrand U, Wallentin L, Jernberg T. Influence of renal function 

on the effects of early revascularization in non-ST-elevation 

myocardial infarction: data from the Swedish Web-System for 

Enhancement and Development of Evidence-Based Care in 

Heart Disease Evaluated According to Recommended Therapies 

(SWEDEHEART). Circulation 2009;120:851-858.


8. Myocardial Revascularisation in 

ST-segment Elevation Myocardial 

Infarction 

8.1 Reperfusion strategies 

A clinical trial comparing primary coronary angioplasty with tissue 

plasminogen activator for acute myocardial infarction. The Global 

Use of Strategies to Open Occluded Coronary Arteries in 

Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy 

Investigators. N Engl J Med 1997;336(23):1621-1628. 

HOTLINE II, TRIANA, elderly AMI patients fare better with 

angioplasty. Eur Heart J 2009;30(21):2543-2544. 

Abbate A, Biondi-Zoccai GG, Appleton DL, Erne P, Schoenenberger 

AW, Lipinski MJ, Agostoni P, Sheiban I, Vetrovec GW. Survival 

and cardiac remodeling benefits in patients undergoing late 

percutaneous coronary intervention of the infarct-related artery: 

evidence from a meta-analysis of randomized controlled trials. J 


Aguirre FV, Varghese JJ, Kelley MP, Lam W, Lucore CL, Gill JB, 

Page L, Turner L, Davis C, Mikell FL. Rural interhospital transfer 

of ST-elevation myocardial infarction patients for percutaneous 

coronary revascularization: the Stat Heart Program. Circulation 

2008;117(9):1145-1152. 

Appleton DL, Abbate A, Biondi-Zoccai GG. Late percutaneous 

coronary intervention for the totally occluded infarct-related 

artery: a meta-analysis of the effects on cardiac function and 

remodeling. Catheter Cardiovasc Interv 2008;71(6):772-781. 

Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic 

treatment in acute myocardial infarction: reappraisal of the golden 

hour. Lancet 1996;348(9030):771-775. 

Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. 

Efficacy and Safety of Immediate Angioplasty Versus Ischemia- 

Guided Management After Thrombolysis in Acute Myocardial 

Infarction in Areas With Very Long Transfer Distances Results of 

the NORDISTEMI (NORwegian study on DIstrict treatment of 

ST-Elevation Myocardial Infarction). 

Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, 

Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, 

Cassagnes J, Dissait F, Touboul P. Primary angioplasty versus 

prehospital fibrinolysis in acute myocardial infarction: a randomised 

study. Lancet 2002;360(9336):825-829. 

Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, 

Roumanis SA, Curtis JP, Nallamothu BK, Magid DJ, McNamara RL, 

Parkosewich J, Loeb JM, Krumholz HM. Strategies for reducing 

the door-to-balloon time in acute myocardial infarction. N Engl J 

Med 2006;355(22):2308-2320. 

Braxton JH, Hammond GL, Letsou GV, Franco KL, Kopf GS, 

Elefteriades JA, Baldwin JC. Optimal timing of coronary artery 

bypass graft surgery after acute myocardial infarction. Circulation 

1995;92(9 Suppl):II66-II68. 

Buszman P, Szkrobka I, Gruszka A, Parma R, Tendera Z, Lesko B, 

Wilczynski M, Bochenek T, Wojakowski W, Bochenek A, Tendera 

M. Comparison of effectiveness of coronary artery bypass grafting 

versus percutaneous coronary intervention in patients with 

ischemic cardiomyopathy. Am J Cardiol 2007;99(1):36-41. 

Corpus RA, House JA, Marso SP, Grantham JA, Huber KC, Jr., Laster 

SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford 

BD. Multivessel percutaneous coronary intervention in patients 

with multivessel disease and acute myocardial infarction. Am 

Heart J 2004;148(3):493-500. 

Cragg DR, Friedman HZ, Bonema JD, Jaiyesimi IA, Ramos RG, 

Timmis GC, O’Neill WW, Schreiber TL. Outcome of patients with 

acute myocardial infarction who are ineligible for thrombolytic 

therapy. Ann Intern Med 1991;115(3):173-177. 

de Boer MJ, Ottervanger JP, van ‘t Hof AW, Hoorntje JC, 

Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients 

with acute myocardial infarction: a randomized comparison of 

primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 

2002;39(11):1723-1728. 

De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time 

delay to treatment and mortality in primary angioplasty for acute 

myocardial infarction: every minute of delay counts. Circulation 

2004;109(10):1223-1225. 

Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena 

E, Dimopoulos K, Manari A, Gaspardone A, Ochala A, Zmudka 

K, Bolognese L, Steg PG, Flather M. Immediate angioplasty versus 

standard therapy with rescue angioplasty after thrombolysis in the 

Combined Abciximab REteplase Stent Study in Acute Myocardial 

Infarction (CARESS-in-AMI): an open, prospective, randomised, 

multicentre trial. Lancet 2008;371(9612):559-568. 

Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela 

P, Stefano DS, Angelo R, Stefania C, Anna F, Carmelo C, Antonio 

C, Monzini N, Bonardi MA. Single vs multivessel treatment 

during primary angioplasty: results of the multicentre randomised 

HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial 

Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 2004;6(3- 

4):128-133. 

Dudek D, Siudak Z, Kuta M, Dziewierz A, Mielecki W, Rakowski 

T, Giszterowicz D, Dubiel JS. Management of myocardial 

infarction with ST-segment elevation in district hospitals without 

catheterisation laboratory--Acute Coronary Syndromes Registry 

of Malopolska 2002-2003. Kardiol Pol 2006;64(10):1053-1060. 

Ellis SG, da Silva ER, Heyndrickx G, Talley JD, Cernigliaro C, Steg 

G, Spaulding C, Nobuyoshi M, Erbel R, Vassanelli C, . Randomized 

comparison of rescue angioplasty with conservative management 

of patients with early failure of thrombolysis for acute anterior 

myocardial infarction. Circulation 1994;90(5):2280-2284. 

Fernandez-Aviles F, Alonso JJ, Pena G, Blanco J, Alonso-Briales J, 

Lopez-Mesa J, Fernandez-Vazquez F, Moreu J, Hernandez RA, 

Castro-Beiras A, Gabriel R, Gibson CM, Sanchez PL. Primary 

angioplasty vs. early routine post-fibrinolysis angioplasty for acute 

myocardial infarction with ST-segment elevation: the GRACIA-2 

non-inferiority, randomized, controlled trial. Eur Heart J 

2007;28(8):949-960. 

Fosbol EL, Thune JJ, Kelbaek H, Andersen HR, Saunamaki K, 

Nielsen TT, Mortensen LS, Kober L. Long-term outcome of 

primary angioplasty compared with fibrinolysis across age groups: 

a Danish Multicenter Randomized Study on Fibrinolytic Therapy 

Versus Acute Coronary Angioplasty in Acute Myocardial Infarction 

(DANAMI-2) substudy. Am Heart J 2008;156(2):391-396. 

Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe 

J, Overlie P, Donohue B, Chelliah N, Timmis GC, . A comparison 

of immediate angioplasty with thrombolytic therapy for acute 

myocardial infarction. The Primary Angioplasty in Myocardial 

Infarction Study Group. N Engl J Med 1993;328(10):673-679. 

Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry 

CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell 

MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT, Wang 

YL, Larson DM. A regional system to provide timely access to 

percutaneous coronary intervention for ST-elevation myocardial 

infarction. Circulation 2007;116(7):721-728. 

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley 

JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel 

TH. Early revascularization in acute myocardial infarction 

complicated by cardiogenic shock. SHOCK Investigators. 

Should We Emergently Revascularize Occluded Coronaries for 

Cardiogenic Shock. N Engl J Med 1999;341(9):625-634.


Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, 

Col J, White HD. Early revascularization and long-term survival in 

cardiogenic shock complicating acute myocardial infarction. JAMA 

2006;295(21):2511-2515. 

Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij 

F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, 

Laarman G. Complete versus culprit vessel percutaneous coronary 

intervention in multivessel disease: a randomized comparison. Am 

Heart J 2004;148(3):467-474. 

Kalarus Z, Lenarczyk R, Kowalczyk J, Kowalski O, Gasior M, Was T, 

Zebik T, Krupa H, Chodor P, Polonski L, Zembala M. Importance 

of complete revascularization in patients with acute myocardial 

infarction treated with percutaneous coronary intervention. Am 

Heart J 2007;153(2):304-312. 

Keeley EC, Boura JA, Grines CL. Comparison of primary and 

facilitated percutaneous coronary interventions for ST-elevation 

myocardial infarction: quantitative review of randomised trials. 

Lancet 2006;367(9510):579-588. 

Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen SD, Van’ 

TH, Weidinger F, Janzon M, Norgaard BL, Soerensen JT, van de 

Wetering H, Thygesen K, Bergsten PA, Digerfeldt C, Potgieter 

A, Tomer N, Fajadet J. How to set up an effective national 

primary angioplasty network: lessons learned from five European 

countries. EuroIntervention 2009;5(3):299, 301-309. 

Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells 

GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O’Brien 

ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M. 

A citywide protocol for primary PCI in ST-segment elevation 

myocardial infarction. N Engl J Med 2008;358(3):231-240. 

Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy 

D, Maloney J, McKibbin T, Quinn B, Beanlands RS, Glover C, 

Marquis JF, O’Brien ER, Williams WL, Higginson LA. Combined 

angioplasty and pharmacological intervention versus thrombolysis 

alone in acute myocardial infarction (CAPITAL AMI study). J Am 

Coll Cardiol 2005;46(3):417-424. 

Lee DC, Oz MC, Weinberg AD, Ting W. Appropriate timing of 

surgical intervention after transmural acute myocardial infarction. 

J Thorac Cardiovasc Surg 2003;125(1):115-119. 

Madsen JK, Grande P, Saunamaki K, Thayssen P, Kassis E, Eriksen U, 

Rasmussen K, Haunso S, Nielsen TT, Haghfelt T, Fritz-Hansen P, 

Hjelms E, Paulsen PK, Alstrup P, Arendrup H, Niebuhr-Jorgensen 

U, Andersen LI. Danish multicenter randomized study of invasive 

versus conservative treatment in patients with inducible ischemia 

after thrombolysis in acute myocardial infarction (DANAMI). 

DANish trial in Acute Myocardial Infarction. Circulation 

1997;96(3):748-755. 

Manari A, Ortolani P, Guastaroba P, Casella G, Vignali L, Varani 

E, Piovaccari G, Guiducci V, Percoco G, Tondi S, Passerini F, 

Santarelli A, Marzocchi A. Clinical impact of an inter-hospital 

transfer strategy in patients with ST-elevation myocardial 

infarction undergoing primary angioplasty: the Emilia-Romagna 

ST-segment elevation acute myocardial infarction network. Eur 

Heart J 2008;29(15):1834-1842. 

Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment 

in primary percutaneous coronary intervention. N Engl J Med 

2007;357(16):1631-1638. 

Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham 

RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Jr., 

Antman EM, Cannon CP, Gibson CM. Hospital delays in reperfusion 

for ST-elevation myocardial infarction: implications when selecting 

a reperfusion strategy. Circulation 2006;114(19):2019-2025. 

Post P, Kuijpers M, Ebels T, Zijlstra F. The relation between volume 

and outcome of coronary interventions; a systematic review and 

meta-analysis. European Heart Journal (2010) 31, 1985–1992; 

doi:10.1093/eurheartj/ehq151. 

Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, 

Krumholz HM. Association of door-to-balloon time and mortality 

in patients admitted to hospital with ST elevation myocardial 

infarction: national cohort study. BMJ 2009;338:b1807. 

Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola 

M, Uslenghi E. Comparison of thrombolytic therapy and primary 

coronary angioplasty with liberal stenting for inferior myocardial 

infarction with precordial ST-segment depression: immediate 

and long-term results of a randomized study. J Am Coll Cardiol 

1998;32(6):1687-1694. 

Saia F, Marrozzini C, Ortolani P, Palmerini T, Guastaroba P, Cortesi 

P, Pavesi PC, Gordini G, Pancaldi LG, Taglieri N, di PG, Branzi 

A, Marzocchi A. Optimisation of therapeutic strategies for STsegment 

elevation acute myocardial infarction: the impact of a 

territorial network on reperfusion therapy and mortality. Heart 

2009;95(5):370-376. 

Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, 

Winter H, Nickenig G, Bohm M. Beneficial effects of immediate 

stenting after thrombolysis in acute myocardial infarction. J Am 

Coll Cardiol 2003;42(4):634-641. 

Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache 

J, Martinoff S, Neumann FJ, Schwaiger M. Coronary stenting 

plus platelet glycoprotein IIb/IIIa blockade compared with tissue 

plasminogen activator in acute myocardial infarction. Stent versus 

Thrombolysis for Occluded Coronary Arteries in Patients with 

Acute Myocardial Infarction Study Investigators. N Engl J Med 

2000;343(6):385-391. 

Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J, Jr., Koch 

KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. A systematic 

review and meta-analysis of intra-aortic balloon pump therapy 

in ST-elevation myocardial infarction: should we change the 

guidelines? Eur Heart J 2009;30(4):459-468. 

Suryapranata H, De Luca G, van ‘t Hof AW, Ottervanger JP, 

Hoorntje JC, Dambrink JH, Gosselink AT, Zijlstra F, de Boer MJ. 

Is routine stenting for acute myocardial infarction superior to 

balloon angioplasty? A randomised comparison in a large cohort 

of unselected patients. Heart 2005;91:641-645. 

Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech 

ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, 

Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA. 

A randomized trial of rescue angioplasty versus a conservative 

approach for failed fibrinolysis in ST-segment elevation myocardial 

infarction: the Middlesbrough Early Revascularization to Limit 

INfarction (MERLIN) trial. J Am Coll Cardiol 2004;44(2):287- 

296. 

Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, 

Niebauer J, Schuler G. Randomized comparison of intra-aortic 

balloon support with a percutaneous left ventricular assist 

device in patients with revascularized acute myocardial infarction 

complicated by cardiogenic shock. Eur Heart J 2005;26(13):1276- 

1283. 

Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, 

Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional 

systems of care to optimize timeliness of reperfusion therapy 

for ST-elevation myocardial infarction: the Mayo Clinic STEMI 

Protocol. Circulation 2007;116(7):729-736. 

Van De Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, 

Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, 

Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian 

A, Camm J, De CR, Dean V, Dickstein K, Filippatos G, Funck- 

Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem 

U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre 

FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, 

Danchin N, Di MC, Dudek D, Gulba D, Halvorsen S, Kaufmann P, 

Kornowski R, Lip GY, Rutten F. Management of acute myocardial


infarction in patients presenting with persistent ST-segment 

elevation: the Task Force on the Management of ST-Segment 

Elevation Acute Myocardial Infarction of the European Society of 

Cardiology. Eur Heart J 2008;29(23):2909-2945. 

Voisine P, Mathieu P, Doyle D, Perron J, Baillot R, Raymond 

G, Metras J, Dagenais F. Influence of time elapsed between 

myocardial infarction and coronary artery bypass grafting surgery 

on operative mortality. Eur J Cardiothorac Surg 2006;29(3):319- 

323. 

Widimsky P, Bilkova D, Penicka M, Novak M, Lanikova M, Porizka 

V, Groch L, Zelizko M, Budesinsky T, Aschermann M. Long-term 

outcomes of patients with acute myocardial infarction presenting 

to hospitals without catheterization laboratory and randomized 

to immediate thrombolysis or interhospital transport for primary 

percutaneous coronary intervention. Five years’ follow-up of the 

PRAGUE-2 Trial. Eur Heart J 2007;28(6):679-684. 

Widimsky P, Wijns W, Fajadet J, de BM, Knot J, Aaberge L, 

Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, 

Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva 

M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, 

Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, de SS, 

Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger 

F, Witkowski A, Zeymer U. Reperfusion therapy for ST elevation 

acute myocardial infarction in Europe: description of the current 

situation in 30 countries. Eur Heart J 2010;31:943-957. 

Wijns W, Kolh P. Experience with revascularisation procedures 

does matter: low volume means worse ouctome. Eur Heart J 

2010;European Heart Journal (2010) 31, 1954–1957; doi:10.1093/ 

eurheartj/ehq172. 

Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, 

McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance 

of the thrombolysis in myocardial infarction risk index in the 

National Registry of Myocardial Infarction-3 and -4: a simple 

index that predicts mortality in ST-segment elevation myocardial 

infarction. J Am Coll Cardiol 2004;44(4):783-789. 

Zijlstra F, Beukema WP, van ‘t Hof AW, Liem A, Reiffers S, Hoorntje 

JC, Suryapranata H, de Boer MJ. Randomized comparison of 

primary coronary angioplasty with thrombolytic therapy in low 

risk patients with acute myocardial infarction. J Am Coll Cardiol 

1997;29(5):908-912. 

Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, 

Ottervanger JP, van ‘t Hof AW, Suryapranata H. Long-term benefit 

of primary angioplasty as compared with thrombolytic therapy for 

acute myocardial infarction. N Engl J Med 1999;341(19):1413-1419. 

8.2 Cardiogenic shock and mechanical 

complications 

Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, 

Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, 

Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert 

JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, 

Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines 

for the management of patients with ST-elevation myocardial 

infarction--executive summary: a report of the American College 

of Cardiology/American Heart Association Task Force on Practice 

Guidelines (Writing Committee to Revise the 1999 Guidelines for 

the Management of Patients With Acute Myocardial Infarction). 

Circulation 2004;110(5):588-636. 

Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo 

MJ, Antman EM. Fatal cardiac rupture among patients treated 

with thrombolytic agents and adjunctive thrombin antagonists: 

observations from the Thrombolysis and Thrombin Inhibition in 

Myocardial Infarction 9 Study. J Am Coll Cardiol 1999;33(2):479- 

487. 

Blanche C, Khan SS, Matloff JM, Chaux A, DeRobertis MA, Czer 

LS, Kass RM, Tsai TP. Results of early repair of ventricular septal 

defect after an acute myocardial infarction. J Thorac Cardiovasc 

Surg 1992;104(4):961-965. 

Burkhoff D, Cohen H, Brunckhorst C, O’Neill WW. A randomized 

multicenter clinical study to evaluate the safety and efficacy of 

the TandemHeart percutaneous ventricular assist device versus 

conventional therapy with intraaortic balloon pumping for 

treatment of cardiogenic shock. Am Heart J 2006;152(3):469-8. 

Chen Q, Darlymple-Hay MJ, Alexiou C, Ohri SK, Haw MP, 

Livesey SA, Monro JL. Mitral valve surgery for acute papillary 

muscle rupture following myocardial infarction. J Heart Valve Dis 

2002;11(1):27-31. 

Chevalier P, Burri H, Fahrat F, Cucherat M, Jegaden O, Obadia JF, 

Kirkorian G, Touboul P. Perioperative outcome and long-term 

survival of surgery for acute post-infarction mitral regurgitation. 


Cox FF, Plokker HW, Morshuis WJ, Kelder JC, Vermeulen FE. 

Importance of coronary revascularization for late survival 

after postinfarction ventricular septal rupture. A reason to 

perform coronary angiography prior to surgery. Eur Heart J 

1996;17(12):1841-1845. 

Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, 

Kleiman NS, Vahanian A, Califf RM, Topol EJ. Risk factors, 

angiographic patterns, and outcomes in patients with ventricular 

septal defect complicating acute myocardial infarction. GUSTO-I 

(Global Utilization of Streptokinase and TPA for Occluded 

Coronary Arteries) Trial Investigators. Circulation 2000;101(1):27- 

32. 

Creswell LL, Moulton MJ, Cox JL, Rosenbloom M. Revascularization 

after acute myocardial infarction. Ann Thorac Surg 1995;60(1):19- 

26. 

Fattouch K, Guccione F, Dioguardi P, Sampognaro R, Corrado 

E, Caruso M, Ruvolo G. Off-pump versus on-pump myocardial 

revascularization in patients with ST-segment elevation 

myocardial infarction: a randomized trial. J Thorac Cardiovasc 

Surg 2009;137(3):650-656. 

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley 

JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel 

TH. Early revascularization in acute myocardial infarction 

complicated by cardiogenic shock. SHOCK Investigators. 

Should We Emergently Revascularize Occluded Coronaries for 

Cardiogenic Shock. N Engl J Med 1999;341(9):625-634. 

Kent DM, Schmid CH, Lau J, Selker HP. Is primary angioplasty for 

some as good as primary angioplasty for all? J Gen Intern Med 

2002;17(12):887-894. 

Labrousse L, Choukroun E, Chevalier JM, Madonna F, Robertie 

F, Merlico F, Coste P, Deville C. Surgery for post infarction 

ventricular septal defect (VSD): risk factors for hospital death and 

long term results. Eur J Cardiothorac Surg 2002;21(4):725-731. 

Loisance DY, Deleuze P, Hillion ML, Cachera JP. Are there indications 

for reconstructive surgery in severe mitral regurgitation after acute 

myocardial infarction? Eur J Cardiothorac Surg 1990;4(7):394- 

397. 

Lopez-Sendon J, Gurfinkel EP, Lopez de SE, Agnelli G, Gore JM, 

Steg PG, Eagle KA, Cantador JR, FitzGerald G, Granger CB. 

Factors related to heart rupture in acute coronary syndromes 

in the Global Registry of Acute Coronary Events. Eur Heart J 

2010;31:1449-1456. 

Patel JJ, Kopisyansky C, Boston B, Kuretu ML, McBride R, Cohen 

M. Prospective evaluation of complications associated with 

percutaneous intraaortic balloon counterpulsation. Am J Cardiol 

1995;76(16):1205-1207. 

Perrotta S, Lentini S. In patients undergoing surgical repair of 

post-infarction ventricular septal defect, does concomitant


revascularization improve prognosis? Interact Cardiovasc Thorac 

Surg 2009;9(5):879-887. 

Puskas JD, Thourani VH, Kilgo P, Cooper W, Vassiliades T, Vega JD, 

Morris C, Chen E, Schmotzer BJ, Guyton RA, Lattouf OM. Offpump 

coronary artery bypass disproportionately benefits highrisk 

patients. Ann Thorac Surg 2009;88(4):1142-1147. 

Rastan AJ, Eckenstein JI, Hentschel B, Funkat AK, Gummert 

JF, Doll N, Walther T, Falk V, Mohr FW. Emergency coronary 

artery bypass graft surgery for acute coronary syndrome: beating 

heart versus conventional cardioplegic cardiac arrest strategies. 

Circulation 2006;114(1 Suppl):I477-I485. 

Skillington PD, Davies RH, Luff AJ, Williams JD, Dawkins KD, 

Conway N, Lamb RK, Shore DF, Monro JL, Ross JK. Surgical 

treatment for infarct-related ventricular septal defects. Improved 

early results combined with analysis of late functional status. J 

Thorac Cardiovasc Surg 1990;99(5):798-808. 

Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger 

M, Schuler G. Immediate primary transcatheter closure of 

postinfarction ventricular septal defects. Eur Heart J 2009;30(1):81- 

88. 

Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular 

assist devices in acute myocardial infarction complicated by 

cardiogenic shock. Eur Heart J 2007;28(17):2057-2063. 

Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen 

HR, Nielsen TT, Kober L, Kelbaek H. Simple risk stratification 

at admission to identify patients with reduced mortality from 

primary angioplasty. Circulation 2005;112(13):2017-2021. 

9. Special Conditions 

9.1 Diabetes 

Seven-year outcome in the Bypass Angioplasty Revascularization 

Investigation (BARI) by treatment and diabetic status. J Am Coll 

Cardiol 2000;35:1122-1129. 

Baseline characteristics of patients with diabetes and 

coronary artery disease enrolled in the Bypass Angioplasty 

Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am 

Heart J 2008;156(3):528-536, 536. 

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: 

epidemiology, pathophysiology, and management. JAMA 

2002;287(19):2570-2581. 

Kornowski R, Lansky AJ. Current perspectives on interventional 

treatment strategies in diabetic patients with coronary artery 

disease. Catheter Cardiovasc Interv 2000;50(2):245-254. 

9.1.1 Indications for myocardial revascularisation 

Baseline characteristics of patients with diabetes and 

coronary artery disease enrolled in the Bypass Angioplasty 

Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am 

Heart J 2008;156(3):528-536, 536. 





1104. 

9.1.2 Type of intervention: CABG versus PCI 

Seven-year outcome in the Bypass Angioplasty Revascularization 

Investigation (BARI) by treatment and diabetic status. J Am Coll 

Cardiol 2000;35(5):1122-1129. 

Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor 

JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky 

MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A 

randomized trial of therapies for type 2 diabetes and coronary 

artery disease. N Engl J Med 2009;360(24):2503-2515. 

9.1.3 Specific aspects of PCI 

Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong 

MK, Rhee KS, Chae JK, Ko JK, Park JH, Lee JH, Choi SW, Jeong 

JO, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Kim HS, Park 

SJ. A randomized comparison of sirolimus- versus paclitaxeleluting 

stent implantation in patients with diabetes mellitus 2-year 

clinical outcomes of the DES-DIABETES trial. J Am Coll Cardiol 

2009;53(9):812-813. 

Maeng M, Jensen LO, Galloe AM, Thayssen P, Christiansen 

EH, Hansen KN, Helqvist S, Botker HE, Lassen JF, Thuesen L. 

Comparison of the sirolimus-eluting versus paclitaxel-eluting 

coronary stent in patients with diabetes mellitus: the diabetes and 

drug-eluting stent (DiabeDES) randomized angiography trial. Am 

J Cardiol 2009;103(3):345-349. 

9.1.4 Type of CABG intervention 

Calafiore AM, Di MM. Bilateral internal mammary artery grafting. 

Expert Rev Cardiovasc Ther 2006;4(3):395-403. 

Salehi OA, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi 

N, Abbasi K, Boroumand MA, Davoodi S, Moshtaghi N. Superficial 

and deep sternal wound infection after more than 9000 coronary 

artery bypass graft (CABG): incidence, risk factors and mortality. 

BMC Infect Dis 2007;7:112. 

Taggart DP, Lees B, Gray A, Altman DG, Flather M, Channon 

K. Protocol for the Arterial Revascularisation Trial (ART). A 

randomised trial to compare survival following bilateral versus 

single internal mammary grafting in coronary revascularisation 

[ISRCTN46552265]. Trials 2006;7:7. 

Toumpoulis IK, Theakos N, Dunning J. Does bilateral internal 

thoracic artery harvest increase the risk of mediastinitis? Interact 

Cardiovasc Thorac Surg 2007;6(6):787-791. 

9.1.5 Antithrombotic pharmacotherapy 

Mehilli J, Kastrati A, Schuhlen H, Dibra A, Dotzer F, von BN, Bollwein 

H, Pache J, Dirschinger J, Berger PP, Schomig A. Randomized 

clinical trial of abciximab in diabetic patients undergoing elective 

percutaneous coronary interventions after treatment with a high 

loading dose of clopidogrel. Circulation 2004;110(24):3627-3635. 

Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan 

MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland 

I, Fox KA. Effects of pretreatment with clopidogrel and 

aspirin followed by long-term therapy in patients undergoing 

percutaneous coronary intervention: the PCI-CURE study. Lancet 

2001;358(9281):527-533. 

Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen 

C, Hamm CW, Moliterno DJ, Califf RM, White HD, Kleiman NS, 

Theroux P, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors reduce 

mortality in diabetic patients with non-ST-segment-elevation 

acute coronary syndromes. Circulation 2001;104(23):2767-2771. 

Stuckey TD, Stone GW, Cox DA, Tcheng JE, Garcia E, Carroll 

J, Guagliumi G, Rutherford BD, Griffin JJ, Turco M, Lansky AJ, 

Mehran R, Fahy M, Brodie BR, Grines CL. Impact of stenting and 

abciximab in patients with diabetes mellitus undergoing primary 

angioplasty in acute myocardial infarction (the CADILLAC trial). 

Am J Cardiol 2005;95(1):1-7. 

Valgimigli M, Campo G, de CN, Meliga E, Vranckx P, Furgieri A, 

Angiolillo DJ, Sabate M, Hamon M, Repetto A, Colangelo S, 

Brugaletta S, Parrinello G, Percoco G, Ferrari R. Intensifying 

platelet inhibition with tirofiban in poor responders to aspirin, 

clopidogrel, or both agents undergoing elective coronary 

intervention: results from the double-blind, prospective,


randomized Tailoring Treatment with Tirofiban in Patients 

Showing Resistance to Aspirin and/or Resistance to Clopidogrel 

study. Circulation 2009;119(25):3215-3222. 

Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt 

FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe 

CH, Antman EM. Greater clinical benefit of more intensive oral 

antiplatelet therapy with prasugrel in patients with diabetes 

mellitus in the trial to assess improvement in therapeutic outcomes 

by optimizing platelet inhibition with prasugrel-Thrombolysis in 

Myocardial Infarction 38. Circulation 2008;118(16):1626-1636. 

9.1.6 Antidiabetic medications 

Danchin N, Charpentier G, Ledru F, Vaur L, Gueret P, Hanania 

G, Blanchard D, Lablanche JM, Genes N, Cambou JP. Role of 

previous treatment with sulfonylureas in diabetic patients with 

acute myocardial infarction: results from a nationwide French 

registry. Diabetes Metab Res Rev 2005;21(2):143-149. 

Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes 

DR, Jr. Sulfonylurea drugs increase early mortality in patients with 

diabetes mellitus after direct angioplasty for acute myocardial 

infarction. J Am Coll Cardiol 1999;33(1):119-124. 

Heupler FA, Jr. Guidelines for performing angiography in patients 

taking metformin. Members of the Laboratory Performance 

Standards Committee of the Society for Cardiac Angiography and 

Interventions. Cathet Cardiovasc Diagn 1998;43(2):121-123. 

Singh S, Furberg CD. Thiazolidinediones and cardiovascular 

outcomes in type 2 diabetes. Heart 2009;95(1):1-3. 

9.2 Myocardial Revascularisation in 

Patients with Chronic Kidney Disease 

K/DOQI clinical practice guidelines for chronic kidney disease: 

evaluation, classification, and stratification. Am J Kidney Dis 

2002;39(2 Suppl 1):S1-266. 

Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, Chu J, Yan J, Zhang R, 

Kwan TW. Clinical outcomes of contrast-induced nephropathy 

in patients undergoing percutaneous coronary intervention: a 

prospective, multicenter, randomized study to analyze the effect 

of hydration and acetylcysteine. Int J Cardiol 2008;126(3):407- 

413. 

Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, 

Sneed JD, Booth DC, Ziada KM. Impact of drug-eluting stents 

on outcomes of patients with end-stage renal disease undergoing 

percutaneous coronary revascularization. J Invasive Cardiol 

2006;18(9):405-408. 

de la Torre-Hernandez JM, Alfonso F, Hernandez F, Elizaga J, 

Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, de Prado 

AP, Hernandez JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman 

M, Diarte JA, Rodriguez-Collado J, Rumoroso JR, Lopez-Minguez 

JR, Mauri J. Drug-eluting stent thrombosis: results from the 

multicenter Spanish registry ESTROFA (Estudio ESpanol sobre 

TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 

2008;51(10):986-990. 

Gang S, Dabhi M, Rajapurkar MM. Ischaemia imaging in type 2 

diabetic kidney transplant candidates--is coronary angiography 

essential? Nephrol Dial Transplant 2007;22(8):2334-2338. 

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic 

kidney disease and the risks of death, cardiovascular events, and 

hospitalization. N Engl J Med 2004;351(13):1296-1305. 

Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock 

D, Iskandrian AE, de Mattos AM, Aqel RA. Predictors of survival 

in patients with end-stage renal disease evaluated for kidney 

transplantation. Am J Cardiol 2007;100(6):1020-1025. 

Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson 

BH, Leon MB, Russell ME, Ellis SG, Stone GW. Impact of moderate 

renal insufficiency on restenosis and adverse clinical events after 

paclitaxel-eluting and bare metal stent implantation: results from 

the TAXUS-IV Trial. Am Heart J 2005;150(6):1163-1170. 

Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. 

Clinical outcomes following percutaneous coronary intervention 

with drug-eluting vs. bare-metal stents in dialysis patients. J 

Invasive Cardiol 2006;18(12):577-583. 

Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, 

Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, 

Weissman NJ, Waksman R. Clinical outcomes after percutaneous 

coronary intervention with drug-eluting stents in dialysis patients. 

J Invasive Cardiol 2006;18(6):273-277. 

Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson 

ML, Ghali WA. Survival after coronary revascularization among 

patients with kidney disease. Circulation 2004;110(14):1890-1895. 

Heupler FA, Jr. Guidelines for performing angiography in patients 

taking metformin. Members of the Laboratory Performance 

Standards Committee of the Society for Cardiac Angiography and 

Interventions. Cathet Cardiovasc Diagn 1998;43(2):121-123. 

Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic 

G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, 

Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. 

Incidence, predictors, and outcome of thrombosis after successful 

implantation of drug-eluting stents. JAMA 2005;293(17):2126- 

2130. 

Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, 

Park SJ. Impact of significant chronic kidney disease on long-term 

clinical outcomes after drug-eluting stent versus bare metal stent 

implantation. Int J Cardiol 2008;125(1):36-40. 

Kolh PH. Renal insufficiency after cardiac surgery: a challenging 

clinical problem. Eur Heart J 2009;43:513-515. 

Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong AT, Saia F, Van 

der Giessen WJ, McFadden EP, Sianos G, Smits PC, De FP, Hofma 

SH, van Domburg RT, Serruys PW. Impact of baseline renal 

function on mortality after percutaneous coronary intervention 

with sirolimus-eluting stents or bare metal stents. Am J Cardiol 

2005;95(2):167-172. 

Lentine KL, Schnitzler MA, Brennan DC, Snyder JJ, Hauptman 

PJ, Abbott KC, Axelrod D, Salvalaggio PR, Kasiske B. Cardiac 

evaluation before kidney transplantation: a practice patterns 

analysis in Medicare-insured dialysis patients. Clin J Am Soc 

Nephrol 2008;3(4):1115-1124. 

Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, 

Kusek JW, Van LF. Using standardized serum creatinine values in the 

modification of diet in renal disease study equation for estimating 

glomerular filtration rate. Ann Intern Med 2006;145(4):247-254. 

Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, 

Banerjee D, Kaski JC, Cubero J, Cruz JM. The reno-protective 

effect of hydration with sodium bicarbonate plus N-acetylcysteine 

in patients undergoing emergency percutaneous coronary 

intervention: the RENO Study. J Am Coll Cardiol 2007;49(12):1283- 

1288. 

Ribichini F, graziani m, gambaro g, pasoli p, pighi m, pesarini g, 

abaterusso c, yabarek t, brunelleschi s, rizzotti p, lupo a, Vassanelli 

C. Early creatinine shifts predict contrast-induced nephropathy 

and persistent renal damage after angiography. Am J Med 

2010;123:755-763. 

Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo 

A, Condorelli G. Contrast agents and renal cell apoptosis. Eur 

Heart J 2008;29(20):2569-2576. 

Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney 

function--measured and estimated glomerular filtration rate. N 

Engl J Med 2006;354(23):2473-2483.


Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, 

Stenestrand U, Wallentin L, Jernberg T. Influence of renal 

function on the effects of early revascularization in non-STelevation 

myocardial infarction: data from the Swedish Web- 

System for Enhancement and Development of Evidence-Based 

Care in Heart Disease Evaluated According to Recommended 

Therapies (SWEDEHEART). Circulation 2009;120(10):851-858. 

Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K. Routine 

coronary angiography in diabetic nephropathy patients before 

transplantation. Am J Transplant 2006;6:2403-2408. 

Witczak BJ, Jenssen T, Endresen K, Roislien J, Hartmann A. Risk 

factors for mortality in diabetic nephropathy patients accepted 

for transplantation. Transplantation 2007;84(3):356-361. 


Patients Requiring Valve Surgery 

Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper 

GS, Cohn LH. Effectiveness of same day percutaneous coronary 

intervention followed by minimally invasive aortic valve 

replacement for aortic stenosis and moderate coronary disease 

(«hybrid approach»). Am J Cardiol 2006;98(11):1501-1503. 

Brown JM, O’Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. 

Isolated aortic valve replacement in North America comprising 

108,687 patients in 10 years: changes in risks, valve types, and 

outcomes in the Society of Thoracic Surgeons National Database. 


Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn 

LH. Staged initial percutaneous coronary intervention followed 

by valve surgery («hybrid approach») for patients with complex 

coronary and valve disease. J Am Coll Cardiol 2005;45(1):14-18. 

Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong 

SC, Minutello RM. Comparison of outcomes of percutaneous 

coronary interventions in patients of three age groups (80 years) (from the New York State Angioplasty 


Greelish JP, Ahmad RM, Balaguer JM, Petracek M, Byrne JG. 

Reoperative Valve Surgery. In: Cohn LH, ed. Cardiac Surgery in 

the Adult. Third Edition ed. New York, McGraw-Hill; 2008. p. 

1164-1170. 

Grossi EA, Galloway AC, LaPietra A, Ribakove GH, Ursomanno 

P, Delianides J, Culliford AT, Bizekis C, Esposito RA, Baumann 

FG, Kanchuger MS, Colvin SB. Minimally invasive mitral valve 

surgery: a 6-year experience with 714 patients. Ann Thorac Surg 

2002;74(3):660-663. 

Hannan EL, Samadashvili Z, Lahey SJ, Smith CR, Culliford AT, Higgins 

RS, Gold JP, Jones RH. Aortic valve replacement for patients with 

severe aortic stenosis: risk factors and their impact on 30-month 

mortality. Ann Thorac Surg 2009;87(6):1741-1749. 

Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, 

Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma 

E, Ravaud P, Vahanian A. A prospective survey of patients with 

valvular heart disease in Europe: The Euro Heart Survey on 

Valvular Heart Disease. Eur Heart J 2003;24(13):1231-1243. 

Khaladj N, Shrestha M, Peterss S, Kutschka I, Strueber M, Hoy L, 

Haverich A, Hagl C. Isolated surgical aortic valve replacement 

after previous coronary artery bypass grafting with patent grafts: 

is this old-fashioned technique obsolete? Eur J Cardiothorac Surg 

2009;35:260-264. 

LaPar DJ, Yang Z, Stukenborg GJ, Peeler BB, Kern JA, Kron IL, 

Ailawadi G. Outcomes of reoperative aortic valve replacement 

after previous sternotomy. J Thorac Cardiovasc Surg 2010;139:263- 

272. 

Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David 

TE. Redo valvular surgery in elderly patients. Ann Thorac Surg 

2009;87(2):521-525. 

Rumsfeld JS. Valve surgery in the elderly: question of quality (of life)? 


Soltesz EG, Cohn LH. Minimally invasive valve surgery. Cardiol Rev 

2007;15(3):109-115. 

Tabata M, Umakanthan R, Cohn LH, Bolman RM, III, Shekar PS, 

Chen FY, Couper GS, Aranki SF. Early and late outcomes of 1000 

minimally invasive aortic valve operations. Eur J Cardiothorac 

Surg 2008;33(4):537-541. 

Vahanian A, Alfieri O, Al-Attar N, antunes m, Bax J, cormier b, 

cribier a, de Jaegere PP, fournial g, Kappetein AP, Kovac J, ludgate 

s, maisano f, moat n, Mohr FW, Nataf P, Pierard L, Pomar J, Schofer 

J, Tornos P, Tuzcu EM, van hout b, von segesser l, Walther T. 

Transcatheter valve implantation for patients with aortic stenosis: 

a position statement from EACTS and ESC, in collaboration with 

EAPCI. Eur Heart J 2008;29:1463-1470. 

Vahanian A, Alfieri O, Al-Attar N, antunes m, Bax J, cormier b, 

cribier a, de Jaegere PP, fournial g, Kappetein AP, Kovac J, ludgate 

s, maisano f, moat n, Mohr FW, Nataf P, Pierard L, Pomar J, Schofer 

JJ, Tornos P, Tuzcu EM, van hout b, von segesser l, Walther T. 

Transcatheter valve implantation for patients with aortic stenosis: 

a position statement from EACTS and ESC, in collaboration with 

EAPCI. Eur J Cardiothorac Surg 2008;34:1-8. 

9.4 Associated Carotid / Peripheral 

Arterial Disease 

9.4.1 Associated coronary and carotid artery disease 

Abbott AL. Medical (nonsurgical) intervention alone is now best 

for prevention of stroke associated with asymptomatic severe 

carotid stenosis: results of a systematic review and analysis. Stroke 

2009;40:e573-e583. 

Aboyans V, Lacroix P. Indications for carotid screening in patients 

with coronary artery disease. Presse Med 2009;38(6):977-986. 

Baiou D, Karageorge A, Spyt T, Naylor AR. Patients undergoing 

cardiac surgery with asymptomatic unilateral carotid stenoses 

have a low risk of peri-operative stroke. Eur J Vasc Endovasc Surg 

2009;38(5):556-559. 

Berens ES, Kouchoukos NT, Murphy SF, Wareing TH. Preoperative 

carotid artery screening in elderly patients undergoing cardiac 

surgery. J Vasc Surg 1992;15:313-321. 

D’Agostino RS, Svensson LG, Neumann DJ, Balkhy HH, Williamson 

WA, Shahian DM. Screening carotid ultrasonography and risk 

factors for stroke in coronary artery surgery patients. Ann Thorac 

Surg 1996;62(6):1714-1723. 

Derdeyn CP. Carotid stenting for asymptomatic carotid stenosis: 

trial it. Stroke 2007;38(2 Suppl):715-720. 

Durand DJ, Perler BA, Roseborough GS, Grega MA, Borowicz 

LM, Jr., Baumgartner WA, Yuh DD. Mandatory versus selective 

preoperative carotid screening: a retrospective analysis. Ann 

Thorac Surg 2004;78(1):159-166. 

Faggioli GL, Curl GR, Ricotta JJ. The role of carotid screening 

before coronary artery bypass. J Vasc Surg 1990;12:724-729. 

Goessens BM, Visseren FL, Kappelle LJ, Algra A, van der Graaf Y. 

Asymptomatic carotid artery stenosis and the risk of new vascular 

events in patients with manifest arterial disease: the SMART study. 

Stroke 2007;38(5):1470-1475. 

Gurm HS, Nallamothu BK, Yadav J. Safety of carotid artery stenting 

for symptomatic carotid artery disease: a meta-analysis. Eur Heart 

J 2008;29(1):113-119. 

Gurm HS, Yadav J, fayad p, katzen bt, Mishkel GJ, bajwa tk, ansel g, 

strickman ne, Wang H, Cohen SA, Massaro J, Cutlip D, SAPPHIRE 

Investigators. Long-term results of carotid stenting versus


endarterectomy in high-risk patients. N Engl J Med 2008;358:1572- 

1579. 

Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas 

D. Prevention of disabling and fatal strokes by successful carotid 

endarterectomy in patients without recent neurological symptoms: 

randomised controlled trial. Lancet 2004;363:1491-1502. 

Hogue CW, Jr., Murphy SF, Schechtman KB, Davila-Roman VG. 

Risk factors for early or delayed stroke after cardiac surgery. 

Circulation 1999;100(6):642-647. 

Illuminati G, Ricco JB, Greco C, Mangieri E, Calio’ F, Ceccanei G, 

Pacile MA, Schiariti M, Tanzilli G, Barilla F, Paravati V, Mazzesi 

G, Miraldi F, Tritapepe L. Systematic preoperative coronary 

angiography and stenting improves postoperative results of 

carotid endarterectomy in patients with asymptomatic coronary 

artery disease: a randomised controlled trial. Eur J Vasc Endovasc 

Surg 2010;39(2):139-145. 

Kolh PH, comte l, tchana-sato v, honore c, kerzmann a, mauer m, 

limet r. Concurrent coronary and carotid artery surgery: factors 

influencing perioperative outcome and long-term results. Eur 

Heart J 2006;27:49-56. 

Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. 

Circulation 2006;114(1):63-75. 

Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of 

ipsilateral stroke in patients with asymptomatic carotid stenosis 

on best medical treatment: a prospective, population-based study. 

Stroke 2010;41:e11-e17. 

McKhann GM, Grega MA, Borowicz LM, Jr., Baumgartner WA, 

Selnes OA. Stroke and encephalopathy after cardiac surgery: an 

update. Stroke 2006;37(2):562-571. 

Murad MH, Flynn DN, Elamin MB, Guyatt GH, Hobson RW, Erwin 

PJ, Montori VM. Endarterectomy vs stenting for carotid artery 

stenosis: a systematic review and meta-analysis. J Vasc Surg 

2008;48(2):487-493. 

Naylor AR, Mehta Z, Rothwell PM. A systematic review and 

meta-analysis of 30-day outcomes following staged carotid 

artery stenting and coronary bypass. Eur J Vasc Endovasc Surg 

2009;37(4):379-387. 

Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease 

and stroke during coronary artery bypass: a critical review of the 

literature. Eur J Vasc Endovasc Surg 2002;23(4):283-294. 

Roffi M, Mukherjee D, Clair DG. Carotid artery stenting vs. 

endarterectomy. Eur Heart J 2009;30(22):2693-2704. 

Rosenfield K, Babb JD, Cates CU, Cowley MJ, Feldman T, Gallagher A, 

Gray W, Green R, Jaff MR, Kent KC, Ouriel K, Roubin GS, Weiner 

BH, White CJ. Clinical competence statement on carotid stenting: 

training and credentialing for carotid stenting--multispecialty 

consensus recommendations: a report of the SCAI/SVMB/SVS 

Writing Committee to develop a clinical competence statement 

on carotid interventions. J Am Coll Cardiol 2005;45(1):165-174. 

Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg 

MR, Warlow CP, Barnett HJ. Analysis of pooled data from the 

randomised controlled trials of endarterectomy for symptomatic 

carotid stenosis. Lancet 2003;361(9352):107-116. 

Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. 

Endarterectomy for symptomatic carotid stenosis in relation to 

clinical subgroups and timing of surgery. Lancet 2004;363(9413):915- 

924. 

Selim M. Perioperative stroke. N Engl J Med 2007;356(7):706-713. 

Sharony R, Bizekis CS, Kanchuger M, Galloway AC, Saunders PC, 

Applebaum R, Schwartz CF, Ribakove GH, Culliford AT, Baumann 

FG, Kronzon I, Colvin SB, Grossi EA. Off-pump coronary artery 

bypass grafting reduces mortality and stroke in patients with 

atheromatous aortas: a case control study. Circulation 2003;108 

Suppl 1:II15-II20. 

Stamou SC, Hill PC, Dangas G, Pfister AJ, Boyce SW, Dullum MK, 

Bafi AS, Corso PJ. Stroke after coronary artery bypass: incidence, 

predictors, and clinical outcome. Stroke 2001;32(7):1508-1513. 

Versaci F, Reimers B, Del GC, Schofer J, Giacomin A, Sacca S, 

Gandini R, Albiero R, Pellegrino A, Bertoldo F, Simonetti G, 

Chiariello L. Simultaneous hybrid revascularization by carotid 

stenting and coronary artery bypass grafting: the SHARP study. 

JACC Cardiovasc Interv 2009;2(5):393-401. 

Wong SC, Minutello R, Hong MK. Neurological complications 

following percutaneous coronary interventions (a report from the 

2000-2001 New York State Angioplasty Registry). Am J Cardiol 

2005;96(9):1248-1250. 

Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, 

bajwa tk, Whitlow P, strickman ne, Jaff MR, Popma JJ, Snead DB, 

Cutlip DE, Firth BG, Ouriel K. Protected carotid-artery stenting 

versus endarterectomy in high-risk patients. N Engl J Med 

2004;351(15):1493-1501. 

9.4.2 Associated coronary and peripheral arterial disease 

Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, Chew P, 

Gilbert SJ, Lau J. Effectiveness of management strategies for 

renal artery stenosis: a systematic review. Ann Intern Med 

2006;145(12):901-912. 

De Bruyne B, Manoharan G, Pijls NH, verhamme k, madaric j, 

Bartunek J, Vanderheyden M, Heyndrickx G. Assessment of renal 

artery stenosis severity by pressure gradient measurements. J Am 

Coll Cardiol 2006;48:1851-1855. 

de Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, 

Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of 

renal artery stenosis severity by pressure gradient measurements. 


O’Rourke DJ, Quinton HB, Piper W, Hernandez F, Morton J, 

Hettleman B, Hearne M, Nugent W, O’Connor GT, Malenka 

DJ. Survival in patients with peripheral vascular disease after 

percutaneous coronary intervention and coronary artery bypass 

graft surgery. Ann Thorac Surg 2004;78(2):466-470. 

Schouten O, van Kuijk JP, Flu WJ, Winkel TA, Welten GM, Boersma 

E, Verhagen HJ, Bax JJ, Poldermans D. Long-term outcome of 

prophylactic coronary revascularization in cardiac high-risk 

patients undergoing major vascular surgery (from the randomized 

DECREASE-V Pilot Study). Am J Cardiol 2009;103:897-901. 

Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, 

Brooks MM, Grogan M, Sopko G, Keller N, Jandova R. Long-term 

prognostic value of clinically evident noncoronary vascular disease 

in patients undergoing coronary revascularization in the Bypass 

Angioplasty Revascularization Investigation (BARI). Am J Cardiol 

1998;81(4):375-381. 


Chronic Heart Failure 

Athanasuleas CL, Buckberg GD, Stanley AW, Siler W, Dor V, Di 

DM, Menicanti L, Almeida De OS, Beyersdorf F, Kron IL, Suma 

H, Kouchoukos NT, Moore W, McCarthy PM, Oz MC, Fontan 

F, Scott ML, Accola KA. Surgical ventricular restoration in the 

treatment of congestive heart failure due to post-infarction 

ventricular dilation. J Am Coll Cardiol 2004;44(7):1439-1445. 

Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. 

Management of heart failure. III. The role of revascularization in 

the treatment of patients with moderate or severe left ventricular 

systolic dysfunction. JAMA 1994;272(19):1528-1534. 

Bax JJ, Schinkel AF, Boersma E, Elhendy A, Rizzello V, Maat A, 

Roelandt JR, van der Wall EE, Poldermans D. Extensive left 

ventricular remodeling does not allow viable myocardium to 

improve in left ventricular ejection fraction after revascularization


and is associated with worse long-term prognosis. Circulation 

2004;110(11 Suppl 1):II18-II22. 

Bax JJ, van der Wall EE, Harbinson M. Radionuclide techniques 

for the assessment of myocardial viability and hibernation. Heart 

2004;90 Suppl 5:v26-v33. 

Bourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O’connor 

CM. Revascularization in patients with coronary artery disease, 

left ventricular dysfunction, and viability: a meta-analysis. Am 

Heart J 2003;146(4):621-627. 

Di Donato m, Sabatier M, Dor V, Toso A, Maioli M, fantini f. Akinetic 

versus dyskinetic postinfarction scar: relation to surgical outcome 

in patients undergoing endovascular circular patch plasty repair. J 

Am Coll Cardiol 1997;29(1569):1575. 

Di Donato M, Sabatier M, Dor V, Toso A, Maioli M, Fantini F. 

Akinetic versus dyskinetic postinfarction scar: relation to surgical 

outcome in patients undergoing endoventricular circular patch 

plasty repair. J Am Coll Cardiol 1997;29(7):1569-1575. 

Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia MF, White J. 

Revascularization in severe left ventricular dysfunction: outcome 

comparison of drug-eluting stent implantation versus coronary 

artery by-pass grafting. Catheter Cardiovasc Interv 2007;70(1):26- 

33. 

Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J, 

Stipal R. Prognostic value of the amount of dysfunctional but 

viable myocardium in revascularized patients with coronary 

artery disease and left ventricular dysfunction. Investigators of 

this Multicenter Study. J Am Coll Cardiol 1998;32(4):912-920. 

Menicanti L, Castelvecchio S, Ranucci M, Frigiola A, Santambrogio 

C, de VC, Brankovic J, Di DM. Surgical therapy for ischemic heart 

failure: single-center experience with surgical anterior ventricular 

restoration. J Thorac Cardiovasc Surg 2007;134(2):433-441. 

Ribeiro GA, da Costa CE, Lopes MM, Albuquerque AN, Antoniali 

F, Reinert GA, Franchini KG. Left ventricular reconstruction 

benefits patients with ischemic cardiomyopathy and non-viable 

myocardium. Eur J Cardiothorac Surg 2006;29(2):196-201. 

Schinkel AF, Poldermans D, Rizzello V, Vanoverschelde JL, Elhendy 

A, Boersma E, Roelandt JR, Bax JJ. Why do patients with ischemic 

cardiomyopathy and a substantial amount of viable myocardium 

not always recover in function after revascularization? J Thorac 

Cardiovasc Surg 2004;127(2):385-390. 

Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, 

Mensah GA, Narula J, Shor ES, Young JB, Hong Y. Prevention 

of heart failure: a scientific statement from the American 

Heart Association Councils on Epidemiology and Prevention, 

Clinical Cardiology, Cardiovascular Nursing, and High Blood 

Pressure Research; Quality of Care and Outcomes Research 

Interdisciplinary Working Group; and Functional Genomics and 

Translational Biology Interdisciplinary Working Group. Circulation 

2008;117(19):2544-2565. 

Tsuyuki RT, Shrive FM, Galbraith PD, Knudtson ML, Graham 

MM. Revascularization in patients with heart failure. CMAJ 

2006;175(4):361-365. 

9.6 Crossed Revascularisation Procedures 

9.6.1 Revascularisation for acute graft failure 

Adams MR, Orford JL, Blake GJ, Wainstein MV, Byrne JG, Selwyn 

AP. Rescue percutaneous coronary intervention following 

coronary artery bypass graft--a descriptive analysis of the changing 

interface between interventional cardiologist and cardiac surgeon. 

Clin Cardiol 2002;25(6):280-286. 

Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson 

TB, Jr., Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, 

Califf RM, Kouchoukos NT. Efficacy and safety of edifoligide, an 

E2F transcription factor decoy, for prevention of vein graft failure 

following coronary artery bypass graft surgery: PREVENT IV: a 

randomized controlled trial. JAMA 2005;294(19):2446-2454. 

Balacumaraswami L, Taggart DP. Intraoperative imaging techniques 

to assess coronary artery bypass graft patency. Ann Thorac Surg 

2007;83(6):2251-2257. 

Campbell PG, Teo KS, Worthley SG, Kearney MT, Tarique A, 

Natarajan A, Zaman AG. Non-invasive assessment of saphenous 

vein graft patency in asymptomatic patients. Br J Radiol 

2009;82(976):291-295. 

Dunning J, Fabbri A, Kolh PH, Levine A, Lockowandt U, Mackay 

J, Pavie AJ, Strang T, Versteegh MI, Nashef SA. Guideline for 

resuscitation in cardiac arrest after cardiac surgery. Eur J 


Fabricius AM, Gerber W, Hanke M, Garbade J, Autschbach R, 

Mohr FW. Early angiographic control of perioperative ischemia 

after coronary artery bypass grafting. Eur J Cardiothorac Surg 

2001;19(6):853-858. 

Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure 

R, Moliterno D. Thrombus predicts ischemic complications during 

percutaneous coronary intervention in saphenous vein grafts: 

results from TARGET (do Tirofiban and ReoPro give similar 

efficacy trial?). Catheter Cardiovasc Interv 2007;69(5):623-629. 

Nathoe HM, van DD, Jansen EW, Suyker WJ, Diephuis JC, van 

Boven WJ, de la Riviere AB, Borst C, Kalkman CJ, Grobbee DE, 

Buskens E, de Jaegere PP. A comparison of on-pump and offpump 

coronary bypass surgery in low-risk patients. N Engl J Med 

2003;348(5):394-402. 

Reifart N, Storger H, Schwarz F, Besser R, Iversen S. [From surgical 

to interventional standby?]. Z Kardiol 1998;87 Suppl 3:8-11. 

Sabik JF, III, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove DM. 

Comparison of saphenous vein and internal thoracic artery graft 

patency by coronary system. Ann Thorac Surg 2005;79(2):544- 

551. 

Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to 

coronary conduits over 15 years. Ann Thorac Surg 2004;77(1):93- 

101. 

Thielmann M, Massoudy P, Jaeger BR, Neuhauser M, Marggraf G, 

Sack S, Erbel R, Jakob H. Emergency re-revascularization with 

percutaneous coronary intervention, reoperation, or conservative 

treatment in patients with acute perioperative graft failure 

following coronary artery bypass surgery. Eur J Cardiothorac Surg 

2006;30(1):117-125. 

Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, 

Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, 

Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, 

Bonow R, van der Wall EE, Bassand JP, Wijns W, Ferguson TB, 

Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, 

Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson 

PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, 

Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, 

Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, 

De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano 

C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber 

S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, 

Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl 

S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar 

N. Universal definition of myocardial infarction. Circulation 

2007;116:2634-2653. 

Vouhe P, Grondin CM. Reoperation for coronary graft failure: 

clinical and angiographic results in 43 patients. Ann Thorac Surg 

1979;27(4):328-334.


9.6.2 Revascularisation for late graft failure 

Berger PB, Bell MR, Grill DE, Simari R, Reeder G, Holmes DR, Jr. 

Influence of procedural success on immediate and long-term clinical 

outcome of patients undergoing percutaneous revascularization 

of occluded coronary artery bypass vein grafts. J Am Coll Cardiol 

1996;28(7):1732-1737. 

Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich 

P, Jr., Wacholder S, Sniderman A. The relation of risk factors to 

the development of atherosclerosis in saphenous-vein bypass 

grafts and the progression of disease in the native circulation. A 

study 10 years after aortocoronary bypass surgery. N Engl J Med 

1984;311(21):1329-1332. 

Canos DA, Mintz GS, Berzingi CO, Apple S, Kotani J, Pichard AD, 

Satler LF, Suddath WO, Waksman R, Lindsay J, Jr., Weissman NJ. 

Clinical, angiographic, and intravascular ultrasound characteristics 

of early saphenous vein graft failure. J Am Coll Cardiol 

2004;44(1):53-56. 

Chen L, Theroux P, Lesperance J, Shabani F, Thibault B, De GP. 

Angiographic features of vein grafts versus ungrafted coronary 

arteries in patients with unstable angina and previous bypass 

surgery. J Am Coll Cardiol 1996;28(6):1493-1499. 

Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek 

D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers 

B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. 

European perspective in the recanalisation of Chronic Total 

Occlusions (CTO): consensus document from the EuroCTO 

Club. EuroIntervention 2007;3(1):30-43. 

Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton 

JR. Coronary bypass graft fate and patient outcome: angiographic 

follow-up of 5,065 grafts related to survival and reoperation in 

1,388 patients during 25 years. J Am Coll Cardiol 1996;28(3):616- 

626. 

Frimerman A, Rechavia E, Eigler N, Payton MR, Makkar R, Litvack F. 

Long-term follow-up of a high risk cohort after stent implantation 

in saphenous vein grafts. J Am Coll Cardiol 1997;30(5):1277-1283. 

Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave 

J, Montorfano M, Michev I, Airoldi F, Carlino M, Corvaja N, 

Colombo A. Treatment of saphenous vein graft lesions with 

drug-eluting stents: immediate and midterm outcome. J Am Coll 

Cardiol 2005;45(7):989-994. 

Gruberg L, Dangas G, Mehran R, Hong MK, Waksman R, Mintz 

GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon 

MB. Percutaneous revascularization of the internal mammary 

artery graft: short- and long-term outcomes. J Am Coll Cardiol 

2000;35(4):944-948. 

Heyne JP, Goernig M, Feger J, Kurrat C, Werner GS, Figulla 

HR, Kaiser WA. Impact on adenosine stress cardiac magnetic 

resonance for recanalisation and follow up of chronic total 

coronary occlusions. Eur J Radiol 2007;63(3):384-390. 

Keeley EC, Velez CA, O’Neill WW, Safian RD. Long-term clinical 

outcome and predictors of major adverse cardiac events after 

percutaneous interventions on saphenous vein grafts. J Am Coll 

Cardiol 2001;38(3):659-665. 

Kirschbaum SW, Baks T, van den Ent M, Sianos G, Krestin GP, Serruys 

PW, de Feyter PJ, van Geuns RJ. Evaluation of left ventricular 

function three years after percutaneous recanalization of chronic 

total coronary occlusions. Am J Cardiol 2008;101(2):179-185. 

Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. 

Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: 

paucity of late clinical stent-related problems. J Am Coll Cardiol 

1996;28(4):820-826. 

Le May MR, Labinaz M, Marquis JF, Laramee LA, O’Brien ER, 

Williams WL, Jelley JL, Woodend K, Higginson LA. Predictors of 

long-term outcome after stent implantation in a saphenous vein 

graft. Am J Cardiol 1999;83(5):681-686. 

Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR, Jr. 

Comparison of percutaneous interventions for unstable angina 

pectoris in patients with and without previous coronary artery 

bypass grafting. Am J Cardiol 2000;86(9):931-937. 

Meier B. Chronic total occlusion: how do we get there from here? 

J Invasive Cardiol 2001;13(3):233-235. 

Morrison DA, Crowley ST, Veerakul G, Barbiere CC, Grover F, 

Sacks J. Percutaneous transluminal angioplasty of saphenous vein 

grafts for medically refractory unstable angina. J Am Coll Cardiol 

1994;23(5):1066-1070. 

Najm HK, Leddy D, Hendry PJ, Marquis JF, Richardson D, Keon WJ. 

Postoperative symptomatic internal thoracic artery stenosis and 

successful treatment with PTCA. Ann Thorac Surg 1995;59(2):323- 

326. 

Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme L, 

Giachero C, Di MC, Gabrielli G, Spedicato L, Bedogni F. Immediate 

results and one-year clinical outcome after percutaneous coronary 

interventions in chronic total occlusions: data from a multicenter, 

prospective, observational study (TOAST-GISE). J Am Coll 

Cardiol 2003;41(10):1672-1678. 

Peduzzi P, Kamina A, Detre K. Twenty-two-year follow-up in the 

VA Cooperative Study of Coronary Artery Bypass Surgery for 

Stable Angina. Am J Cardiol 1998;81(12):1393-1399. 

Price MJ, Sawhney N, Kao JA, Madrid A, Schatz RA, Teirstein PS. 

Clinical outcomes after sirolimus-eluting stent implantation for 

de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 

2005;65(2):208-211. 

Ribeiro PA, Scavetta K, Oh C, Al-Zaibag M, Jutzy KR, Caldron R, 

Marsa RJ. Long-term clinical results after stent implantation in old 

obstructed saphenous vein grafts. Chest 2000;118(3):750-755. 




551. 

Shimshak TM, Giorgi LV, Johnson WL, McConahay DR, Rutherford 

BD, Ligon R, Hartzler GO. Application of percutaneous 

transluminal coronary angioplasty to the internal mammary artery 

graft. J Am Coll Cardiol 1988;12(5):1205-1214. 

Surber R, Schwarz G, Figulla HR, Werner GS. Resting 12-lead 

electrocardiogram as a reliable predictor of functional recovery 

after recanalization of chronic total coronary occlusions. Clin 

Cardiol 2005;28(6):293-297. 

Tejada JG, Velazquez M, Hernandez F, Albarran A, Gomez I, Rodriguez 

S, Andreu J, Tascon J. Percutaneous revascularization in patients 

with previous coronary artery bypass graft surgery. Immediate 

and 1-year clinical outcomes. Int J Cardiol 2009;134(2):201-206. 

Verkkala K, Jarvinen A, Virtanen K, Keto P, Pellinen T, Salminen 

US, Ketonen P, Luosto R. Indications for and risks in reoperation 

for coronary artery disease. Scand J Thorac Cardiovasc Surg 

1990;24(1):1-6. 

Yap CH, Sposato L, Akowuah E, Theodore S, Dinh DT, Shardey 

GC, Skillington PD, Tatoulis J, Yii M, Smith JA, Mohajeri M, Pick 

A, Seevanayagam S, Reid CM. Contemporary results show repeat 

coronary artery bypass grafting remains a risk factor for operative 

mortality. Ann Thorac Surg 2009;87(5):1386-1391. 

Zidar FJ, Kaplan BM, O’Neill WW, Jones DE, Schreiber TL, Safian 

RD, Ajluni SC, Sobolski J, Timmis GC, Grines CL. Prospective, 

randomized trial of prolonged intracoronary urokinase infusion 

for chronic total occlusions in native coronary arteries. J Am Coll 

Cardiol 1996;27(6):1406-1412. 

9.6.3 Revascularisation for acute failure after PCI 

Aiba T, Nonogi H, Itoh T, Morii I, Daikoku S, Goto Y, Miyazaki 

S, Sasako Y, Nakatani T. Appropriate indications for the use of 

a percutaneous cardiopulmonary support system in cases with


cardiogenic shock complicating acute myocardial infarction. Jpn 

Circ J 2001;65(3):145-149. 

Carlsson J, James SN, Stahle E, Hofer S, Lagerqvist B. Outcome of 

percutaneous coronary intervention in hospitals with and without 

on-site cardiac surgery standby. Heart 2007;93(3):335-338. 

Christenson JT, Schmuziger M, Simonet F. Effective surgical 

management of high-risk coronary patients using preoperative 

intra-aortic balloon counterpulsation therapy. Cardiovasc Surg 

2001;9(4):383-390. 

Fenchel G, Karsch KR, Seboldt H, Michel J, Volker W, Hoffmeister 

HE. [Results of emergency aortocoronary venous bypass surgery 

after failed percutaneous transluminal coronary angioplasty 

in patients with unstable angina pectoris]. Helv Chir Acta 

1990;57(2):359-363. 

Ferguson JJ, III, Cohen M, Freedman RJ, Jr., Stone GW, Miller MF, 

Joseph DL, Ohman EM. The current practice of intra-aortic 

balloon counterpulsation: results from the Benchmark Registry. J 


Levenson B, Albrecht A, Gohring S, Haerer W, Herholz H, Reifart 

N, Sauer G, Troger B. [5th Report of the German Association of 

Cardiologists in Private Practice (BNK) on Quality Assurance in 

Cardiac Catheterization and Coronary Intervention 2003-2005]. 

Herz 2007;32(1):73-84. 

Shawl FA, Domanski MJ, Hernandez TJ, Punja S. Emergency 

percutaneous cardiopulmonary bypass support in cardiogenic 

shock from acute myocardial infarction. Am J Cardiol 

1989;64(16):967-970. 

Vallbracht C, Kober G, Klepzig H, Jr., Kaltenbach M. Recurrent 

restenosis after transluminal coronary angioplasty--dilatation or 

surgery? Eur Heart J 1988;9 Suppl C:7-10. 

Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, 

Block PC, Coady P, Cohen H, Cowley M, Dorros G, Faxon D, 

Holmes DR, Jacobs A, Kelsey SF, King SB, III, Myler R, Slater 

J, Stanek V, Vlachos HA, Detre KM. Percutaneous coronary 

intervention in the current era compared with 1985-1986: the 

National Heart, Lung, and Blood Institute Registries. Circulation 

2000;102(24):2945-2951. 

9.6.4 Elective revascularisation for late failure after PCI 

Chocron S, Baillot R, Rouleau JL, Warnica WJ, Block P, Johnstone 

D, Myers MG, Calciu CD, Nozza A, Martineau P, van Gilst 

WH. Impact of previous percutaneous transluminal coronary 

angioplasty and/or stenting revascularization on outcomes after 

surgical revascularization: insights from the imagine study. Eur 

Heart J 2008;29(5):673-679. 

Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G, 

Nasso G, Possati G. Arterial versus venous bypass grafts in patients 

with in-stent restenosis. Circulation 2005;112(9 Suppl):I265-I269. 

Hassan A, Buth KJ, Baskett RJ, Ali IS, Maitland A, Sullivan JA, Ghali 

WA, Hirsch GM. The association between prior percutaneous 

coronary intervention and short-term outcomes after coronary 

artery bypass grafting. Am Heart J 2005;150(5):1026-1031. 

Holmes DR, Jr., Teirstein P, Satler L, Sketch M, O’Malley J, Popma 

JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA. 

Sirolimus-eluting stents vs vascular brachytherapy for in-stent 

restenosis within bare-metal stents: the SISR randomized trial. 

JAMA 2006;295(11):1264-1273. 

Reifart N, Schwarz F, Hofmann M, Gohring S, Storger H, Haase J. 

[Balloon angioplasty of stent restenosis: early and late results of 

first and second PTCA in focal and diffuse stenosis]. Z Kardiol 

1998;87 Suppl 3:65-71. 

Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, 

Bohm M, Speck U. Treatment of coronary in-stent restenosis 

with a paclitaxel-coated balloon catheter. N Engl J Med 

2006;355(20):2113-2124. 

Thielmann M, Leyh R, Massoudy P, Neuhauser M, Aleksic I, Kamler 

M, Herold U, Piotrowski J, Jakob H. Prognostic significance of 

multiple previous percutaneous coronary interventions in patients 

undergoing elective coronary artery bypass surgery. Circulation 

2006;114(1 Suppl):I441-I447. 

Vallbracht C, Kober G, Klepzig H, Jr., Kaltenbach M. Recurrent 

restenosis after transluminal coronary angioplasty--dilatation or 

surgery? Eur Heart J 1988;9 Suppl C:7-10. 

Webb JG, Myler RK, Shaw RE, Anwar A, Murphy MC, Mooney 

JF, Mooney MR, Stertzer SH. Bidirectional crossover and late 

outcome after coronary angioplasty and bypass surgery: 8 to 11 

year follow-up. J Am Coll Cardiol 1990;16(1):57-65. 

9.6.5 Hybrid procedures 

Beyersdorf F, Sarai K, Mitrev Z, Eckel L, Maul FD, Wendt T, Satter 

P. [Surgical revascularization in patients with acute myocardial 

infarction]. Zentralbl Chir 1993;118(4):180-189. 

Braxton JH, Hammond GL, Letsou GV, Franco KL, Kopf GS, 

Elefteriades JA, Baldwin JC. Optimal timing of coronary artery 

bypass graft surgery after acute myocardial infarction. Circulation 

1995;92(9 Suppl):II66-II68. 

Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn 

LH. Staged initial percutaneous coronary intervention followed 

by valve surgery («hybrid approach») for patients with complex 

coronary and valve disease. J Am Coll Cardiol 2005;45(1):14-18. 

Diegeler A, Thiele H, Falk V, Hambrecht R, Spyrantis N, Sick P, 

Diederich KW, Mohr FW, Schuler G. Comparison of stenting with 

minimally invasive bypass surgery for stenosis of the left anterior 

descending coronary artery. N Engl J Med 2002;347(8):561-566. 

Jaffery Z, Kowalski M, Weaver WD, Khanal S. A meta-analysis 

of randomized control trials comparing minimally invasive 

direct coronary bypass grafting versus percutaneous coronary 

intervention for stenosis of the proximal left anterior descending 

artery. Eur J Cardiothorac Surg 2007;31(4):691-697. 

Khattab AA, Otto A, Toelg R, Geist V, Klatt L, Richardt G. Sirolimuseluting 

stent treatment for complex proximal left anterior 

descending artery stenoses: 7-month clinical and angiographic 

results. J Invasive Cardiol 2005;17(11):582-586. 

O’Keefe JH, Jr., Kreamer TR, Jones PG, Vacek JL, Gorton ME, 

Muehlebach GF, Rutherford BD, McCallister BD. Isolated left 

anterior descending coronary artery disease: percutaneous 

transluminal coronary angioplasty versus stenting versus left 

internal mammary artery bypass grafting. Circulation 1999;100(19 

Suppl):II114-II118. 

Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, 

Reyes PA, Zimrin DA. Simultaneous «hybrid» percutaneous 

coronary intervention and minimally invasive surgical bypass 

grafting: feasibility, safety, and clinical outcomes. Am Heart J 

2008;155(4):661-667. 

Riess FC, Bader R, Kremer P, Kuhn C, Kormann J, Mathey D, 

Moshar S, Tuebler T, Bleese N, Schofer J. Coronary hybrid 

revascularization from January 1997 to January 2001: a clinical 

follow-up. Ann Thorac Surg 2002;73(6):1849-1855. 

Riess FC, Schofer J, Kremer P, Riess AG, Bergmann H, Moshar 

S, Mathey D, Bleese N. Beating heart operations including 

hybrid revascularization: initial experiences. Ann Thorac Surg 

1998;66(3):1076-1081. 

Stahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. 

Hybrid robotic coronary artery surgery and angioplasty 

in multivessel coronary artery disease. Ann Thorac Surg 

2002;74(4):S1358-S1362. 

Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to 

coronary conduits over 15 years. Ann Thorac Surg 2004;77(1):93- 

101. 

Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T,


Mohr FW, Schuler G, Falk V. Randomized comparison of minimally 

invasive direct coronary artery bypass surgery versus sirolimuseluting 

stenting in isolated proximal left anterior descending 

coronary artery stenosis. J Am Coll Cardiol 2009;53(25):2324- 

2331. 

Wittwer T, Cremer J, Boonstra P, Grandjean J, Mariani M, Mugge 

A, Drexler H, den HP, Leitner ER, Hepp A, Wehr M, Haverich 

A. Myocardial «hybrid» revascularisation with minimally invasive 

direct coronary artery bypass grafting combined with coronary 

angioplasty: preliminary results of a multicentre study. Heart 

2000;83(1):58-63. 

9.7 Arrhythmias in patients with 

ischaemic heart disease 

9.7.1 Atrial fibrillation 

Abreu Filho CA, Lisboa LA, Dallan LA, Spina GS, Grinberg M, 

Scanavacca M, Sosa EA, Ramires JA, Oliveira SA. Effectiveness 

of the maze procedure using cooled-tip radiofrequency ablation 

in patients with permanent atrial fibrillation and rheumatic mitral 

valve disease. Circulation 2005;112(9 Suppl):I20-I25. 

Akpinar B, Sanisoglu I, Guden M, Sagbas E, Caynak B, Bayramoglu Z. 

Combined off-pump coronary artery bypass grafting surgery and 

ablative therapy for atrial fibrillation: early and mid-term results. 

Ann Thorac Surg 2006;81(4):1332-1337. 

Auer J, Berent R, Weber T, Ng CK, Lassnig E, Lamm G, Eber B. 

Antiarrhythmic therapy on prevention of postoperative atrial 

fibrillation in patients after heart surgery. Curr Med Chem 

Cardiovasc Hematol Agents 2004;2(1):29-34. 

Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman 

CI. Effect of perioperative corticosteroid use on the incidence of 

postcardiothoracic surgery atrial fibrillation and length of stay. 

Heart Rhythm 2007;4(4):461-468. 

Banach M, Mariscalco G, Ugurlucan M, Mikhailidis DP, Barylski M, 

Rysz J. The significance of preoperative atrial fibrillation in patients 

undergoing cardiac surgery: preoperative atrial fibrillation--still 

underestimated opponent. Europace 2008;10(11):1266-1270. 

Benussi S, Pappone C, Nascimbene S, Oreto G, Caldarola A, 

Stefano PL, Casati V, Alfieri O. A simple way to treat chronic atrial 

fibrillation during mitral valve surgery: the epicardial radiofrequency 

approach. Eur J Cardiothorac Surg 2000;17(5):524-529. 

Blomstrom-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensen 

SM, Thelin S, Holmgren A, Edvardsson N, Kallner G, Blomstrom 

P. A randomized double-blind study of epicardial left atrial 

cryoablation for permanent atrial fibrillation in patients undergoing 

mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation 

study (SWEDMAF). Eur Heart J 2007;28(23):2902-2908. 

Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, 

Walter S, Tebbe U. Randomized trial of rate-control versus 

rhythm-control in persistent atrial fibrillation: the Strategies of 

Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 

2003;41(10):1690-1696. 

Chen MC, Chang JP, Chang HW. Preoperative atrial size predicts 

the success of radiofrequency maze procedure for permanent 

atrial fibrillation in patients undergoing concomitant valvular 

surgery. Chest 2004;125(6):2129-2134. 

Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene 

HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, 

Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, 

Waldo AL, Wyse DG. Relationships between sinus rhythm, 

treatment, and survival in the Atrial Fibrillation Follow-Up 

Investigation of Rhythm Management (AFFIRM) Study. Circulation 

2004;109(12):1509-1513. 

Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2-year 

clinical experience with surgery for atrial fibrillation. Ann Surg 

1996;224(3):267-273. 

Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling 

SF, Pagani FD, Bitar C, Meissner MD, Morady F. Preoperative 

amiodarone as prophylaxis against atrial fibrillation after heart 

surgery. N Engl J Med 1997;337(25):1785-1791. 

de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen 

RJ, van den Heijkant AC, Allessie MA, Crijns HJ. Progression from 

paroxysmal to persistent atrial fibrillation clinical correlates and 

prognosis. J Am Coll Cardiol 2010;55:725-731. 

Doukas G, Samani NJ, Alexiou C, Oc M, Chin DT, Stafford PG, Ng 

LL, Spyt TJ. Left atrial radiofrequency ablation during mitral valve 

surgery for continuous atrial fibrillation: a randomized controlled 

trial. JAMA 2005;294(18):2323-2329. 

Ezekowitz MD, Netrebko PI. Anticoagulation in management of 

atrial fibrillation. Curr Opin Cardiol 2003;18(1):26-31. 

Gajewski J, Singer RB. Mortality in an insured population with atrial 

fibrillation. JAMA 1981;245(15):1540-1544. 

Geidel S, Lass M, Krause K, Betzold M, Aslan H, Boczor S, Kuck 

KH, Ostermeyer J. Early and late results of permanent atrial 

fibrillation ablation surgery in aortic valve and CABG patients. 


Geidel S, Lass M, Ostermeyer J. A 5-year clinical experience with 

bipolar radiofrequency ablation for permanent atrial fibrillation 

concomitant to coronary artery bypass grafting and aortic valve 

surgery. Interact Cardiovasc Thorac Surg 2008;7(5):777-780. 

Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, 

Tsikouris JP, Wilcox HA, Kluger J. Oral amiodarone for prevention 

of atrial fibrillation after open heart surgery, the Atrial Fibrillation 

Suppression Trial (AFIST): a randomised placebo-controlled trial. 

Lancet 2001;357(9259):830-836. 

Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous 

amiodarone for the prevention of atrial fibrillation after open 

heart surgery: the Amiodarone Reduction in Coronary Heart 

(ARCH) trial. J Am Coll Cardiol 1999;34(2):343-347. 

Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou 

G, Garrigue S, Le MA, Le MP, Clementy J. Spontaneous initiation 

of atrial fibrillation by ectopic beats originating in the pulmonary 

veins. N Engl J Med 1998;339(10):659-666. 

Hogue CW, Jr., Creswell LL, Gutterman DD, Fleisher LA. 

Epidemiology, mechanisms, and risks: American College of 

Chest Physicians guidelines for the prevention and management 

of postoperative atrial fibrillation after cardiac surgery. Chest 

2005;128(2 Suppl):9S-16S. 

Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial 

fibrillation--Pharmacological Intervention in Atrial Fibrillation 

(PIAF): a randomised trial. Lancet 2000;356(9244):1789-1794. 

Jessurun ER, van Hemel NM, Defauw JA, Stofmeel MA, Kelder 

JC, de la Riviere AB, Ernst JM. Results of maze surgery for lone 

paroxysmal atrial fibrillation. Circulation 2000;101(13):1559-1567. 

Kalavrouziotis D, Buth KJ, Ali IS. The impact of new-onset atrial 

fibrillation on in-hospital mortality following cardiac surgery. 

Chest 2007;131(3):833-839. 

Kalavrouziotis D, Buth KJ, Vyas T, Ali IS. Preoperative atrial 

fibrillation decreases event-free survival following cardiac surgery. 


Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of 

atrial fibrillation; a systematic review. Eur J Cardiothorac Surg 

2005;27(2):258-265. 

Khargi K, Lemke B, Haardt H, Muller KM, Mugge A, Laczkovics A, 

Deneke T. Concomitant anti-arrhythmic surgery, using irrigated 

cooled-tip radiofrequency ablation, to treat permanent atrial 

fibrillation in CABG patients: expansion of the indication? Eur J 


Knaut M, Brose S, Tugtekin SM, Kappert U, Jung F, Matschke K.


Microwave ablation of permanent atrial fibrillation during isolated 

bypass grafting and isolated mitral valve surgery. Heart Surg 

Forum 2007;10(2):E153-E157. 

Knaut M, Tugtekin SM, Spitzer S, Gulielmos V. Combined atrial 

fibrillation and mitral valve surgery using microwave technology. 

Semin Thorac Cardiovasc Surg 2002;14(3):226-231. 

Knaut M, Tugtekin SM, Spitzer SG, Jung F, Matschke K. Intraoperative 

endocardial microwave ablation for treatment of permanent atrial 

fibrillation during coronary artery bypass surgery: 1-year followup. 

Europace 2006;8(1):16-20. 

Kosakai Y. Treatment of atrial fibrillation using the Maze procedure: 

the Japanese experience. Semin Thorac Cardiovasc Surg 

2000;12(1):44-52. 

Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky 

JL, Sebaoun A. Characterization of different subsets of atrial 

fibrillation in general practice in France: the ALFA study. The 

College of French Cardiologists. Circulation 1999;99:3028-3035. 

Magee MJ, Herbert MA, Dewey TM, Edgerton JR, Ryan WH, Prince 

S, Mack MJ. Atrial fibrillation after coronary artery bypass grafting 

surgery: development of a predictive risk algorithm. Ann Thorac 

Surg 2007;83(5):1707-1712. 

Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac 

surgery. Ann Intern Med 2001;135(12):1061-1073. 

Marik PE, Fromm R. The efficacy and dosage effect of corticosteroids 

for the prevention of atrial fibrillation after cardiac surgery: a 

systematic review. J Crit Care 2009;24(3):458-463. 

Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, Vanoli D, 

Domenico BV, Sala A. Observational study on the beneficial effect 

of preoperative statins in reducing atrial fibrillation after coronary 

surgery. Ann Thorac Surg 2007;84(4):1158-1164. 

Martin-Suarez S, Claysset B, Botta L, Ferlito M, Pacini D, Savini 

C, Marinelli G, DiBartolomeo R. Surgery for atrial fibrillation 

with radiofrequency ablation: four years experience. Interact 

Cardiovasc Thorac Surg 2007;6(1):71-76. 

Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, 

Barash PG, Hsu PH, Mangano DT. A multicenter risk index for 

atrial fibrillation after cardiac surgery. JAMA 2004;291(14):1720- 

1729. 

Melo J, Santiago T, Aguiar C, Berglin E, Knaut M, Alfieri O, Benussi 

S, Sie H, Williams M, Hornero F, Marinelli G, Ridley P, Fulquet- 

Carreras E, Ferreira A. Surgery for atrial fibrillation in patients 

with mitral valve disease: results at five years from the International 

Registry of Atrial Fibrillation Surgery. J Thorac Cardiovasc Surg 

2008;135(4):863-869. 

Mohr FW, Fabricius AM, Falk V, Autschbach R, Doll N, Von OU, 

Diegeler A, Kottkamp H, Hindricks G. Curative treatment of 

atrial fibrillation with intraoperative radiofrequency ablation: 

short-term and midterm results. J Thorac Cardiovasc Surg 

2002;123(5):919-927. 

Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman 

DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM. Amiodarone 

versus sotalol for the treatment of atrial fibrillation after open 

heart surgery: the Reduction in Postoperative Cardiovascular 

Arrhythmic Events (REDUCE) trial. Am Heart J 2004;148(4):641- 

648. 

Nitta T. Surgery for atrial fibrillation. Ann Thorac Cardiovasc Surg 

2005;11(3):154-158. 

Nitta T, Ohmori H, Sakamoto S, Miyagi Y, Kanno S, Shimizu K. 

Map-guided surgery for atrial fibrillation. J Thorac Cardiovasc 

Surg 2005;129(2):291-299. 

Nucifora G, Schuijf JD, Tops LF, van Werkhoven JM, Kajander S, 

Jukema JW, Schreur JH, Heijenbrok MW, Trines SA, Gaemperli 

O, Turta O, Kaufmann PA, Knuuti J, Schalij MJ, Bax JJ. Prevalence 

of coronary artery disease assessed by multislice computed 

tomography coronary angiography in patients with paroxysmal or 

persistent atrial fibrillation. Circ Cardiovasc Imaging 2009;2(2):100- 

106. 

Quader MA, McCarthy PM, Gillinov AM, Alster JM, Cosgrove DM, 

III, Lytle BW, Blackstone EH. Does preoperative atrial fibrillation 

reduce survival after coronary artery bypass grafting? Ann Thorac 

Surg 2004;77(5):1514-1522. 

Raman J, Ishikawa S, Storer MM, Power JM. Surgical radiofrequency 

ablation of both atria for atrial fibrillation: results of a multicenter 

trial. J Thorac Cardiovasc Surg 2003;126(5):1357-1366. 

Rogers CA, Angelini GD, Culliford LA, Capoun R, Ascione R. 

Coronary surgery in patients with preexisting chronic atrial 

fibrillation: early and midterm clinical outcome. Ann Thorac Surg 

2006;81(5):1676-1682. 

Schonburg M, Ziegelhoeffer T, Weinbrenner F, Bechtel M, Detter 

C, Krabatsch T, Osswald B, Riess FC, Scholz F, Stamm C, Sievers 

HH, Bartels C. Preexisting atrial fibrillation as predictor for latetime 

mortality in patients with end-stage renal disease undergoing 

cardiac surgery--a multicenter study. Thorac Cardiovasc Surg 

2008;56(3):128-132. 

Schuetz A, Schulze CJ, Sarvanakis KK, Mair H, Plazer H, Kilger 

E, Reichart B, Wildhirt SM. Surgical treatment of permanent 

atrial fibrillation using microwave energy ablation: a prospective 

randomized clinical trial. Eur J Cardiothorac Surg 2003;24(4):475- 

480. 

Sleilaty G, Madi-Jebara S, Yazigi A, Haddad F, Hayeck G, El R, I, 

Ashoush R, Jebara V. Postoperative oral amiodarone versus oral 

bisoprolol as prophylaxis against atrial fibrillation after coronary 

artery bypass graft surgery: a prospective randomized trial. Int J 

Cardiol 2009;137(2):116-122. 

Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based 

study of the long-term risks associated with atrial fibrillation: 

20-year follow-up of the Renfrew/Paisley study. Am J Med 

2002;113(5):359-364. 

Suwalski K, Pytkowski M, Zelazny P, Majstrak F, Kaszczynski 

T, Pasierski T, Rzaczynska M, Wojciechowski D. Surgery as 

an effective nonpharmacological mode of treatment of atrial 

fibrillation resistant to standard therapy. Pacing Clin Electrophysiol 

1994;17(11 Pt 2):2167-2171. 

Tamis JE, Steinberg JS. Atrial fibrillation independently prolongs 

hospital stay after coronary artery bypass surgery. Clin Cardiol 

2000;23(3):155-159. 

Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, Lopez JA, 

Rasekh A, Wilson JM, Massumi A. Postoperative atrial fibrillation 

and mortality after coronary artery bypass surgery. J Am Coll 

Cardiol 2004;43(5):742-748. 

Wattigney WA, Mensah GA, Croft JB. Increased atrial 

fibrillation mortality: United States, 1980-1998. Am J Epidemiol 

2002;155(9):819-826. 

Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. 

Atrial fibrillation after coronary artery bypass surgery: a model 

for preoperative risk stratification. Circulation 2000;101(12):1403- 

1408. 

Zebis LR, Christensen TD, Kristiansen IS, Hjortdal VE. Amiodarone 

cost effectiveness in preventing atrial fibrillation after coronary 

artery bypass graft surgery. Ann Thorac Surg 2008;85(1):28-32. 

Zimmer J, Pezzullo J, Choucair W, Southard J, Kokkinos P, Karasik P, 

Greenberg MD, Singh SN. Meta-analysis of antiarrhythmic therapy 

in the prevention of postoperative atrial fibrillation and the effect 

on hospital length of stay, costs, cerebrovascular accidents, and 

mortality in patients undergoing cardiac surgery. Am J Cardiol 

2003;91(9):1137-1140. 

9.7.2 Supraventricular arrhythmias other than atrial 

fibrillation or flutter 

Dorenkamp M, Zabel M, Sticherling C. Role of coronary angiography


before radiofrequency ablation in patients presenting with 

paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol 

Ther 2007;12(2):137-144. 

Lazorishinets VV, Glagola MD, Stychinsky AS, Rudenko MN, 

Knyshov GV. Surgical treatment of Wolf-Parkinson-White 

syndrome during plastic operations in patients with Ebstein’s 

anomaly. Eur J Cardiothorac Surg 2000;18(4):487-490. 

Nucifora G, Schuijf JD, Tops LF, van Werkhoven JM, Kajander S, 

Jukema JW, Schreur JH, Heijenbrok MW, Trines SA, Gaemperli 

O, Turta O, Kaufmann PA, Knuuti J, Schalij MJ, Bax JJ. Prevalence 

of coronary artery disease assessed by multislice computed 

tomography coronary angiography in patients with paroxysmal or 

persistent atrial fibrillation. Circ Cardiovasc Imaging 2009;2(2):100- 

106. 

9.7.3 Ventricular arrhythmias 

A comparison of antiarrhythmic-drug therapy with implantable 

defibrillators in patients resuscitated from near-fatal ventricular 

arrhythmias. The Antiarrhythmics versus Implantable Defibrillators 

(AVID) Investigators. N Engl J Med 1997;337(22):1576-1583. 

Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins 

CH, Delacretaz E, Bella PD, Hindricks G, Jais P, Josephson ME, 

Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy 

V, Schalij MJ, Schilling R, Soejima K, Wilber D. EHRA/HRS Expert 

Consensus on Catheter Ablation of Ventricular Arrhythmias: 

developed in a partnership with the European Heart Rhythm 

Association (EHRA), a Registered Branch of the European 

Society of Cardiology (ESC), and the Heart Rhythm Society 

(HRS); in collaboration with the American College of Cardiology 

(ACC) and the American Heart Association (AHA). Europace 

2009;11(6):771-817. 

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, 

Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, 

Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, 

Luceri RM, Ip JH. Amiodarone or an implantable cardioverterdefibrillator 

for congestive heart failure. N Engl J Med 

2005;352(3):225-237. 

Barletta G, Toso A, Del BR, Di DM, Sabatier M, Dor V. Preoperative 

and late postoperative mitral regurgitation in ventricular 

reconstruction: role of local left ventricular deformation. Ann 

Thorac Surg 2006;82(6):2102-2109. 

Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, 

Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive 

annuloplasty and coronary revascularization in ischemic mitral 

regurgitation results in reverse left ventricular remodeling. 

Circulation 2004;110(11 Suppl 1):II103-II108. 

Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. 

Accuracy of currently available techniques for prediction of 

functional recovery after revascularization in patients with left 

ventricular dysfunction due to chronic coronary artery disease: 

comparison of pooled data. J Am Coll Cardiol 1997;30(6):1451- 

1460. 

Bonow RO. Identification of viable myocardium. Circulation 

1996;94(11):2674-2680. 

Brugada J, Aguinaga L, Mont L, Betriu A, Mulet J, Sanz G. Coronary 

artery revascularization in patients with sustained ventricular 

arrhythmias in the chronic phase of a myocardial infarction: 

effects on the electrophysiologic substrate and outcome. J Am 

Coll Cardiol 2001;37(2):529-533. 

Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, 

Hafley G. A randomized study of the prevention of sudden death 

in patients with coronary artery disease. Multicenter Unsustained 

Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882- 

1890. 

Cook JR, Rizo-Patron C, Curtis AB, Gillis AM, Bigger JT, Jr., Kutalek 

SP, Coromilas J, Hofer BI, Powell J, Hallstrom AP. Effect of surgical 

revascularization in patients with coronary artery disease and 

ventricular tachycardia or fibrillation in the Antiarrhythmics 

Versus Implantable Defibrillators (AVID) Registry. Am Heart J 

2002;143(5):821-826. 

de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van 

Ree JW, Daemen MJ, Houben LG, Wellens HJ. Out-of-hospital 

cardiac arrest in the 1990’s: a population-based study in the 

Maastricht area on incidence, characteristics and survival. J Am 

Coll Cardiol 1997;30(6):1500-1505. 

Di Carli MF. Assessment of myocardial viability after myocardial 

infarction. J Nucl Cardiol 2002;9(2):229-235. 

Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial 

perfusion imaging in coronary artery disease. J Nucl Med 

2002;43(12):1634-1646. 

Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, III, Freedman 

RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes 

DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, 

Stevenson LW, Sweeney MO, Smith SC, Jr., Jacobs AK, Adams 

CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, 

Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, 

Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington 

LG, Yancy CW. ACC/AHA/HRS 2008 Guidelines for Device- 

Based Therapy of Cardiac Rhythm Abnormalities: a report of the 

American College of Cardiology/American Heart Association 

Task Force on Practice Guidelines (Writing Committee to Revise 

the ACC/AHA/NASPE 2002 Guideline Update for Implantation 

of Cardiac Pacemakers and Antiarrhythmia Devices) developed 

in collaboration with the American Association for Thoracic 

Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 

2008;51(21):e1-62. 

Every NR, Fahrenbruch CE, Hallstrom AP, Weaver WD, Cobb LA. 

Influence of coronary bypass surgery on subsequent outcome of 

patients resuscitated from out of hospital cardiac arrest. J Am 

Coll Cardiol 1992;19(7):1435-1439. 

Geelen P, Primo J, Wellens F, Brugada P. Coronary artery bypass 

grafting and defibrillator implantation in patients with ventricular 

tachyarrhythmias and ischemic heart disease. Pacing Clin 

Electrophysiol 1999;22(8):1132-1139. 

Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, 

Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson 

WG, Zipes DP. American Heart Association/American College 

of Cardiology Foundation/Heart Rhythm Society Scientific 

Statement on Noninvasive Risk Stratification Techniques for 

Identifying Patients at Risk for Sudden Cardiac Death. A scientific 

statement from the American Heart Association Council on 

Clinical Cardiology Committee on Electrocardiography and 

Arrhythmias and Council on Epidemiology and Prevention. J Am 

Coll Cardiol 2008;52(14):1179-1199. 

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, 

McNitt S, Andrews ML. Risk stratification for primary implantation 

of a cardioverter-defibrillator in patients with ischemic left 

ventricular dysfunction. J Am Coll Cardiol 2008;51(3):288-296. 

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson 

KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, 

Schaechter A, Levine JH. Prophylactic defibrillator implantation in 

patients with nonischemic dilated cardiomyopathy. N Engl J Med 

2004;350(21):2151-2158. 

Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ, Jr., Freeman CS, Garan 

H. Surgical coronary revascularization in survivors of prehospital 

cardiac arrest: its effect on inducible ventricular arrhythmias and 

long-term survival. J Am Coll Cardiol 1990;15(2):267-273. 

Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp 

SK, MacIntyre WJ, Thomas JD. Prognosis of patients with left 

ventricular dysfunction, with and without viable myocardium


after myocardial infarction. Relative efficacy of medical therapy 

and revascularization. Circulation 1994;90(6):2687-2694. 

Manolis AS, Rastegar H, Estes NA, III. Effects of coronary 

artery bypass grafting on ventricular arrhythmias: results with 

electrophysiological testing and long-term follow-up. Pacing Clin 

Electrophysiol 1993;16(5 Pt 1):984-991. 

Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, 

Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. 

Improved survival with an implanted defibrillator in patients with 

coronary disease at high risk for ventricular arrhythmia. Multicenter 

Automatic Defibrillator Implantation Trial Investigators. N Engl J 

Med 1996;335(26):1933-1940. 

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, 

Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic 

implantation of a defibrillator in patients with myocardial infarction 

and reduced ejection fraction. N Engl J Med 2002;346(12):877- 

883. 

Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: 

epidemiology, transient risk, and intervention assessment. Ann 

Intern Med 1993;119(12):1187-1197. 

Myerburg RJ, Kessler KM, Estes D, Conde CA, Luceri RM, 

Zaman L, Kozlovskis PL, Castellanos A. Long-term survival after 

prehospital cardiac arrest: analysis of outcome during an 8 year 

study. Circulation 1984;70(4):538-546. 

Natale A, Sra J, Axtell K, Maglio C, Dhala A, Blanck Z, Deshpande 

S, Jazayeri M, Akhtar M. Ventricular fibrillation and polymorphic 

ventricular tachycardia with critical coronary artery stenosis: does 

bypass surgery suffice? J Cardiovasc Electrophysiol 1994;5(12):988- 

994. 

Stollfuss JC, Haas F, Matsunari I, Neverve J, Nekolla S, Ziegler 

S, Schwaiger M. 99mTc-tetrofosmin SPECT for prediction of 

functional recovery defined by MRI in patients with severe left 

ventricular dysfunction: additional value of gated SPECT. J Nucl 

Med 1999;40(11):1824-1831. 

van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall 

EE, Schalij MJ. Impact of viability, ischemia, scar tissue, and 

revascularization on outcome after aborted sudden death. 

Circulation 2003;108(16):1954-1959. 

van der Burg AE, Bax JJ, Boersma E, van EL, Bootsma M, van der Wall 

EE, Schalij MJ. Standardized screening and treatment of patients 

with life-threatening arrhythmias: the Leiden out-of-hospital 

cardiac arrest evaluation study. Heart Rhythm 2004;1(1):51-57. 

Waldo AL, Biblo LA, Carlson MD. General evaluation of out-ofhospital 

sudden cardiac death survivors. Circulation 1992;85(1 

Suppl):I103-I106. 

Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. 

Impact of mitral valve annuloplasty on mortality risk in patients 

with mitral regurgitation and left ventricular systolic dysfunction. 


Zeppenfeld K, Stevenson WG. Ablation of ventricular tachycardia in 

patients with structural heart disease. Pacing Clin Electrophysiol 

2008;31(3):358-374. 

Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer 

M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, 

Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, 

Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor 

K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, 

Smith SC, Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, 

Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel 

B. ACC/AHA/ESC 2006 guidelines for management of patients 

with ventricular arrhythmias and the prevention of sudden 

cardiac death--executive summary: A report of the American 

College of Cardiology/American Heart Association Task Force 

and the European Society of Cardiology Committee for Practice 

Guidelines (Writing Committee to Develop Guidelines for 

Management of Patients with Ventricular Arrhythmias and the 

Prevention of Sudden Cardiac Death) Developed in collaboration 

with the European Heart Rhythm Association and the Heart 

Rhythm Society. Eur Heart J 2006;27(17):2099-2140. 

9.7.4 Concomitant revascularisation in heart failure 

patients candidates for resynchronization therapy 

Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh 

E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp 

RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. 

Cardiac resynchronization in chronic heart failure. N Engl J Med 

2002;346(24):1845-1853. 

Barletta G, Toso A, Del BR, Di DM, Sabatier M, Dor V. Preoperative 

and late postoperative mitral regurgitation in ventricular 

reconstruction: role of local left ventricular deformation. Ann 

Thorac Surg 2006;82(6):2102-2109. 

Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, 

Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive 

annuloplasty and coronary revascularization in ischemic mitral 

regurgitation results in reverse left ventricular remodeling. 

Circulation 2004;110(11 Suppl 1):II103-II108. 

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De 

MT, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, 

Feldman AM. Cardiac-resynchronization therapy with or without 

an implantable defibrillator in advanced chronic heart failure. N 

Engl J Med 2004;350(21):2140-2150. 

Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, 

Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, 

Daubert JC. Effects of multisite biventricular pacing in patients 

with heart failure and intraventricular conduction delay. N Engl J 

Med 2001;344(12):873-880. 

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, 

Kappenberger L, Tavazzi L. The effect of cardiac resynchronization 

on morbidity and mortality in heart failure. N Engl J Med 

2005;352(15):1539-1549. 

Jutley RS, Waller DA, Loke I, Skehan D, Ng A, Stafford P, Chin 

D, Spyt TJ. Video-assisted thoracoscopic implantation of the left 

ventricular pacing lead for cardiac resynchronization therapy. 

Pacing Clin Electrophysiol 2008;31(7):812-818. 

Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector 

H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, 

Trusz-Gluza M. Guidelines for cardiac pacing and cardiac 

resynchronization therapy. The Task Force for Cardiac Pacing and 

Cardiac Resynchronization Therapy of the European Society of 

Cardiology. Developed in collaboration with the European Heart 

Rhythm Association. Europace 2007;9(10):959-998. 

Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. 

Impact of mitral valve annuloplasty on mortality risk in patients 

with mitral regurgitation and left ventricular systolic dysfunction. 


10. Procedural aspects of CABG 

10.1 Preoperative management 

Boudoulas H, Snyder GL, Lewis RP, Kates RE, Karayannacos PE, 

Vasko JS. Safety and rationale for continuation of propranolol 

therapy during coronary bypass operation. Ann Thorac Surg 

1978;26(3):222-227. 

Gomes JA, Ip J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman S, Pe E, 

Newhouse TT, Chao S. Oral d,l sotalol reduces the incidence of 

postoperative atrial fibrillation in coronary artery bypass surgery 

patients: a randomized, double-blind, placebo-controlled study. J 

Am Coll Cardiol 1999;34(2):334-339.


Kim dh, daskalakis c, silvestry sc, sheth mp, lee an, adams s, hohmann 

s, medvedev s, whellan dj. Aspirin and clopidogrel use in the early 

postoperative period following on-pump and off-pump coronary 

artery bypass grafting. J Thorac Cardiovasc Surg 2009;138:1377- 

1384. 

Reduto LA, Berger HJ, Geha A, Hammond G, Cohen LS, Gottschalk 

A, Zaret BL. Radionuclide assessment of ventricular performance 

during propranolol withdrawal prior to aortocoronary bypass 

surgery. Am Heart J 1978;96(6):714-722. 

10.2 Surgical procedures 

Aranki SF, Rizzo RJ, Adams DH, Couper GS, Kinchla NM, Gildea 

JS, Cohn LH. Single-clamp technique: an important adjunct to 

myocardial and cerebral protection in coronary operations. Ann 

Thorac Surg 1994;58(2):296-302. 

Brodman RF, Frame R, Camacho M, Hu E, Chen A, Hollinger I. 

Routine use of unilateral and bilateral radial arteries for coronary 

artery bypass graft surgery. J Am Coll Cardiol 1996;28(4):959- 

963. 

Buxton BF, Raman JS, Ruengsakulrach P, Gordon I, Rosalion A, 

Bellomo R, Horrigan M, Hare DL. Radial artery patency and 

clinical outcomes: five-year interim results of a randomized trial. J 


Calafiore AM, Vitolla G, Iaco AL, Fino C, Di GG, Marchesani F, 

Teodori G, D’Addario G, Mazzei V. Bilateral internal mammary 

artery grafting: midterm results of pedicled versus skeletonized 

conduits. Ann Thorac Surg 1999;67(6):1637-1642. 

D’Ancona G, Karamanoukian HL, Ricci M, Schmid S, Bergsland J, 

Salerno TA. Graft revision after transit time flow measurement 

in off-pump coronary artery bypass grafting. Eur J Cardiothorac 

Surg 2000;17(3):287-293. 

Damgaard S, Wetterslev J, Lund JT, Lilleor NB, Perko MJ, Kelbaek 

H, Madsen JK, Steinbruchel DA. One-year results of total arterial 

revascularization vs. conventional coronary surgery: CARRPO 

trial. Eur Heart J 2009;30(8):1005-1011. 

De Paulis R, de Notaris S, Scaffa R, Nardella S, Zeitani J, Del Giudice 

C, De Peppo AP, Tomai F, Chiariello L. The effect of bilateral 

internal thoracic artery harvesting on superficial and deep sternal 

infection: The role of skeletonization. J Thorac Cardiovasc Surg 

2005;129:536-543. 

Desai ND, Cohen EA, Naylor CD, Fremes SE. A randomized 

comparison of radial-artery and saphenous-vein coronary bypass 

grafts. N Engl J Med 2004;351(22):2302-2309. 

Diez C, Koch D, Kuss O, Silber RE, Friedrich I, Boergermann J. Risk 

factors for mediastinitis after cardiac surgery - a retrospective 

analysis of 1700 patients. J Cardiothorac Surg 2007;2:23. 

Dion R, Verhelst R, Rousseau M, Goenen M, Ponlot R, Kestens- 

Servaye Y, Chalant CH. Sequential mammary grafting. Clinical, 

functional, and angiographic assessment 6 months postoperatively 

in 231 consecutive patients. J Thorac Cardiovasc Surg 

1989;98(1):80-88. 

Gao C, Ren C, Li D, Li L. Clopidogrel and aspirin versus clopidogrel 

alone on graft patency after coronary artery bypass grafting. Ann 

Thorac Surg 2009;88:59-62. 

Glineur D, Hanet C, Poncelet A, D’hoore W, Funken JC, 

Rubay J, Kefer J, Astarci P, Lacroix V, Verhelst R, Etienne PY, 

Noirhomme P, El KG. Comparison of bilateral internal thoracic 

artery revascularization using in situ or Y graft configurations: 

a prospective randomized clinical, functional, and angiographic 

midterm evaluation. Circulation 2008;118(14 Suppl):S216-S221. 

Graham MM, Chambers RJ, Davies RF. Angiographic quantification 

of diffuse coronary artery disease: reliability and prognostic value 

for bypass operations. J Thorac Cardiovasc Surg 1999;118:618- 

627. 

Guru V, Omura J, Alghamdi AA, Weisel R, Fremes SE. Is blood 

superior to crystalloid cardioplegia? A meta-analysis of randomized 

clinical trials. Circulation 2006;114(1 Suppl):I331-I338. 

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger 

EP, Herbosa T, Joseph S, Kibatala PL, Lapitan MC, Merry AF, 

Moorthy K, Reznick RK, Taylor B, Gawande AA. A surgical safety 

checklist to reduce morbidity and mortality in a global population. 

N Engl J Med 2009;360(5):491-499. 

Jacob S, Kallikourdis A, Sellke F, Dunning J. Is blood cardioplegia 

superior to crystalloid cardioplegia? Interact Cardiovasc Thorac 

Surg 2008;7(3):491-498. 

Johnson WD, Flemma RJ, Lepley D, Jr., Ellison EH. Extended 

treatment of severe coronary artery disease: a total surgical 

approach. Ann Surg 1969;170(3):460-470. 

Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, 

Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, 

. Influence of the internal-mammary-artery graft on 10-year 

survival and other cardiac events. N Engl J Med 1986;314(1):1-6. 

Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, 

Harrington RA, Mehta RH, Gibson CM, Mack MJ, Kouchoukos 

NT, Califf RM, Alexander JH. Endoscopic versus open veingraft 

harvesting in coronary-artery bypass surgery. N Engl J Med 

2009;361(3):235-244. 

McNeil M, Buth K, Brydie A, MacLaren A, Baskett R. The impact 

of diffuseness of coronary artery disease on the outcomes of 

patients undergoing primary and reoperative coronary artery 

bypass grafting. Eur J Cardiothorac Surg 2007;31(5):827-833. 

Muneretto C, Bisleri G, Negri A, Manfredi J, Metra M, Nodari S, 

Culot L, Dei CL. Total arterial myocardial revascularization with 

composite grafts improves results of coronary surgery in elderly: a 

prospective randomized comparison with conventional coronary 

artery bypass surgery. Circulation 2003;108 Suppl 1:II29-II33. 

Post P, Kuijpers M, Ebels T, Zijlstra F. The relation between volume 

and outcome of coronary interventions; a systematic review and 

meta-analysis. European Heart Journal (2010) 31, 1985–1992; 

doi:10.1093/eurheartj/ehq151. 

Rankin JS, Tuttle RH, Wechsler AS, Teichmann TL, Glower DD, 

Califf RM. Techniques and benefits of multiple internal mammary 

artery bypass at 20 years of follow-up. Ann Thorac Surg 

2007;83(3):1008-1014. 

Rizzoli G, Schiavon L, Bellini P. Does the use of bilateral internal 

mammary artery (IMA) grafts provide incremental benefit relative 

to the use of a single IMA graft? A meta-analysis approach. Eur J 





551. 

Sergeant P, Blackstone E, Meyns B. Is return of angina after 

coronary artery bypass grafting immutable, can it be delayed, and 

is it important? J Thorac Cardiovasc Surg 1998;116(3):440-453. 

Tector AJ, McDonald ML, Kress DC, Downey FX, Schmahl TM. 

Purely internal thoracic artery grafts: outcomes. Ann Thorac Surg 

2001;72(2):450-455. 

Wareing TH, Davila-Roman VG, Barzilai B, Murphy SF, Kouchoukos 

NT. Management of the severely atherosclerotic ascending aorta 

during cardiac operations. A strategy for detection and treatment. 


10.3 Early postoperative risk 

Bergsland J, Lingaas PS, Skulstad H, Hol PK, Halvorsen PS, Andersen 

R, Smastuen M, Lundblad R, Svennevig J, Andersen K, Fosse E. 

Intracoronary shunt prevents ischemia in off-pump coronary 

artery bypass surgery. Ann Thorac Surg 2009;87(1):54-60.


Cheng DC, Bainbridge D, Martin JE, Novick RJ. Does off-pump 

coronary artery bypass reduce mortality, morbidity, and resource 

utilization when compared with conventional coronary artery 

bypass? A meta-analysis of randomized trials. Anesthesiology 

2005;102(1):188-203. 

Gurbuz A, Emrecan B, Yilik L, Ozsoyler I, Kestelli M, Ozbek C, 

Karahan N. Intracoronary shunt reduces postoperative troponin 

leaks: a prospective randomized study. Eur J Cardiothorac Surg 

2006;29(2):186-189. 

Lev-Ran O, Braunstein R, Sharony R, Kramer A, Paz Y, Mohr R, 

Uretzky G. No-touch aorta off-pump coronary surgery: the effect 

on stroke. J Thorac Cardiovasc Surg 2005;129(2):307-313. 

Pirk J, Vojacek J, Kovac J, Fabian J, Firt P. Improved patency of the 

aortocoronary bypass by antithrombotic drugs. Ann Thorac Surg 

1986;42:312-314. 

Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke 

PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, 

Petersen RJ, Bailey DE, Weintraub WS, Guyton RA. Off-pump 

vs conventional coronary artery bypass grafting: early and 1-year 

graft patency, cost, and quality-of-life outcomes: a randomized 

trial. JAMA 2004;291(15):1841-1849. 

Rizzoli G, Schiavon L, Bellini P. Does the use of bilateral internal 

mammary artery (IMA) grafts provide incremental benefit relative 

to the use of a single IMA graft? A meta-analysis approach. Eur J 


Sergeant P, Blackstone E, Meyns B. Validation and interdependence 

with patient-variables of the influence of procedural variables on 

early and late survival after CABG. K.U. Leuven Coronary Surgery 

Program. Eur J Cardiothorac Surg 1997;12(1):1-19. 

Sergeant P, Blackstone E, Meyns B. Is return of angina after 

coronary artery bypass grafting immutable, can it be delayed, and 

is it important? J Thorac Cardiovasc Surg 1998;116(3):440-453. 

Sergeant PT, Blackstone EH, Meyns BP. Does arterial 

revascularization decrease the risk of infarction after coronary 

artery bypass grafting? Ann Thorac Surg 1998;66(1):1-10. 

11. Procedural aspects of PCI 

Bech GJ, de BB, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, 

Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional 

flow reserve to determine the appropriateness of angioplasty 

in moderate coronary stenosis: a randomized trial. Circulation 

2001;103(24):2928-2934. 

De Vita M, Burzotta F, Biondi-Zoccai GG, Lefevre T, Dudek D, 

Antoniucci D, Orrego PS, De LL, Kaltoft A, Sardella G, Zijlstra F, 

Isshiki T, Crea F. Individual patient-data meta-analysis comparing 

clinical outcome in patients with ST-elevation myocardial infarction 

treated with percutaneous coronary intervention with or without 

prior thrombectomy. ATTEMPT study: a pooled Analysis of 

Trials on ThrombEctomy in acute Myocardial infarction based on 

individual PatienT data. Vasc Health Risk Manag 2009;5(1):243- 

247. 

Exaire JE, Brener SJ, Ellis SG, Yadav JS, Bhatt DL. GuardWire 

emboli protection device is associated with improved myocardial 

perfusion grade in saphenous vein graft intervention. Am Heart J 

2004;148(6):1003-1006. 

Inaba Y, Chen JA, Mehta N, Bergmann SR. Impact of single or 

multicentre study design on the results of trials examining the 

efficacy of adjunctive devices to prevent distal embolisation during 

acute myocardial infarction. EuroIntervention 2009;5(3):375-383. 


Bohm M, Speck U. Two year follow-up after treatment of coronary 

in-stent restenosis with a paclitaxel-coated balloon catheter. Clin 

Res Cardiol 2008;97(10):773-781. 

11.1 Impact of clinical presentation 

Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, 

Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J. Rheolytic 

thrombectomy with percutaneous coronary intervention for 

infarct size reduction in acute myocardial infarction: 30-day 

results from a multicenter randomized study. J Am Coll Cardiol 

2006;48(2):244-252. 

Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J 

2003;24(5):394-403. 

Beran G, Lang I, Schreiber W, Denk S, Stefenelli T, Syeda B, Maurer 

G, Glogar D, Siostrzonek P. Intracoronary thrombectomy with the 

X-sizer catheter system improves epicardial flow and accelerates 

ST-segment resolution in patients with acute coronary syndrome: 

a prospective, randomized, controlled study. Circulation 

2002;105(20):2355-2360. 

Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after 

percutaneous coronary intervention predict outcomes in 2005? 

Periprocedural cardiac enzyme elevation predicts adverse 

outcomes. Circulation 2005;112(6):906-915. 

Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, 

Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, 

Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw 

BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman 

EM. Myonecrosis after revascularization procedures. J Am Coll 

Cardiol 1998;31(2):241-251. 

Cura FA, Escudero AG, Berrocal D, Mendiz O, Trivi MS, Fernandez 

J, Palacios A, Albertal M, Piraino R, Riccitelli MA, Gruberg L, 

Ballarino M, Milei J, Baeza R, Thierer J, Grinfeld L, Krucoff M, 

O’Neill W, Belardi J. Protection of Distal Embolization in High- 

Risk Patients with Acute ST-Segment Elevation Myocardial 

Infarction (PREMIAR). Am J Cardiol 2007;99(3):357-363. 

Dangas G, Stone GW, Weinberg MD, Webb J, Cox DA, Brodie BR, 

Krucoff MW, Gibbons RJ, Lansky AJ, Mehran R. Contemporary 

outcomes of rescue percutaneous coronary intervention for 

acute myocardial infarction: comparison with primary angioplasty 

and the role of distal protection devices (EMERALD trial). Am 

Heart J 2008;155(6):1090-1096. 

de Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived 

from post-stent-implantation intravascular ultrasound predictors 

of 6-month expected restenosis on quantitative coronary 

angiography. Circulation 1999;100(17):1777-1783. 

De Vita M, Burzotta F, Biondi-Zoccai GG, Lefevre T, Dudek D, 

Antoniucci D, Orrego PS, De LL, Kaltoft A, Sardella G, Zijlstra F, 

Isshiki T, Crea F. Individual patient-data meta-analysis comparing 

clinical outcome in patients with ST-elevation myocardial infarction 

treated with percutaneous coronary intervention with or without 

prior thrombectomy. ATTEMPT study: a pooled Analysis of 

Trials on ThrombEctomy in acute Myocardial infarction based on 

individual PatienT data. Vasc Health Risk Manag 2009;5(1):243- 

247. 

Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, 

Pichard AD, Satler LF, Topol EJ, Whitlow PL. Relation of clinical 

presentation, stenosis morphology, and operator technique to 

the procedural results of rotational atherectomy and rotational 

atherectomy-facilitated angioplasty. Circulation 1994;89(2):882- 

892. 

Figulla HR, Mudra H, Reifart N, Werner GS. Direct coronary 

stenting without predilatation: a new therapeutic approach 

with a special balloon catheter design. Cathet Cardiovasc Diagn 

1998;43(3):245-252. 

Funaro S, La TG, Madonna M, Galiuto L, Scara A, Labbadia A, Canali 

E, Mattatelli A, Fedele F, Alessandrini F, Crea F, Agati L. Incidence, 

determinants, and prognostic value of reverse left ventricular 

remodelling after primary percutaneous coronary intervention:


results of the Acute Myocardial Infarction Contrast Imaging 

(AMICI) multicenter study. Eur Heart J 2009;30(5):566-575. 

Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner 

K, Comberg T, Peitz K, Zohlnhofer D, Bassignana V, Buettner 

HJ, Neumann FJ. Randomized evaluation of the effects of filterbased 

distal protection on myocardial perfusion and infarct size 

after primary percutaneous catheter intervention in myocardial 

infarction with and without ST-segment elevation. Circulation 

2005;112(10):1462-1469. 

Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van ‘t Hof AW, 

Hoorntje JC, Suryapranata H. Incidence and clinical significance 

of distal embolization during primary angioplasty for acute 

myocardial infarction. Eur Heart J 2002;23(14):1112-1117. 

Inaba Y, Chen JA, Mehta N, Bergmann SR. Impact of single or 

multicentre study design on the results of trials examining the 

efficacy of adjunctive devices to prevent distal embolisation during 

acute myocardial infarction. EuroIntervention 2009;5(3):375-383. 

Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus 

femoral access for coronary angiography or intervention and the 

impact on major bleeding and ischemic events: a systematic review 

and meta-analysis of randomized trials. Am Heart J 2009;157:132- 

140. 

Kaluski E, Hauptmann KE, Muller R, Tsai S, Klapholz M, Grube 

E. Coronary stenting with MGuard: first-in-man trial. J Invasive 

Cardiol 2008;20(10):511-515. 

Kaplan BM, Safian RD, Mojares JJ, Reddy VM, Gangadharan V, 

Schreiber TL, Grines CL, O’Neill WW. Optimal burr and adjunctive 

balloon sizing reduces the need for target artery revascularization 

after coronary mechanical rotational atherectomy. Am J Cardiol 

1996;78(11):1224-1229. 

Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, 

Klovgaard L, Kaltoft A, Engstrom T, Botker HE, Saunamaki K, 

Krusell LR, Jorgensen E, Hansen HH, Christiansen EH, Ravkilde 

J, Kober L, Kofoed KF, Thuesen L. Randomized comparison of 

distal protection versus conventional treatment in primary 

percutaneous coronary intervention: the drug elution and distal 

protection in ST-elevation myocardial infarction (DEDICATION) 

trial. J Am Coll Cardiol 2008;51(9):899-905. 

Matsuo H, Watanabe S, Watanabe T, Warita S, Kojima T, Hirose 

T, Iwama M, Ono K, Takahashi H, Segawa T, Minatoguchi S, 

Fujiwara H. Prevention of no-reflow/slow-flow phenomenon 

during rotational atherectomy--a prospective randomized study 

comparing intracoronary continuous infusion of verapamil and 

nicorandil. Am Heart J 2007;154(5):994-996. 

Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip 

DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of 

rotational atherectomy with conventional balloon angioplasty in 

the prevention of restenosis of small coronary arteries: results 

of the Dilatation vs Ablation Revascularization Trial Targeting 

Restenosis (DART). Am Heart J 2003;145(5):847-854. 

Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra 

F. Prognostic value of troponin after elective percutaneous 

coronary intervention: A meta-analysis. Catheter Cardiovasc 

Interv 2008;71(3):318-324. 

Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, 

Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, 

Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel 

D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M. Effect of 

cyclosporine on reperfusion injury in acute myocardial infarction. 

N Engl J Med 2008;359:473-481. 

Piscione F, Danzi GB, Cassese S, Esposito G, Cirillo P, Galasso 

G, Rapacciuolo A, Leosco D, Briguori C, Varbella F, Tuccillo B, 

Chiariello M. Multicentre experience with MGuard net protective 

stent in ST-elevation myocardial infarction: Safety, feasibility, and 

impact on myocardial reperfusion. Catheter Cardiovasc Interv 

2009. 

Roffi M, Mukherjee D. Current role of emboli protection devices 

in percutaneous coronary and vascular interventions. Am Heart J 

2009;157(2):263-270. 

Silva-Orrego P, Colombo P, Bigi R, Gregori D, Delgado A, Salvade 

P, Oreglia J, Orrico P, de BA, Piccalo G, Bossi I, Klugmann S. 

Thrombus aspiration before primary angioplasty improves 

myocardial reperfusion in acute myocardial infarction: the DEAR- 

MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial 

Infarction) study. J Am Coll Cardiol 2006;48(8):1552-1559. 

Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G. 

Coronary microembolization. Basic Res Cardiol 2006;101(5):373- 

382. 

Stone GW, Cox DA, Babb J, Nukta D, Bilodeau L, Cannon L, 

Stuckey TD, Hermiller J, Cohen EA, Low R, Bailey SR, Lansky AJ, 

Kuntz RE. Prospective, randomized evaluation of thrombectomy 

prior to percutaneous intervention in diseased saphenous vein 

grafts and thrombus-containing coronary arteries. J Am Coll 

Cardiol 2003;42(11):2007-2013. 

Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, 

Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, 

Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal 

microcirculatory protection during percutaneous coronary 

intervention in acute ST-segment elevation myocardial infarction: 

a randomized controlled trial. JAMA 2005;293(9):1063-1072. 

Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van 

den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer 

AJ, Zijlstra F. Thrombus aspiration during primary percutaneous 

coronary intervention. N Engl J Med 2008;358(6):557-567. 

Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J 

Med 2007;357(11):1121-1135. 

11.2 Specific lesion subsets 

Albiero R, Silber S, Di MC, Cernigliaro C, Battaglia S, Reimers B, 

Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice MC, Cremonesi 

A, Schofer J, Bortone A, Colombo A. Cutting balloon versus 

conventional balloon angioplasty for the treatment of in-stent 

restenosis: results of the restenosis cutting balloon evaluation 

trial (RESCUT). J Am Coll Cardiol 2004;43(6):943-949. 

Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti 

V, Lopez-Minguez JR, Angel J, Mantilla R, Moris C, Cequier A, 

Sabate M, Escaned J, Moreno R, Banuelos C, Suarez A, Macaya 

C. A randomized comparison of sirolimus-eluting stent with 

balloon angioplasty in patients with in-stent restenosis: results 

of the Restenosis Intrastent: Balloon Angioplasty Versus Elective 

Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 

2006;47(11):2152-2160. 

Bossi I, Klersy C, Black AJ, Cortina R, Choussat R, Cassagneau B, 

Jordan C, Laborde JC, Laurent JP, Bernies M, Fajadet J, Marco J. Instent 

restenosis: long-term outcome and predictors of subsequent 

target lesion revascularization after repeat balloon angioplasty. J 


Brar SS, Gray WA, Dangas G, Leon MB, Aharonian VJ, Brar 

SK, Moses JW. Bifurcation stenting with drug-eluting stents: 

a systematic review and meta-analysis of randomised trials. 

EuroIntervention 2009;5(4):475-484. 

Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, 

Sheiban I, Paloscia L, Grube E, Schofer J, Bolognese L, Orlandi 

M, Niccoli G, Latib A, Airoldi F. Randomized study of the crush 

technique versus provisional side-branch stenting in true coronary 

bifurcations: the CACTUS (Coronary Bifurcations: Application of 

the Crushing Technique Using Sirolimus-Eluting Stents) Study. 

Circulation 2009;119(1):71-78. 

Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek


D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers 

B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. 

European perspective in the recanalisation of Chronic Total 

Occlusions (CTO): consensus document from the EuroCTO 

Club. EuroIntervention 2007;3(1):30-43. 

Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno MJ, 

Mehilli J, Schomig A. Effectiveness of drug-eluting stents in patients 

with bare-metal in-stent restenosis: meta-analysis of randomized 

trials. J Am Coll Cardiol 2007;49(5):616-623. 

Doi H, Maehara A, Mintz GS, Dani L, Leon MB, Grube E. Serial 

intravascular ultrasound analysis of bifurcation lesions treated 

using the novel self-expanding sideguard side branch stent. Am J 

Cardiol 2009;104(9):1216-1221. 

Erglis A, Kumsars I, Niemela M, Kervinen K, Maeng M, Lassen JF, 

Gunnes P, Stavnes S, Jensen JS, Galloe A, Narbute I, Sondore D, 

Makikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, 

Mannsverk J, Thayssen P, Hansen KN, Syvanne M, Helqvist S, 

Kjell N, Wiseth R, Aaroe J, Puhakka M, Thuesen L. Randomized 

comparison of coronary bifurcation stenting with the crush versus 

the culotte technique using sirolimus eluting stents: the Nordic 

stent technique study. Circ Cardiovasc Interv 2009;2(1):27-34. 

Exaire JE, Brener SJ, Ellis SG, Yadav JS, Bhatt DL. GuardWire 

emboli protection device is associated with improved myocardial 

perfusion grade in saphenous vein graft intervention. Am Heart J 

2004;148(6):1003-1006. 

Fasseas P, Orford JL, Panetta CJ, Bell MR, Denktas AE, Lennon 

RJ, Holmes DR, Berger PB. Incidence, correlates, management, 

and clinical outcome of coronary perforation: analysis of 16,298 

procedures. Am Heart J 2004;147(1):140-145. 

Fonseca A, Costa JR, Jr., Abizaid A, Feres F, Abizaid AS, Costa R, 

Staico R, Mattos LA, Sousa AG, Grube E, Sousa JE. Intravascular 

ultrasound assessment of the novel AngioSculpt scoring balloon 

catheter for the treatment of complex coronary lesions. J Invasive 

Cardiol 2008;20(1):21-27. 

Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM, 

Montorfano M, Chieffo A, Carlino M, Corvaja N, Colombo A. 

Clinical and angiographic outcome after implantation of drugeluting 

stents in bifurcation lesions with the crush stent technique: 

importance of final kissing balloon post-dilation. J Am Coll Cardiol 

2005;46(4):613-620. 

Gil RJ, Vassilev D, Formuszewicz R, Rusicka-Piekarz T, Doganov 

A. The carina angle-new geometrical parameter associated with 

periprocedural side branch compromise and the long-term results 

in coronary bifurcation lesions with main vessel stenting only. J 

Interv Cardiol 2009;22(6):E1-E10. 

Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens 

J, Verheye S, Grube E, Honda Y, Fitzgerald PJ. Analysis of left main 

coronary artery bifurcation lesions treated with biolimus-eluting 

DEVAX AXXESS plus nitinol self-expanding stent: intravascular 

ultrasound results of the AXXENT trial. Catheter Cardiovasc 

Interv 2009;73(1):34-41. 

Holmes DR, Jr., Teirstein P, Satler L, Sketch M, O’Malley J, Popma 

JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA. 

Sirolimus-eluting stents vs vascular brachytherapy for in-stent 

restenosis within bare-metal stents: the SISR randomized trial. 

JAMA 2006;295(11):1264-1273. 

Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard 

AD, Kent KM, Satler LF, Stone GW, Leon MB. Creatine kinase- 

MB enzyme elevation following successful saphenous vein graft 

intervention is associated with late mortality. Circulation 

1999;100(24):2400-2405. 

Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. 

Percutaneous coronary intervention for chronic total 

occlusions: the Thoraxcenter experience 1992-2002. Eur Heart 

J 2005;26(24):2630-2636. 

Kastrati A, Mehilli J, von BN, Dibra A, Hausleiter J, Pache J, Schuhlen 

H, Schmitt C, Dirschinger J, Schomig A. Sirolimus-eluting stent 

or paclitaxel-eluting stent vs balloon angioplasty for prevention 

of recurrences in patients with coronary in-stent restenosis: a 

randomized controlled trial. JAMA 2005;293(2):165-171. 

Koo BK, Park KW, Kang HJ, Cho YS, Chung WY, Youn TJ, Chae 

IH, Choi DJ, Tahk SJ, Oh BH, Park YB, Kim HS. Physiological 

evaluation of the provisional side-branch intervention strategy 

for bifurcation lesions using fractional flow reserve. Eur Heart J 

2008;29(6):726-732. 

Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carrozza JP, Sharma S, 

McCormick DJ, Schmidt DA, Lansky AJ, Ho KK, Dandreo KJ, 

Setum CM, Ramee SR. A trial comparing rheolytic thrombectomy 

with intracoronary urokinase for coronary and vein graft 

thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J 

Cardiol 2002;89(3):326-330. 

Latib A, Colombo A, Sangiorgi GM. Bifurcation stenting: current 

strategies and new devices. Heart 2009;95(6):495-504. 

Lefevre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet 

L, Reimers B, Brunel P, Wijns W, Buettner HJ, Hartmann F, 

Veldhof S, Miquel K, Su X, Van der Giessen WJ. The Frontier 

stent registry: safety and feasibility of a novel dedicated stent for 

the treatment of bifurcation coronary artery lesions. J Am Coll 

Cardiol 2005;46(4):592-598. 

Legrand V, Thomas M, Zelisko M, de BB, Reifart N, Steigen T, Hildick- 

Smith D, Albiero R, Darremont O, Stankovic G, Pan M, Lassen 

JF, Louvard Y, Lefevre T. Percutaneous coronary intervention 

of bifurcation lesions: state-of-the-art. Insights from the second 

meeting of the European Bifurcation Club. EuroIntervention 

2007;3(1):44-49. 

Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan 

M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen 

JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky 

A, Meerkin D, Legrand V, Medina A, Lefevre T. Classification of 

coronary artery bifurcation lesions and treatments: time for a 

consensus! Catheter Cardiovasc Interv 2008;71(2):175-183. 

Medina A, Suarez de LJ, Pan M. [A new classification of coronary 

bifurcation lesions]. Rev Esp Cardiol 2006;59(2):183. 

Onuma Y, Muller R, Ramcharitar S, van Geuns RJ, Louvard Y, Morel 

MA, Morice MC, Davis R, Kaplan AV, Lefevre T, Grube E, Serruys 

PW. Tryton I, First-In-Man (FIM) study: six month clinical and 

angiographic outcome, analysis with new quantitative coronary 

angiography dedicated for bifurcation lesions. EuroIntervention 

2008;3(5):546-552. 

Reifart N, Enayat D, Giokoglu K. A novel penetration catheter 

(Tornus) as bail-out device after balloon failure to recanalise long, 

old calcified chronic occlusions. EuroIntervention 2008;3(5):617- 

621. 

Ribichini F, pugno f, Ferrero V, Wijns W, Vacca G, Vassanelli C, 

Virmani R. Long-term histological and immunohistochemical 

findings in human venous aorto-coronary bypass grafts. Clin Sci 

2008;114:211-220. 

Roffi M, Mukherjee D. Current role of emboli protection devices 

in percutaneous coronary and vascular interventions. Am Heart J 

2009;157(2):263-270. 

Sianos G, Barlis P, Di MC, Papafaklis MI, Buttner J, Galassi AR, 

Schofer J, Werner G, Lefevre T, Louvard Y, Serruys PW, Reifart 

N. European experience with the retrograde approach for the 

recanalisation of coronary artery chronic total occlusions. 

A report on behalf of the euroCTO club. EuroIntervention 

2008;4(1):84-92. 

Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese 

L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart 

N, Heyndrickx GR, Saunamaki K, Morice MC, Sgura FA, Di 

MC. Randomized evaluation of polytetrafluoroethylene-covered


stent in saphenous vein grafts: the Randomized Evaluation of 

polytetrafluoroethylene COVERed stent in Saphenous vein grafts 

(RECOVERS) Trial. Circulation 2003;108(1):37-42. 

Stankovic G, Darremont O, Ferenc M, Hildick-Smith D, Louvard 

Y, Albiero R, Pan M, Lassen JF, Lefevre T. Percutaneous coronary 

intervention for bifurcation lesions: 2008 consensus document 

from the fourth meeting of the European Bifurcation Club. 

EuroIntervention 2009;5(1):39-49. 

Stone GW, Cox DA, Babb J, Nukta D, Bilodeau L, Cannon L, 

Stuckey TD, Hermiller J, Cohen EA, Low R, Bailey SR, Lansky AJ, 

Kuntz RE. Prospective, randomized evaluation of thrombectomy 

prior to percutaneous intervention in diseased saphenous vein 

grafts and thrombus-containing coronary arteries. J Am Coll 

Cardiol 2003;42(11):2007-2013. 

Stone GW, Ellis SG, O’Shaughnessy CD, Martin SL, Satler L, 

McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell 

ME. Paclitaxel-eluting stents vs vascular brachytherapy for instent 

restenosis within bare-metal stents: the TAXUS V ISR 

randomized trial. JAMA 2006;295(11):1253-1263. 

Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, 

Johnson WL, Rutherford BD. Procedural outcomes and longterm 

survival among patients undergoing percutaneous coronary 

intervention of a chronic total occlusion in native coronary 

arteries: a 20-year experience. J Am Coll Cardiol 2001;38(2):409- 

414. 

Vaknin-Assa H, Assali A, Kornowski R. Preliminary experiences 

using the MGuard stent platform in saphenous vein graft lesions. 

Catheter Cardiovasc Interv 2009;74(7):1055-1057. 

van der Waal EC, Mintz GS, Garcia-Garcia HM, Bui AB, Pehlivanova 

M, Girasis C, Serruys PW, Van der Giessen WJ, Weissman NJ. 

Intravascular ultrasound and 3D angle measurements of coronary 

bifurcations. Catheter Cardiovasc Interv 2009;73(7):910-916. 

Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, 

Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky 

AJ. 9-month clinical, angiographic, and intravascular ultrasound 

results of a prospective evaluation of the Axxess self-expanding 

biolimus A9-eluting stent in coronary bifurcation lesions: the 

DIVERGE (Drug-Eluting Stent Intervention for Treating Side 

Branches Effectively) study. J Am Coll Cardiol 2009;53(12):1031- 

1039. 

Verheye S, Grube E, Ramcharitar S, Schofer JJ, Witzenbichler 

B, Kovac J, Hauptmann KE, Agostoni P, Wiemer M, Lefevre T, 

Serruys PW, van Geuns RJ. First-in-man (FIM) study of the 

Stentys bifurcation stent--30 days results. EuroIntervention 

2009;4(5):566-571. 

Werner GS, Di MC, Galassi AR, Gershlick A, Reimers B, Sianos G, 

Sievert H, Lefevre T, Reifart N. Chronic total coronary occlusions 

and the occluded artery trial. A critical appraisal. EuroIntervention 

2008;4(1):23-27. 

11.3 Drug-eluting stents 

NICE (National Institute for Clinical Excellence): Coronary artery 

stents. 2008. 

Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, 

Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev 

I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori 

C, Grube E. Incidence and predictors of drug-eluting stent 

thrombosis during and after discontinuation of thienopyridine 

treatment. Circulation 2007;116(7):745-754. 

Aoki J, Serruys PW, van BH, Ong AT, McFadden EP, Sianos G, Van 

der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, 

Kutryk MJ. Endothelial progenitor cell capture by stents coated 

with antibody against CD34: the HEALING-FIM (Healthy 

Endothelial Accelerated Lining Inhibits Neointimal Growth-First 

In Man) Registry. J Am Coll Cardiol 2005;45(10):1574-1579. 

Carlsson J, James SK, Lindback J, Schersten F, Nilsson T, Stenestrand 

U, Lagerqvist B. Outcome of drug-eluting versus bare-metal 

stenting used according to on- and off-label criteria. J Am Coll 

Cardiol 2009;53(16):1389-1398. 

Di Lorenzo E, De LG, Sauro R, Varricchio A, Capasso M, Lanzillo T, 

Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato 

G. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare 

Metal Stent in Primary Angioplasty) Randomized Trial. JACC 


Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, 

Slagboom T, Kiemeneij F, Laarman GJ. Two year follow-up after 

primary PCI with a paclitaxel-eluting stent versus a bare-metal 

stent for acute ST-elevation myocardial infarction (the PASSION 

trial): a follow-up study. EuroIntervention 2008;4(1):64-70. 

Duckers HJ, Silber S, de WR, den HP, Rensing B, Rau M, Mudra H, 

Benit E, Verheye S, Wijns W, Serruys PW. Circulating endothelial 

progenitor cells predict angiographic and intravascular ultrasound 

outcome following percutaneous coronary interventions in the 

HEALING-II trial: evaluation of an endothelial progenitor cell 

capturing stent. EuroIntervention 2007;3(1):67-75. 

Erbel R, Di MC, Bartunek J, Bonnier J, de BB, Eberli FR, Erne P, Haude 

M, Heublein B, Horrigan M, Ilsley C, Bose D, Koolen J, Luscher 

TF, Weissman N, Waksman R. Temporary scaffolding of coronary 

arteries with bioabsorbable magnesium stents: a prospective, nonrandomised 

multicentre trial. Lancet 2007;369(9576):1869-1875. 

Fasseas P, Orford JL, Panetta CJ, Bell MR, Denktas AE, Lennon 

RJ, Holmes DR, Berger PB. Incidence, correlates, management, 

and clinical outcome of coronary perforation: analysis of 16,298 

procedures. Am Heart J 2004;147(1):140-145. 

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini 

A, aspardone A, acca G, e Luca L, assanelli C, ibichini F. Long-term 

results of immunosuppressive oral prednisone after coronary 

angioplasty in non-diabetic patients with elevated C-reactive 

protein levels. EuroIntervention 2009;(5):250-254. 

Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn 

I, Detre K, Veltri L, Ricci D, Nobuyoshi M, . A randomized 

comparison of coronary-stent placement and balloon angioplasty 

in the treatment of coronary artery disease. Stent Restenosis 

Study Investigators. N Engl J Med 1994;331(8):496-501. 

Grube E, Lansky A, Hauptmann KE, Di MC, Di SG, Colombo A, 

Silber S, Stumpf J, Reifart N, Fajadet J, Marzocchi A, Schofer J, 

Dumas P, Hoffmann R, Guagliumi G, Pitney M, Russell ME. Highdose 

7-hexanoyltaxol-eluting stent with polymer sleeves for 

coronary revascularization: one-year results from the SCORE 

randomized trial. J Am Coll Cardiol 2004;44(7):1368-1372. 

Hanekamp CE, Koolen JJ, den HP, Schalij MJ, Piek JJ, Bar FW, De 

S, I, Bonnier HJ, Pijls NH. Randomized study to compare balloon 

angioplasty and elective stent implantation in venous bypass grafts: 

the Venestent study. Catheter Cardiovasc Interv 2003;60(4):452- 

457. 

Hausleiter J, Kastrati A, Mehilli J, Vogeser M, Zohlnhofer D, 

Schuhlen H, Goos C, Pache J, Dotzer F, Pogatsa-Murray G, 

Dirschinger J, Heemann U, Schomig A. Randomized, doubleblind, 

placebo-controlled trial of oral sirolimus for restenosis 

prevention in patients with in-stent restenosis: the Oral Sirolimus 

to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 

2004;110(7):790-795. 

James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, 

Nilsson T, Wallentin L, Lagerqvist B. Long-term safety and efficacy 

of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 

2009;360(19):1933-1945. 

Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Klovgaard 

L, Kaltoft A, Andersen B, Thuesen H, Engstrom T, Botker HE, 

Saunamaki K, Krusell LR, Jorgensen E, Hansen HH, Christiansen


EH, Ravkilde J, Kober L, Kofoed KF, Terkelsen CJ, Lassen JF. 

Drug-eluting versus bare metal stents in patients with st-segmentelevation 

myocardial infarction: eight-month follow-up in the 

Drug Elution and Distal Protection in Acute Myocardial Infarction 

(DEDICATION) trial. Circulation 2008;118:1155-1162. 

Klomp M, Beijk MA, Verouden NJ, Tijssen JG, de Winter RJ. 

Design and rationale of the TRI-stent adjudication study (TRIAS) 

program. Am Heart J 2009;158(4):527-532. 

Laarman GJ, Suttorp MJ, Dirksen MT, van HL, Kiemeneij F, Slagboom 

T, van der Wieken LR, Tijssen JG, Rensing BJ, Patterson M. 

Paclitaxel-eluting versus uncoated stents in primary percutaneous 

coronary intervention. N Engl J Med 2006;355:1105-1113. 

Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, 

Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, 

yang jy, lee sg, kim ks, Yoon J, jeong mh, seung kb, hong tj, Park SJ. 

Comparison of the efficacy and safety of zotarolimus-, sirolimus-, 

and paclitaxel-eluting stents in patients with ST-elevation 

myocardial infarction. Am J Cardiol 2009;104:1370-1376. 

Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma 

MR, Zhou Z, Normand SL. Drug-eluting or bare-metal stents for 

acute myocardial infarction. N Engl J Med 2008;359:1330-1342. 

Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, 

Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald 

PJ. Clinical and angiographic results with the next-generation 

resolute stent system: a prospective, multicenter, first-in-human 

trial. JACC Cardiovasc Interv 2009;2(10):977-985. 

Mollmann H, Nef HM, Hamm CW, Bohm M, Cremers B. Highlights 

from Transcatheter Cardiovascular Therapeutics 2009. Clin Res 

Cardiol 2009. 

Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban HE, Perin M, 

Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, 

Falotico R. A randomized comparison of a sirolimus-eluting stent 

with a standard stent for coronary revascularization. N Engl J Med 

2002;346(23):1773-1780. 

Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold 

HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing 

and increased late stent thrombosis at culprit sites after drugeluting 

stent placement for acute myocardial infarction patients: 

an autopsy study. Circulation 2008;118:1138-1145. 

Nikolsky E, Lansky AJ, Sudhir K, Doostzadeh J, Cutlip DE, Piana R, 

Su X, White R, Simonton CA, Stone GW. SPIRIT IV trial design: 

a large-scale randomized comparison of everolimus-eluting stents 

and paclitaxel-eluting stents in patients with coronary artery 

disease. Am Heart J 2009;158(4):520-526. 

Nordmann AJ, Hengstler P, Leimenstoll BM, Harr T, Young J, Bucher 

HC. Clinical outcomes of stents versus balloon angioplasty in nonacute 

coronary artery disease. A meta-analysis of randomized 

controlled trials. Eur Heart J 2004;25(1):69-80. 

Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster 

MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A 

bioabsorbable everolimus-eluting coronary stent system for 

patients with single de-novo coronary artery lesions (ABSORB): a 

prospective open-label trial. Lancet 2008;371(9616):899-907. 

Ormiston JA, Webster MW, Armstrong G. First-in-human 

implantation of a fully bioabsorbable drug-eluting stent: the BVS 

poly-L-lactic acid everolimus-eluting coronary stent. Catheter 


Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR, 

Jr., O’Neill WW, Stebbins A, Van De Werf F, Armstrong PW, 

Granger CB. Comparison of six-month outcomes for primary 

percutaneous revascularization for acute myocardial infarction 

with drug-eluting versus bare metal stents (from the APEX-AMI 

study). Am J Cardiol 2009;103:181-186. 

Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati 

F, Crea F, Vassanelli C. Immunosuppressive oral prednisone after 

percutaneous interventions in patients with multi-vessel coronary 

artery disease. The IMPRESS-2/MVD study. EuroIntervention 

2005;1(2):173-180. 

Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, 

Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo 

AM, Schulz D, Raizner AE, Palacios I, O’Neill W, Kaluza GL, Stone 

G. Oral rapamycin after coronary bare-metal stent implantation to 

prevent restenosis: the Prospective, Randomized Oral Rapamycin 

in Argentina (ORAR II) Study. J Am Coll Cardiol 2006;47(8):1522- 

1529. 

Savage MP, Douglas JS, Jr., Fischman DL, Pepine CJ, King SB, III, 

Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, 

Goldberg S. Stent placement compared with balloon angioplasty 

for obstructed coronary bypass grafts. Saphenous Vein De Novo 

Trial Investigators. N Engl J Med 1997;337(11):740-747. 


Bohm M, Speck U. Two year follow-up after treatment of coronary 

in-stent restenosis with a paclitaxel-coated balloon catheter. Clin 

Res Cardiol 2008;97(10):773-781. 

Schomig A, Dibra A, Windecker S, Mehilli J, Suarez de LJ, Kaiser 

C, Park SJ, Goy JJ, Lee JH, Di LE, Wu J, Juni P, Pfisterer ME, 

Meier B, Kastrati A. A meta-analysis of 16 randomized trials of 

sirolimus-eluting stents versus paclitaxel-eluting stents in patients 

with coronary artery disease. J Am Coll Cardiol 2007;50(14):1373- 

1380. 

Schulz S, Schuster T, Mehilli J, Byrne RA, Ellert J, Massberg S, Goedel 

J, Bruskina O, Ulm K, Schomig A, Kastrati A. Stent thrombosis 

after drug-eluting stent implantation: incidence, timing, and 

relation to discontinuation of clopidogrel therapy over a 4-year 

period. Eur Heart J 2009;30(22):2714-2721. 

Serruys PW, de JP, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx 

G, Emanuelsson H, Marco J, Legrand V, Materne P, . A comparison 

of balloon-expandable-stent implantation with balloon angioplasty 

in patients with coronary artery disease. Benestent Study Group. 

N Engl J Med 1994;331(8):489-495. 

Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den HP, De 

FP, Buszman P, Schomig A, Marco J, Polonski L, Thuesen L, Zeiher 

AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, 

Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L, Virmani 

R. Actinomycin-eluting stent for coronary revascularization: a 

randomized feasibility and safety study: the ACTION trial. J Am 

Coll Cardiol 2004;44(7):1363-1367. 

Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. 

Intravascular stents to prevent occlusion and restenosis after 

transluminal angioplasty. N Engl J Med 1987;316(12):701-706. 

Silber S, Borggrefe M, Bohm M, Hoffmeister HM, Dietz R, Ertl G, 

Heusch G. [Drug-eluting coronary stents and drug eluting balloon 

catheters: summary of the position papers of the DGK]. Clin Res 

Cardiol 2008;97(8):548-563. 

Smits P. COMPARE: a physician initiated single center prospective 

randomized trial comparing the Taxus Liberté versus Xience 

V stent in an all-comer / real world situation. 2009. 

Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, Slama 

MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll 

HP, Snead DB, Bode C. Sirolimus-eluting versus uncoated stents 

in acute myocardial infarction. N Engl J Med 2006;355(11):1093- 

1104. 

Steg PG, Fox KA, Eagle KA, Furman M, Van De Werf F, Montalescot 

G, Goodman SG, Avezum A, Huang W, Gore JM. Mortality 

following placement of drug-eluting and bare-metal stents for 

ST-segment elevation acute myocardial infarction in the Global 

Registry of Acute Coronary Events. Eur Heart J 2009;30:321-329. 

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, 

Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, 

Mockel M, Ochala A, Kellock A, Parise H, Mehran R. Paclitaxel-


eluting stents versus bare-metal stents in acute myocardial 

infarction. N Engl J Med 2009;360(19):1946-1959. 

Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, Nakamura T, 

Fujita S, Takeda S, Motohara S, Uehata H. Biodegradable stents as 

a platform to drug loading. Int J Cardiovasc Intervent 2003;5(1):13- 

16. 

van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, 

Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, 

van der Wall EE, Schalij MJ. Sirolimus-eluting stents versus baremetal 

stents in patients with ST-segment elevation myocardial 

infarction: 9-month angiographic and intravascular ultrasound 

results and 12-month clinical outcome results from the MISSION! 

Intervention Study. J Am Coll Cardiol 2008;51:618-626. 

Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens 

C, Bruining N, van den Branden F, Van LG. Randomized doubleblind 

comparison of sirolimus-eluting stent versus bare-metal 

stent implantation in diseased saphenous vein grafts: six-month 

angiographic, intravascular ultrasound, and clinical follow-up of 

the RRISC Trial. J Am Coll Cardiol 2006;48(12):2423-2431. 

Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens 

C, van den Branden F, Van LG. Increased late mortality after 

sirolimus-eluting stents versus bare-metal stents in diseased 

saphenous vein grafts: results from the randomized DELAYED 

RRISC Trial. J Am Coll Cardiol 2007;50(3):261-267. 

Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, 

Ghini AS, Ferrero V, Chiariello L, Gioffre PA, Romeo F, Crea F. 

Immunosuppressive Therapy for the Prevention of Restenosis 

after Coronary Artery Stent Implantation (IMPRESS Study). J Am 

Coll Cardiol 2002;40(11):1935-1942. 

Waksman R, Ajani AE, Pichard AD, Torguson R, Pinnow E, Canos 

D, Satler LF, Kent KM, Kuchulakanti P, Pappas C, Gambone L, 

Weissman N, Abbott MC, Lindsay J. Oral rapamycin to inhibit 

restenosis after stenting of de novo coronary lesions: the Oral 

Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol 

2004;44(7):1386-1392. 

11.4 Adjunctive invasive diagnostic tools 

Bech GJ, de BB, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, 

Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional 

flow reserve to determine the appropriateness of angioplasty 

in moderate coronary stenosis: a randomized trial. Circulation 

2001;103(24):2928-2934. 





2005;46(3):438-442. 

Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. 

Intracoronary optical coherence tomography: a comprehensive 

review clinical and research applications. JACC Cardiovasc Interv 

2009;2(11):1035-1046. 

De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, 

Wijns W. Simultaneous coronary pressure and flow velocity 

measurements in humans. Feasibility, reproducibility, and 

hemodynamic dependence of coronary flow velocity reserve, 

hyperemic flow versus pressure slope index, and fractional flow 

reserve. Circulation 1996;94(8):1842-1849. 

De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De WH, Van 

CP, Heyndrickx GR, Wijns W. Fractional flow reserve in patients 

with prior myocardial infarction. Circulation 2001;104(2):157-162. 

Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER, 

Gimple LW, Ragosta M. Comparison between visual assessment 

and quantitative angiography versus fractional flow reserve for 

native coronary narrowings of moderate severity. Am J Cardiol 

2002;90(3):210-215. 

Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS, 

Cleman MW, Deutsch E, Diver DJ, Leon MB, Moses JW, Oesterle 

SN, Overlie PA, Pepine CJ, Safian RD, Shani J, Simonton CA, 

Smalling RW, Teirstein PS, Zidar JP, Yeung AC, Kuntz RE, Yock 

PG. Final results of the Can Routine Ultrasound Influence Stent 

Expansion (CRUISE) study. Circulation 2000;102(5):523-530. 

Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno 

G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, 

Heyndrickx GR, Wijns W, de BB. Long-term clinical outcome 

after fractional flow reserve-guided treatment in patients with 

angiographically equivocal left main coronary artery stenosis. 

Circulation 2009;120(15):1505-1512. 

Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, Kim 

YH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Intravascular 

ultrasound predictors of angiographic restenosis after sirolimuseluting 

stent implantation. Eur Heart J 2006;27(11):1305-1310. 

Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. 

Frequency of stress testing to document ischemia prior to elective 

percutaneous coronary intervention. JAMA 2008;300(15):1765- 

1773. 

Lopez-Palop R, Pinar E, Lozano I, Saura D, Pico F, Valdes M. Utility 

of the fractional flow reserve in the evaluation of angiographically 

moderate in-stent restenosis. Eur Heart J 2004;25(22):2040- 

2047. 

Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, Melikian 

N, Vanderheyden M, Heyndrickx GR, Wyffels E, Wijns W, de 

BB. Severity of coronary arterial stenoses responsible for acute 

coronary syndromes. Am J Cardiol 2009;103(9):1183-1188. 

Melikian N, De BP, Tonino P, De WO, Wyffels E, Bartunek J, 

Heyndrickx GR, Fearon WF, Pijls NH, Wijns W, de BB. Fractional 

flow reserve and myocardial perfusion imaging in patients 

with angiographic multivessel coronary artery disease. JACC 


Mudra H, Di MC, de JP, Figulla HR, Macaya C, Zahn R, Wennerblom B, 

Rutsch W, Voudris V, Regar E, Henneke KH, Schachinger V, Zeiher 

A. Randomized comparison of coronary stent implantation under 

ultrasound or angiographic guidance to reduce stent restenosis 

(OPTICUS Study). Circulation 2001;104(12):1343-1349. 

Orford JL, Lerman A, Holmes DR. Routine intravascular ultrasound 

guidance of percutaneous coronary intervention: a critical 

reappraisal. J Am Coll Cardiol 2004;43(8):1335-1342. 

Pijls NH, de BB, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek 

JKJ, Koolen JJ. Measurement of fractional flow reserve to assess 

the functional severity of coronary-artery stenoses. N Engl J Med 

1996;334(26):1703-1708. 

Prati F, Regar E, Mintz GS, Arbustini E, Di MC, Jang IK, Akasaka T, 

Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW. 

Expert review document on methodology, terminology, and clinical 

applications of optical coherence tomography: physical principles, 

methodology of image acquisition, and clinical application for 

assessment of coronary arteries and atherosclerosis. Eur Heart 

J 2010;31:401-415. 

Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, 

Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard 

AD, Weissman NJ, Lindsay J, Waksman R. The potential clinical 

utility of intravascular ultrasound guidance in patients undergoing 

percutaneous coronary intervention with drug-eluting stents. Eur 

Heart J 2008;29(15):1851-1857. 

Schiele F, Meneveau N, Vuillemenot A, Zhang DD, Gupta S, Mercier 

M, Danchin N, Bertrand B, Bassand JP. Impact of intravascular 

ultrasound guidance in stent deployment on 6-month restenosis 

rate: a multicenter, randomized study comparing two strategies-with 

and without intravascular ultrasound guidance. RESIST Study 

Group. REStenosis after Ivus guided STenting. J Am Coll Cardiol


1998;32(2):320-328. 

Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DW, Schork NJ, 

Schork MA, Loop FD. Analysis of coronary angioplasty practice in 

the United States with an insurance-claims data base. Circulation 

1993;87(5):1489-1497. 

12. Antithrombotic 

Pharmacotherapy 

12.1 Elective PCI 

Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, 

Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA. 

Randomized comparison of a high clopidogrel maintenance dose 

in patients with diabetes mellitus and coronary artery disease: 

results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus 

(OPTIMUS) study. Circulation 2007;115(6):708-716. 

Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, 

Wong SC. Efficacy of high-dose clopidogrel treatment (600 mg) 

less than two hours before percutaneous coronary intervention 

in patients with non-ST-segment elevation acute coronary 

syndromes. Am J Cardiol 2010;105(3):323-332. 

Kastrati A, Mehilli J, Schuhlen H, Dirschinger J, Dotzer F, ten Berg 

JM, Neumann FJ, Bollwein H, Volmer C, Gawaz M, Berger PB, 

Schomig A. A clinical trial of abciximab in elective percutaneous 

coronary intervention after pretreatment with clopidogrel. N 

Engl J Med 2004;350(3):232-238. 

Mehilli J, Kastrati A, Schuhlen H, Dibra A, Dotzer F, von BN, Bollwein 

H, Pache J, Dirschinger J, Berger PP, Schomig A. Randomized 

clinical trial of abciximab in diabetic patients undergoing elective 

percutaneous coronary interventions after treatment with a high 

loading dose of clopidogrel. Circulation 2004;110(24):3627-3635. 

Montalescot G, Sideris G, Meuleman C, Bal-dit-Sollier C, Lellouche 

N, Steg PG, Slama M, Milleron O, Collet JP, Henry P, Beygui F, 

Drouet L. A randomized comparison of high clopidogrel loading 

doses in patients with non-ST-segment elevation acute coronary 

syndromes: the ALBION (Assessment of the Best Loading Dose 

of Clopidogrel to Blunt Platelet Activation, Inflammation and 

Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48(5):931-938. 

Widimsky P, Motovska Z, Simek S, Kala P, Pudil R, Holm F, Petr 

R, Bilkova D, Skalicka H, Kuchynka P, Poloczek M, Miklik R, Maly 

M, Aschermann M. Clopidogrel pre-treatment in stable angina: 

for all patients > 6 h before elective coronary angiography or 

only for angiographically selected patients a few minutes before 

PCI? A randomized multicentre trial PRAGUE-8. Eur Heart J 

2008;29(12):1495-1503. 

12.2 Non ST-segment Elevation Acute 

Coronary Syndrome 

Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, 

Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis 

BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo 

W, Verheugt F, Wallentin L. Apixaban, an oral, direct, selective 

factor Xa inhibitor, in combination with antiplatelet therapy after 

acute coronary syndrome: results of the Apixaban for Prevention 

of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation 

2009;119(22):2877-2885. 

Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky 

P, Chandna H, Macias W, McCabe CH, Braunwald E. Early 

and late benefits of prasugrel in patients with acute coronary 

syndromes undergoing percutaneous coronary intervention: a 

TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic 

Outcomes by Optimizing Platelet InhibitioN with Prasugrel- 

Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol 

2008;51(21):2028-2033. 

de Araujo GP, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, 

PURSUIT, and GRACE risk scores: sustained prognostic value 

and interaction with revascularization in NSTE-ACS. Eur Heart 

J 2005;26(9):865-872. 

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, 

Buonamici P, Antoniucci D, Abbate R, Gensini GF. Cardiovascular 

death and nonfatal myocardial infarction in acute coronary 

syndrome patients receiving coronary stenting are predicted by 

residual platelet reactivity to ADP detected by a point-of-care 

assay: a 12-month follow-up. Circulation 2009;119(2):237-242. 

Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, 

Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, 

Markov V, Oppenheimer L, Gibson CM. Rivaroxaban versus 

placebo in patients with acute coronary syndromes (ATLAS 

ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet 

2009;374(9683):29-38. 

Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, 

Huber K, Lopez-Sendon J, McCabe CH, Braunwald E. Reduction 

in recurrent cardiovascular events with prasugrel compared with 

clopidogrel in patients with acute coronary syndromes from the 

TRITON-TIMI 38 trial. Eur Heart J 2008;29(20):2473-2479. 

Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, 

McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo 

A, Manoukian SV, Lansky AJ, Mehran R, Moses JW. Bivalirudin 

in patients with acute coronary syndromes undergoing 

percutaneous coronary intervention: a subgroup analysis from the 

Acute Catheterization and Urgent Intervention Triage strategy 

(ACUITY) trial. Lancet 2007;369(9565):907-919. 

12.3 ST-segment Elevation Myocardial 

Infarction 

Davlouros PA, Arseniou A, Hahalis G, Chiladakis J, Mazarakis 

A, Damelou A, Karakantza M, Paliogianni F, Karogiannis N, 

Alexopoulos D. Timing of clopidogrel loading before percutaneous 

coronary intervention in clopidogrel-naive patients with stable 

or unstable angina: a comparison of two strategies. Am Heart J 

2009;158:585-591. 

De Luca G, Gibson CM, Bellandi F, Murphy S, Maioli M, Noc M, 

Zeymer U, Dudek D, Arntz HR, Zorman S, Gabriel HM, Emre 

A, Cutlip D, Biondi-Zoccai G, Rakowski T, Gyongyosi M, Marino 

P, Huber K, van’t Hof AW. Early glycoprotein IIb-IIIa inhibitors in 

primary angioplasty (EGYPT) cooperation: an individual patient 

data meta-analysis. Heart 2008;94(12):1548-1558. 

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, 

Buonamici P, Antoniucci D, Abbate R, Gensini GF. Cardiovascular 

death and nonfatal myocardial infarction in acute coronary 

syndrome patients receiving coronary stenting are predicted by 

residual platelet reactivity to ADP detected by a point-of-care 

assay: a 12-month follow-up. Circulation 2009;119(2):237-242. 

Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, 

Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, 

Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise 

H, Dangas GD, Stone GW. Bivalirudin in patients undergoing 

primary angioplasty for acute myocardial infarction (HORIZONS- 

AMI): 1-year results of a randomised controlled trial. Lancet 

2009;374(9696):1149-1159. 

Montalescot G, Borentain M, Payot L, Collet JP, Thomas D. Early 

vs late administration of glycoprotein IIb/IIIa inhibitors in primary 

percutaneous coronary intervention of acute ST-segment elevation 

myocardial infarction: a meta-analysis. JAMA 2004;292(3):362- 

366.


Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, 

Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel 

JS, Partyka L, Dudek D. Early abciximab administration before 

transfer for primary percutaneous coronary interventions for 

ST-elevation myocardial infarction reduces 1-year mortality in 

patients with high-risk profile. Results from EUROTRANSFER 

registry. Am Heart J 2009;158(4):569-575. 

Zeymer U, Arntz HR, Darius H, Huber K, Senges J. Efficacy and 

safety of clopidogrel 600 mg administered pre-hospitally to 

improve primary percutaneous coronary intervention in patients 

with acute myocardial infarction (CIPAMI): study rationale and 

design. Cardiology 2007;108(4):265-272. 

12.4 Points of Interest and Special 

Conditions 

Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri 

M, Anselmi M, Vassanelli C, Zardini P, Louvard Y, Hamon M. Radial 

versus femoral approach for percutaneous coronary diagnostic 

and interventional procedures; Systematic overview and metaanalysis 

of randomized trials. J Am Coll Cardiol 2004;44:349-356. 

Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, 

Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev 

I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori 

C, Grube E. Incidence and predictors of drug-eluting stent 

thrombosis during and after discontinuation of thienopyridine 

treatment. Circulation 2007;116(7):745-754. 

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg 

CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, 

Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul 

S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson 

RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 

expert consensus document on reducing the gastrointestinal risks 

of antiplatelet therapy and NSAID use: a report of the American 

College of Cardiology Foundation Task Force on Clinical Expert 

Consensus Documents. J Am Coll Cardiol 2008;52(18):1502- 

1517. 

Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS, 

Lachno DR, Salazar D, Winters KJ. Common polymorphisms 

of CYP2C19 and CYP2C9 affect the pharmacokinetic and 

pharmacodynamic response to clopidogrel but not prasugrel. J 

Thromb Haemost 2007;5(12):2429-2436. 

Brasselet C, Tassan S, Nazeyrollas P, Hamon M, Metz D. Randomised 

comparison of femoral versus radial approach for percutaneous 

coronary intervention using abciximab in acute myocardial 

infarction: results of the FARMI trial. Heart 2007;93:1556-1561. 

Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi 

D, Berry B, Hilton JD. Association of the arterial access site at 

angioplasty with transfusion and mortality: the M.O.R.T.A.L study 

(Mortality benefit Of Reduced Transfusion after percutaneous 

coronary intervention via the Arm or Leg). Heart 2008;94:1019- 

1025. 

Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, 

Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson 

ED, Schulman KA, Califf RM. Clopidogrel use and long-term 

clinical outcomes after drug-eluting stent implantation. JAMA 

2007;297(2):159-168. 

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, 

Rumsfeld JS. Risk of adverse outcomes associated with concomitant 

use of clopidogrel and proton pump inhibitors following acute 

coronary syndrome. JAMA 2009;301(9):937-944. 

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry 

DA, Kopp A, Mamdani MM. A population-based study of the drug 

interaction between proton pump inhibitors and clopidogrel. 

CMAJ 2009;180(7):713-718. 

Lip YH, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset 

T, Crichhof P, Marin F. Management of antithrombotic therapy in 

atrial fibrillation patients presenting with acute coronary syndrome 

and/or undergoing percutaneous coronary intervention/stenting. 

Thromb Haemost 2010;103:13-28. 

Melloni C, Mahaffey KW. Management of acute coronary 

syndromes in patients with renal dysfunction. Curr Opin Cardiol 

2008;23(4):320-326. 

Neubauer H, Mugge A. Thienopyridines and statins: assessing a 

potential drug-drug interaction. Curr Pharm Des 2006;12(10):1271- 

1280. 

Saito S, Tanaka S, Hiroe Y, Miyashita Y, Takahashi S, Tanaka 

K, Satake S. Comparative study on transradial approach vs. 

transfemoral approach in primary stent implantation for patients 

with acute myocardial infarction: results of the test for myocardial 

infarction by prospective unicenter randomization for access sites 

(TEMPURA) trial. Catheter Cardiovasc Interv 2003;59:26-33. 

Savonitto S, D’Urbano M, Caracciolo M, Barlocco F, Mariani G, 

Nichelatti M, Klugmann S, de SS. Urgent surgery in patients with 

a recently implanted coronary drug-eluting stent: a phase II study 

of ‘bridging’ antiplatelet therapy with tirofiban during temporary 

withdrawal of clopidogrel. Br J Anaesth 2010;104(3):285-291. 

Shahian DM, Edwards FH, Ferraris VA, Haan CK, Rich JB, Normand 

SL, DeLong ER, O’Brien SM, Shewan CM, Dokholyan RS, 

Peterson ED. Quality measurement in adult cardiac surgery: part 

1--Conceptual framework and measure selection. Ann Thorac 

Surg 2007;83(4 Suppl):S3-12. 

Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, 

Schomig A, Kastrati A, von BN. Impact of proton pump inhibitors 

on the antiplatelet effects of clopidogrel. Thromb Haemost 

2009;101(4):714-719. 

Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization 

procedure for patients with aspirin hypersensitivity undergoing 

coronary stenting. Am J Cardiol 2005;95(4):509-510. 

Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. 

Effects of pantoprazole and esomeprazole on platelet inhibition 

by clopidogrel. Am Heart J 2009;157(1):148-5. 

Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, 

Meneveau N, Steg PG, Ferrieres J, Danchin N, Becquemont 

L. Genetic determinants of response to clopidogrel and 

cardiovascular events. N Engl J Med 2009;360(4):363-375. 

13 Secondary prevention 

13.1 Background and rationale 

Fraker TD, Jr., Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, 

Deedwania PC, Douglas JS, Ferguson TB, Jr., Gardin JM, O’Rourke 

RA, Williams SV, Smith SC, Jr., Jacobs AK, Adams CD, Anderson 

JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, 

Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, 

Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused 

update of the ACC/AHA 2002 guidelines for the management 

of patients with chronic stable angina: a report of the American 


on Practice Guidelines Writing Group to develop the focused 

update of the 2002 guidelines for the management of patients with 

chronic stable angina. J Am Coll Cardiol 2007;50(23):2264-2274. 

Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim 

S. Exercise-based rehabilitation for coronary heart disease. 

Cochrane Database Syst Rev 2001;(1):CD001800. 

Kotseva K, Wood D, De BG, De BD, Pyorala K, Keil U. EUROASPIRE 

III: a survey on the lifestyle, risk factors and use of cardioprotective


drug therapies in coronary patients from 22 European countries. 

Eur J Cardiovasc Prev Rehabil 2009;16(2):121-137. 

13.2 Modalities 

Ezetimibe--an update. Drug Ther Bull 2009;47(8):91-95. 

AACVPR. Chapter 6. Guidelines for cardiac rehabilitation and 

secondary prevention. 4th Edition ed. Human Kinetics; 2003. p. 

83-84. 

Cook JR, Dillie KS, Hakeem A, Bhatti S, Chang SM. Effectiveness of 

anemia and chronic kidney disease as predictors for presence and 

severity of coronary artery disease in patients undergoing stress 

myocardial perfusion study. Am J Cardiol 2008;102(3):266-271. 

Fraker TD, Jr., Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, 

Deedwania PC, Douglas JS, Ferguson TB, Jr., Gardin JM, O’Rourke 

RA, Williams SV, Smith SC, Jr., Jacobs AK, Adams CD, Anderson 

JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, 

Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, 

Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused 

update of the ACC/AHA 2002 guidelines for the management 

of patients with chronic stable angina: a report of the American 


on Practice Guidelines Writing Group to develop the focused 

update of the 2002 guidelines for the management of patients with 

chronic stable angina. J Am Coll Cardiol 2007;50(23):2264-2274. 

Giannuzzi P, Mezzani A, Saner H, Bjornstad H, Fioretti P, Mendes 

M, Cohen-Solal A, Dugmore L, Hambrecht R, Hellemans I, 

McGee H, Perk J, Vanhees L, Veress G. Physical activity for 

primary and secondary prevention. Position paper of the Working 

Group on Cardiac Rehabilitation and Exercise Physiology of the 

European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 

2003;10(5):319-327. 

Giannuzzi P, Saner H, Bjornstad H, Fioretti P, Mendes M, Cohen- 

Solal A, Dugmore L, Hambrecht R, Hellemans I, McGee H, Perk 

J, Vanhees L, Veress G. Secondary prevention through cardiac 

rehabilitation: position paper of the Working Group on Cardiac 

Rehabilitation and Exercise Physiology of the European Society of 

Cardiology. Eur Heart J 2003;24(13):1273-1278. 

Gluckman TJ, Sachdev M, Schulman SP, Blumenthal RS. A simplified 

approach to the management of non-ST-segment elevation acute 

coronary syndromes. JAMA 2005;293(3):349-357. 

Goto Y, Sumida H, Ueshima K, Adachi H, Nohara R, Itoh H. 

Safety and implementation of exercise testing and training after 

coronary stenting in patients with acute myocardial infarction. 

Circ J 2002;66(10):930-936. 

Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, 

Hunninghake DB, Pasternak RC, Smith SC, Jr., Stone NJ. 

Implications of recent clinical trials for the National Cholesterol 

Education Program Adult Treatment Panel III guidelines. 

Circulation 2004;110(2):227-239. 

Hebert PC, Van der Linden P, Biro G, Hu LQ. Physiologic aspects of 

anemia. Crit Care Clin 2004;20(2):187-212. 

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, 

Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, 

randomized, controlled clinical trial of transfusion requirements 

in critical care. Transfusion Requirements in Critical Care 

Investigators, Canadian Critical Care Trials Group. N Engl J Med 

1999;340(6):409-417. 

Josan K, Majumdar SR, McAlister FA. The efficacy and safety of 

intensive statin therapy: a meta-analysis of randomized trials. 

CMAJ 2008;178(5):576-584. 

Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 

polyunsaturated fatty acids and cardiovascular diseases. J Am Coll 

Cardiol 2009;54(7):585-594. 

Piepoli MF, Corra U, Benzer W, et al. Secondary prevention 

through cardiac rehabilitation: physical activity counselling and 

exercise training. Key components from the Position Paper from 

the Cardiac Rehabilitation Section of the European Association of 

Cardiac Prevention and Rehabilitation. European Heart Journal 

(2010) 31, 1967–1976;doi:10.1093/eurheartj/ehq236 

Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological 

interventions for coronary heart disease. Cochrane Database 

Syst Rev 2004;(2):CD002902. 

Roffi M, Wenaweser P, Windecker S, Mehta H, Eberli FR, Seiler 

C, Fleisch M, Garachemani A, Pedrazzini GB, Hess OM, Meier B. 

Early exercise after coronary stenting is safe. J Am Coll Cardiol 

2003;42(9):1569-1573. 

Thompson PD. Exercise prescription and proscription for patients 

with coronary artery disease. Circulation 2005;112(15):2354- 

2363. 

Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus 

BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon 

NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK. Exercise and 

physical activity in the prevention and treatment of atherosclerotic 

cardiovascular disease: a statement from the Council on Clinical 

Cardiology (Subcommittee on Exercise, Rehabilitation, and 

Prevention) and the Council on Nutrition, Physical Activity, and 

Metabolism (Subcommittee on Physical Activity). Circulation 

2003;107(24):3109-3116. 

Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. 

Am Heart J 1972;83(3):415-426. 

Wilkins. Chapter 8. ACM’s Guidelines for exercise testing. 7th 

Edition ed. Lippincott Williams; 2006. p. 67-71. 

Wisløff U, Ellingsen Ø, Kemi O. High-Intensity Interval Training to 

Maximize Cardiac Benefits of Exercise Training? Exercise & Sport 

Sciences Reviews 2009;37:139-146. 

13.3 Settings 

Giannuzzi P. Rehabilitation Modalities. In: Perk J, Mathes P, Golhke 

H, Hellemans I, McGee H, Sellier P, Saner H, eds. Cardiovascular 

prevention and rehabilitation. Springer-Verlag London Limited; 

2007. p. 454-459. 

Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, 

Ceci V, Chieffo C, Gattone M, Griffo R, Schweiger C, Tavazzi L, 

Urbinati S, Valagussa F, Vanuzzo D. Global secondary prevention 

strategies to limit event recurrence after myocardial infarction: 

results of the GOSPEL study, a multicenter, randomized controlled 

trial from the Italian Cardiac Rehabilitation Network. Arch Intern 

Med 2008;168(20):2194-2204. 

14 Strategies for follow-up 

Third Report of the National Cholesterol Education Program 

(NCEP) Expert Panel on Detection, Evaluation, and Treatment of 

High Blood Cholesterol in Adults (Adult Treatment Panel III) final 

report. Circulation 2002;106(25):3143-3421. 

Aboul-Enein H, Bengston JR, Adams DB, Mostafa MA, Ibrahim MM, 

Hifny AA, Sheikh KH. Effect of the degree of effort on exercise 

echocardiography for the detection of restenosis after coronary 

artery angioplasty. Am Heart J 1991;122(2):430-437. 

Alazraki NP, Krawczynska EG. Thallium imaging in management of 

post-revascularization patients. Q J Nucl Med 1996;40(1):85-90. 

Becher H, Chambers J, Fox K, Jones R, Leech GJ, Masani N, 

Monaghan M, More R, Nihoyannopoulos P, Rimington H, Senior 

R, Warton G. BSE procedure guidelines for the clinical application 

of stress echocardiography, recommendations for performance 

and interpretation of stress echocardiography: a report of the 

British Society of Echocardiography Policy Committee. Heart


2004;90 Suppl 6:vi23-vi30. 

Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. 

Exercise training intervention after coronary angioplasty: the 

ETICA trial. J Am Coll Cardiol 2001;37(7):1891-1900. 

Beleslin BD, Ostojic M, Djordjevic-Dikic A, Babic R, Nedeljkovic M, 

Stankovic G, Stojkovic S, Marinkovic J, Nedeljkovic I, Stepanovic 

J, Saponjski J, Petrasinovic Z, Nedeljkovic S, Kanjuh V. Integrated 

evaluation of relation between coronary lesion features and stress 

echocardiography results: the importance of coronary lesion 

morphology. J Am Coll Cardiol 1999;33(3):717-726. 

Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic 

S, Nedeljkovic M, Stankovic G, Petrasinovic Z, Gojkovic L, 

Vasiljevic-Pokrajcic Z, . Stress echocardiography in the detection 

of myocardial ischemia. Head-to-head comparison of exercise, 

dobutamine, and dipyridamole tests. Circulation 1994;90(3):1168- 

1176. 

Broderick T, Sawada S, Armstrong WF, Ryan T, Dillon JC, Bourdillon 

PD, Feigenbaum H. Improvement in rest and exercise-induced 

wall motion abnormalities after coronary angioplasty: an exercise 

echocardiographic study. J Am Coll Cardiol 1990;15(3):591-599. 

Burgstahler C, Beck T, Kuettner A, Drosch T, Kopp AF, Heuschmid 

M, Claussen CD, Schroeder S. Non-invasive evaluation of 

coronary artery bypass grafts using 16-row multi-slice computed 

tomography with 188 ms temporal resolution. Int J Cardiol 

2006;106(2):244-249. 

Corra U, Mendes M, Piepoli M, Saner H. Future perspectives 

in cardiac rehabilitation: a new European Association for 

Cardiovascular Prevention and Rehabilitation Position Paper 

on ‘secondary prevention through cardiac rehabilitation’. Eur J 

Cardiovasc Prev Rehabil 2007;14(6):723-725. 

DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel 

SE, Kostis JB, Kloner RA, Lakin M, Meston CM, Mittleman M, 

Muller JE, Padma-Nathan H, Rosen RC, Stein RA, Zusman R. 

Management of sexual dysfunction in patients with cardiovascular 

disease: recommendations of The Princeton Consensus Panel. 

Am J Cardiol 2000;86(2):175-181. 

Djordjevic-Dikic AD, Ostojic MC, Beleslin BD, Stepanovic J, 

Petrasinovic Z, Babic R, Stojkovic SM, Stankovic G, Nedeljkovic 

M, Nedeljkovic I, Kanjuh V. High dose adenosine stress 

echocardiography for noninvasive detection of coronary artery 

disease. J Am Coll Cardiol 1996;28(7):1689-1695. 

Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Peterson 

ED, Hendel RC, Stainback RF, Blaivas M, Des Prez RD, Gillam 

LD, Golash T, Hiratzka LF, Kussmaul WG, Labovitz AJ, Lindenfeld 

J, Masoudi FA, Mayo PH, Porembka D, Spertus JA, Wann LS, 

Wiegers SE, Brindis RG, Douglas PS, Hendel RC, Patel MR, 

Peterson ED, Wolk MJ, Allen JM. ACCF/ASE/ACEP/AHA/ASNC/ 

SCAI/SCCT/SCMR 2008 appropriateness criteria for stress 

echocardiography: a report of the American College of Cardiology 

Foundation Appropriateness Criteria Task Force, American 

Society of Echocardiography, American College of Emergency 

Physicians, American Heart Association, American Society of 

Nuclear Cardiology, Society for Cardiovascular Angiography and 

Interventions, Society of Cardiovascular Computed Tomography, 

and Society for Cardiovascular Magnetic Resonance endorsed 

by the Heart Rhythm Society and the Society of Critical Care 

Medicine. J Am Coll Cardiol 2008;51(11):1127-1147. 

Eisenberg MJ, Wilson B, Lauzon C, Huynh T, Eisenhauer M, Mak 

KH, Blankenship JC, Doucet M, Pilote L. Routine functional 

testing after percutaneous coronary intervention: results of the 

aggressive diagnosis of restenosis in high-risk patients (ADORE II) 

trial. Acta Cardiol 2007;62(2):143-150. 

Galassi AR, Grasso C, Azzarelli S, Ussia G, Moshiri S, Tamburino 

C. Usefulness of exercise myocardial scintigraphy in multivessel 

coronary disease after incomplete revascularization with coronary 

stenting. Am J Cardiol 2006;97(2):207-215. 

Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, 

Froelicher VF, Mark DB, Marwick TH, McCallister BD, Thompson 

PD, Jr., Winters WL, Yanowitz FG, Ritchie JL, Gibbons RJ, Cheitlin 

MD, Eagle KA, Gardner TJ, Garson A, Jr., Lewis RP, O’Rourke RA, 

Ryan TJ. ACC/AHA Guidelines for Exercise Testing. A report of 

the American College of Cardiology/American Heart Association 

Task Force on Practice Guidelines (Committee on Exercise 

Testing). J Am Coll Cardiol 1997;30(1):260-311. 

Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, 

Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly 

MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon 

DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, 

Smith SC. ACC/AHA 2002 guideline update for exercise testing: 

summary article. A report of the American College of Cardiology/ 

American Heart Association Task Force on Practice Guidelines 

(Committee to Update the 1997 Exercise Testing Guidelines). J 


Giedd KN, Bergmann SR. Myocardial perfusion imaging following 

percutaneous coronary intervention: the importance of 

restenosis, disease progression, and directed reintervention. J Am 

Coll Cardiol 2004;43(3):328-336. 

Kafka H, Leach AJ, Fitzgibbon GM. Exercise echocardiography 

after coronary artery bypass surgery: correlation with coronary 

angiography. J Am Coll Cardiol 1995;25(5):1019-1023. 

Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman 

DS, O’Gara PT, Carabello BA, Russell RO, Jr., Cerqueira MD, St 

John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani 

MS, Williams KA, Antman EM, Smith SC, Jr., Alpert JS, Gregoratos 

G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs 

AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the 

clinical use of cardiac radionuclide imaging--executive summary: 

a report of the American College of Cardiology/American Heart 

Association Task Force on Practice Guidelines (ACC/AHA/ASNC 

Committee to Revise the 1995 Guidelines for the Clinical Use of 

Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42(7):1318- 

1333. 

Labovitz AJ. Exercise echocardiography after coronary angioplasty: 

expanding applications. J Am Coll Cardiol 1990;15(3):600-601. 

Malagutti P, Nieman K, Meijboom WB, van Mieghem CA, Pugliese 

F, Cademartiri F, Mollet NR, Boersma E, de Jaegere PP, de Feyter 

PJ. Use of 64-slice CT in symptomatic patients after coronary 

bypass surgery: evaluation of grafts and coronary arteries. Eur 

Heart J 2007;28(15):1879-1885. 

Manyari DE, Dzavik V. Stress testing after percutaneous coronary 

interventions. Can J Cardiol 2000;16(6):734-738. 

Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly S, Kruger S, Meyer 

J. Exercise echocardiography for the evaluation of patients after 

nonsurgical coronary artery revascularization. J Am Coll Cardiol 

1993;21(5):1087-1093. 

Miller DD, Verani MS. Current status of myocardial perfusion 

imaging after percutaneous transluminal coronary angioplasty. J 


Nedeljkovic I, Ostojic M, Beleslin B, Djordjevic-Dikic A, Stepanovic 

J, Nedeljkovic M, Stojkovic S, Stankovic G, Saponjski J, Petrasinovic 

Z, Giga V, Mitrovic P. Comparison of exercise, dobutamineatropine 

and dipyridamole-atropine stress echocardiography 

in detecting coronary artery disease. Cardiovasc Ultrasound 

2006;4:22. 

Nieman K, Pattynama PM, Rensing BJ, van Geuns RJ, de Feyter 

PJ. Evaluation of patients after coronary artery bypass surgery: 

CT angiographic assessment of grafts and coronary arteries. 

Radiology 2003;229(3):749-756. 

Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, 

Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria


AN. Effect of intensive compared with moderate lipid-lowering 

therapy on progression of coronary atherosclerosis: a randomized 

controlled trial. JAMA 2004;291(9):1071-1080. 

Ostojic M, Picano E, Beleslin B, Dordjevic-Dikic A, Distante A, 

Stepanovic J, Reisenhofer B, Babic R, Stojkovic S, Nedeljkovic M, . 

Dipyridamole-dobutamine echocardiography: a novel test for the 

detection of milder forms of coronary artery disease. J Am Coll 

Cardiol 1994;23(5):1115-1122. 











Cardiol 2009;53(6):530-553. 

Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, 

Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise 

P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig 

KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren 

F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore 

D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte 

D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, 

Reybrouck T, Senden J, Spataro A, Thiene G. Recommendations 

for competitive sports participation in athletes with cardiovascular 

disease: a consensus document from the Study Group of Sports 

Cardiology of the Working Group of Cardiac Rehabilitation and 

Exercise Physiology and the Working Group of Myocardial and 

Pericardial Diseases of the European Society of Cardiology. Eur 

Heart J 2005;26(14):1422-1445. 

Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the 

European Society of Cardiology Consensus Recommendations 

revisited a comparison of U.S. and European criteria for eligibility 

and disqualification of competitive athletes with cardiovascular 

abnormalities. J Am Coll Cardiol 2008;52(24):1990-1996. 

Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart 

F. Silent ischemia after percutaneous transluminal coronary 

angioplasty: incidence and prognostic significance. J Am Coll 

Cardiol 1993;22(5):1446-1454. 

Picano E. Informed consent and communication of risk from 

radiological and nuclear medicine examinations: how to escape 

from a communication inferno. BMJ 2004;329(7470):849-851. 

Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title 

LM, Eisenberg D, Shurzinske L, McCormick LS. Aggressive lipidlowering 

therapy compared with angioplasty in stable coronary 

artery disease. Atorvastatin versus Revascularization Treatment 

Investigators. N Engl J Med 1999;341(2):70-76. 

Rigo F. Coronary flow reserve in stress-echo lab. From 

pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 

2005;3:8. 

Ropers D, Pohle FK, Kuettner A, Pflederer T, Anders K, Daniel 

WG, Bautz W, Baum U, Achenbach S. Diagnostic accuracy of 

noninvasive coronary angiography in patients after bypass surgery 

using 64-slice spiral computed tomography with 330-ms gantry 

rotation. Circulation 2006;114(22):2334-2341. 

Salm LP, Bax JJ, Jukema JW, Schuijf JD, Vliegen HW, Lamb HJ, van 

der Wall EE, de RA. Comprehensive assessment of patients after 

coronary artery bypass grafting by 16-detector-row computed 

tomography. Am Heart J 2005;150(4):775-781. 

Saraste M, Koskenvuo JW, Mikkola J, Pelttari L, Toikka JO, Hartiala JJ. 

Technical achievement: transthoracic Doppler echocardiography 

can be used to detect LAD restenosis after coronary angioplasty. 

Clin Physiol 2000;20(6):428-433. 

Saraste M, Vesalainen RK, Ylitalo A, Saraste A, Koskenvuo JW, 

Toikka JO, Vaittinen MA, Hartiala JJ, Airaksinen KE. Transthoracic 

Doppler echocardiography as a noninvasive tool to assess coronary 

artery stenoses--a comparison with quantitative coronary 

angiography. J Am Soc Echocardiogr 2005;18(6):679-685. 

Senior R, Becher H, Monaghan M, Agati L, Zamorano J, 

Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: 

evidence-based recommendations by European Association of 

Echocardiography. Eur J Echocardiogr 2009;10:194-212. 

Serruys PW, De FP, Macaya C, Kokott N, Puel J, Vrolix M, Branzi 

A, Bertolami MC, Jackson G, Strauss B, Meier B. Fluvastatin 

for prevention of cardiac events following successful first 

percutaneous coronary intervention: a randomized controlled 

trial. JAMA 2002;287(24):3215-3222. 

Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti 

P, Poldermans D, Voigt JU, Zamorano JL. Stress Echocardiography 

Expert Consensus Statement--Executive Summary: European 

Association of Echocardiography (EAE) (a registered branch of 

the ESC). Eur Heart J 2009;30(3):278-289. 

Stauder NI, Kuttner A, Schroder S, Drosch T, Beck T, Stauder H, 

Blumenstock G, Claussen CD, Kopp AF. Coronary artery bypass 

grafts: assessment of graft patency and native coronary artery 

lesions using 16-slice MDCT. Eur Radiol 2006;16(11):2512-2520.


www.escardio.org/guidelines 

© 2010 The European Society of Cardiology 

No part of this document may be translated or reproduced in any 

form without written permission from the ESC. 

The following material was adapted from the Joint ESC-EACTS Guidelines on Myocardial 

Revascularisation (European Heart Journal 2010 - doi:10.1093/eurheartj/ehq277 

& European Journal of Cardio-Thoracic Surgery 2010 - doi:10.1016/j.ejcts.2010.08.019). 

To read the full report as published by the European Society of Cardiology, visit our Web Site at: 

www.escardio.org/guidelines 

copyright © european society of cardiology 2010 - all rights reserved. 

The content of these European Society of Cardiology (ESC) Guidelines has been published for personal 

and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be 

translated or reproduced in any form without written permission from the ESC. Permission can be 

obtained upon submission of a written request to ESC, Practice Guidelines Department, 2035, route 

des Colles - Les Templiers - BP179 - 06903 Sophia Antipolis Cedex - France. 

disclaimer: 

The ESC Guidelines represent the views of the ESC which were arrived at after careful consideration 

of the available evidence at the time they were written. Health professionals are encouraged to take 

them fully into account when exercising their clinical judgment. The guidelines do not, however, 

override the individual responsibility of health professionals to make appropriate decisions in the 

circumstances of the individual patients, in consultation with that patient, and where appropriate 

and necessary the patient’s guardian or carer. It is also the health professional’s responsibility to verify 

the rules and regulations applicable to drugs and devices at the time of prescription.

EUROPEAN SOCIETY OF CARDIOLOGY 

2035, ROUTE DES COLLES 

LES TEMPLIERS - BP 179 

06903 SOPHIA ANTIPOLIS CEDEX - FRANCE 

PHONE: +33 (0)4 92 94 76 00 

FAX: +33 (0)4 92 94 76 01 

E-mail: guidelines@escardio.org 


www.escardio.org/guidelines

Related Materials - European Society of Cardiology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?